=== МЕТАДАННЫЕ ===
{
  "original_filename": "eurheartj_39_21_1883.pdf",
  "converted_date": "2026-01-31T14:48:16.703036",
  "file_size_bytes": 5303974,
  "original_format": "pdf",
  "document_type": "Guidelines",
  "source_folder": "Guidelines",
  "full_path": "00_RAW_CARDIOLOGY/Guidelines/eurheartj_39_21_1883.pdf"
}

=== СОДЕРЖАНИЕ ===

--- Страница 1 ---
ESC GUIDELINES
EuropeanHeartJournal(2018)39,1883–1948
doi:10.1093/eurheartj/ehy037
2018 ESC Guidelines for the diagnosis and
management of syncope
The Task Force for the diagnosis and management of syncope of
the European Society of Cardiology (ESC)
Developed with the special contribution of the European Heart
Rhythm Association (EHRA)
Endorsed by: European Academy of Neurology (EAN), European
Federation of Autonomic Societies (EFAS), European Federation of
Internal Medicine (EFIM), European Union Geriatric Medicine Society
(EUGMS), European Society of Emergency Medicine (EuSEM)
Authors/Task Force Members: Michele Brignole* (Chairperson) (Italy),
Angel Moya* (Co-chairperson) (Spain), Frederik J. de Lange (The Netherlands),
Jean-Claude Deharo (France), Perry M. Elliott (UK), Alessandra Fanciulli (Austria),
Artur Fedorowski (Sweden), Raffaello Furlan (Italy), Rose Anne Kenny (Ireland),
Alfonso Mart(cid:2)ın (Spain), Vincent Probst (France), Matthew J. Reed (UK),
Ciara P. Rice (Ireland), Richard Sutton (Monaco), Andrea Ungar (Italy), and
J. Gert van Dijk (The Netherlands)
*Correspondingauthors:MicheleBrignole,DepartmentofCardiology,OspedaliDelTigullio,ViaDonBobbio25,IT-16033Lavagna,(GE)Italy.Tel:þ390185329567,
Fax:þ390185306506,Email:mbrignole@asl4.liguria.it;AngelMoya,ArrhythmiaUnit,HospitalValld’Hebron,PValld’Hebron119-129,ES-08035Barcelona,Spain.
Tel:þ34932746166,Fax:þ34932746002,Email:amoyamitjans@gmail.com.
ESCCommitteeforPracticeGuidelines(CPG)andNationalCardiacSocietiesdocumentreviewers:listedintheAppendix.
1RepresentingtheEuropeanAcademyofNeurology(EAN)
2RepresentingtheEuropeanFederationofInternalMedicine(EFIM)
3RepresentingtheEuropeanSocietyofEmergencyMedicine(EuSEM)
ESCentitieshavingparticipatedinthedevelopmentofthisdocument:
Associations:EuropeanHeartRhythmAssociation(EHRA)
Councils:CouncilonCardiovascularNursingandAlliedProfessions,CouncilforCardiologyPractice,CouncilonCardiovascularPrimaryCare
WorkingGroups:MyocardialandPericardialDiseases
ThecontentoftheseEuropeanSocietyofCardiology(ESC)Guidelineshasbeenpublishedforpersonalandeducationaluseonly.Nocommercialuseisauthorized.Nopartofthe
ESCGuidelinesmaybetranslatedorreproducedinanyformwithoutwrittenpermissionfromtheESC.PermissioncanbeobtaineduponsubmissionofawrittenrequesttoOxford
UniversityPress,thepublisheroftheEuropeanHeartJournalandthepartyauthorizedtohandlesuchpermissionsonbehalfoftheESC(journals.permissions@oxfordjournals.org).
Disclaimer.TheESCGuidelinesrepresenttheviewsoftheESCandwereproducedaftercarefulconsiderationofthescientificandmedicalknowledgeandtheevidenceavailable
atthetimeoftheirpublication.TheESCisnotresponsibleintheeventofanycontradiction,discrepancyand/orambiguitybetweentheESCGuidelinesandanyotherofficialrecom-
mendationsorguidelinesissuedbytherelevantpublichealthauthorities,inparticularinrelationtogooduseofhealthcareortherapeuticstrategies.Healthprofessionalsareencour-
agedtotaketheESCGuidelinesfullyintoaccountwhenexercisingtheirclinicaljudgment,aswellasinthedeterminationandtheimplementationofpreventive,diagnosticor
therapeuticmedicalstrategies;however,theESCGuidelinesdonotoverride,inanywaywhatsoever,theindividualresponsibilityofhealthprofessionalstomakeappropriateand
accuratedecisionsinconsiderationofeachpatient’shealthconditionandinconsultationwiththatpatientand,whereappropriateand/ornecessary,thepatient’scaregiver.Nordo
theESCGuidelinesexempthealthprofessionalsfromtakingintofullandcarefulconsiderationtherelevantofficialupdatedrecommendationsorguidelinesissuedbythecompetent
publichealthauthorities,inordertomanageeachpatient’scaseinlightofthescientificallyaccepteddatapursuanttotheirrespectiveethicalandprofessionalobligations.Itisalsothe
healthprofessional’sresponsibilitytoverifytheapplicablerulesandregulationsrelatingtodrugsandmedicaldevicesatthetimeofprescription.
VC TheEuropeanSocietyofCardiology2018.Allrightsreserved.Forpermissionspleaseemail:journals.permissions@oxfordjournals.org
Downloaded
from
https://academic.oup.com/eurheartj/article/39/21/1883/4939241
by
guest
on
22
January
2026
--- Страница 2 ---
1884 ESCGuidelines
DocumentReviewers:AdamTorbicki(CPGReviewCoordinator)(Poland),JavierMoreno(CPGReview
Coordinator)(Spain),VictorAboyans(France),StefanAgewall(Norway),RiccardoAsteggiano(Italy),
Jean-JacquesBlanc(France),NatanBornstein1(Israel),SergeBoveda(France),He´ctorBueno(Spain),
HaranBurri(Switzerland),AntonioCoca(Spain),Jean-PhilippeCollet(France),GiorgioCostantino2
(Italy),ErnestoD(cid:2)ıaz-Infante(Spain),VictoriaDelgado(TheNetherlands),FaasDolmans
(TheNetherlands),OliverGaemperli(Switzerland),JacekGajek(Poland),GerhardHindricks(Germany),
JosefKautzner(CzechReplublic),JuhaniKnuuti(Finland),PiotrKulakowski(Poland),
EkateriniLambrinou(Cyprus),ChristopheLeclercq(France),PhilippeMabo(France),CarlosA.Morillo
(Canada),MassimoFrancescoPiepoli(Italy),MarcoRoffi(Switzerland),WinK.Shen(USA),
IainA.Simpson(UK),MartinStockburger(Germany),PeterVanbrabant3(Belgium),
StephanWindecker(Switzerland),andJoseLuisZamorano(Spain)
ThedisclosureformsofallexpertsinvolvedinthedevelopmentoftheseGuidelinesareavailableonthe
ESCwebsitehttp://www.escardio.org/guidelines.
FortheSupplementaryDatawhichincludebackgroundinformationanddetaileddiscussionofthedata
thathaveprovidedthebasisfortheGuidelinesseehttps://academic.oup.com/eurheartj/article-lookup/doi/
10.1093/eurheartj/ehy037#supplementary-data
ClickheretoaccessthecorrespondingchapterinESCCardioMed-Section39Syncope
Onlinepublish-ahead-of-print19March2018
...................................................................................................................................................................................................
Keywords Guidelines (cid:129) Syncope (cid:129) Transientlossofconsciousness (cid:129) Vasovagalsyncope (cid:129) Reflex
syncope (cid:129) Orthostatichypotension (cid:129) Cardiacsyncope (cid:129) Suddencardiacdeath (cid:129) Electrophysiological
study (cid:129) ProlongedECGmonitoring (cid:129) Tilttesting (cid:129) Carotidsinusmassage (cid:129) Cardiacpacing (cid:129) Implantable
cardioverterdefibrillator (cid:129) Syncopeunit (cid:129) Emergencydepartment
.
Table of Contents .. 4.2.4Electrocardiographicmonitoring(non-invasive
.
.. andinvasive) .............................................. 1905
.
1.Preamble...................................................... 1886 .. 4.2.4.1In-hospitalmonitoring ......................... 1905
.
2.Introduction................................................... 1887 .. 4.2.4.2Holtermonitoring............................. 1905
.
2.1Whatisnewinthe2018version?........................... 1889 .. 4.2.4.3Prospectiveexternaleventrecorders........... 1905
.
3.Definitions,classification,andpathophysiology.................. 1889 .. 4.2.4.4Smartphoneapplications....................... 1906
.
3.1Definitions................................................. 1889 .. 4.2.4.5Externallooprecorders........................ 1906
.
3.2Classificationandpathophysiologyofsyncopeandtransient .. 4.2.4.6Remote(athome)telemetry................... 1906
.
.
lossofconsciousness.......................................... 1890 . 4.2.4.7Implantablelooprecorders.................... 1906
. .
3.2.1Syncope.............................................. 1890 . 4.2.4.8Diagnosticcriteria............................. 1906
.
.
3.2.2Non-syncopalformsof(realorapparent)transient . 4.2.5Videorecordinginsuspectedsyncope................. 1907
.
.
lossofconsciousness....................................... 1890 . 4.2.5.1In-hospitalvideorecording..................... 1907 .
.
4.Diagnosticevaluationandmanagementaccordingto . 4.2.5.2Homevideorecording......................... 1908 .
.
riskstratification ................................................. 1892 . 4.2.6Electrophysiologicalstudy............................. 1908 .
.
4.1Initialevaluation............................................ 1892 .. 4.2.6.1Asymptomaticsinusbradycardia–suspected
.
4.1.1Diagnosisofsyncope.................................. 1893 .. sinusarrestcausingsyncope ........................... 1908
.
4.1.2Managementofsyncopeintheemergencydepartment .. 4.2.6.2Syncopeinbifascicularbundlebranchblock
.
basedonriskstratification.................................. 1895 .. (impendinghigh-degreeatrioventricularblock)......... 1908
.
4.2Diagnostictests............................................ 1900 .. 4.2.6.3Suspectedtachycardia.......................... 1908
.
4.2.1Carotidsinusmassage................................. 1900 .. 4.2.7Endogenousadenosineandotherbiomarkers.......... 1909
.
4.2.2Orthostaticchallenge................................. 1901 .. 4.2.7.1Adenosine(triphosphate)testandplasma
.
4.2.2.1Activestanding................................ 1901 .. concentration......................................... 1909
.
4.2.2.2Tilttesting..................................... 1903 .. 4.2.7.2Cardiovascularbiomarkers...................... 1910
.
4.2.3Basicautonomicfunctiontests......................... 1904 .. 4.2.7.3Immunologicalbiomarkers...................... 1910
.
4.2.3.1Valsalvamanoeuvre............................ 1904 .. 4.2.8Echocardiography .................................... 1910
.
4.2.3.2Deepbreathing................................ 1904 .. 4.2.8.1Exercisestressechocardiography............... 1910
.
4.2.3.3Otherautonomicfunctiontests................ 1904 .. 4.2.9Exercisestresstesting................................. 1911
.
4.2.3.4Twenty-four-hourambulatoryandhome .. 4.2.10Coronaryangiography................................ 1911
.
bloodpressuremonitoring............................ 1904 .. 5.Treatment..................................................... 1911
.
Downloaded
from
https://academic.oup.com/eurheartj/article/39/21/1883/4939241
by
guest
on
22
January
2026
--- Страница 3 ---
ESCGuidelines 1885
.
5.1Generalprinciplesoftreatmentofsyncope.................. 1911 .. 5.6.5.1LongQTsyndrome............................. 1926
.
5.2Treatmentofreflexsyncope................................ 1911 .. 5.6.5.2Brugadasyndrome.............................. 1926
.
5.2.1Educationandlifestylemodifications................... 1912 .. 5.6.5.3Otherforms ................................... 1927
.
5.2.2Discontinuation/reductionofhypotensivetherapy ..... 1913 .. 6.Specialissues.................................................. 1927
.
5.2.3Physicalcounter-pressuremanoeuvres................ 1914 .. 6.1Syncopeinpatientswithcomorbidityandfrailty............. 1927
.
.
5.2.4Tilttraining........................................... 1914 . 6.1.1Comorbidityandpolypharmacy....................... 1927
.
.
5.2.5Pharmacologicaltherapy.............................. 1914 . 6.1.2Falls.................................................. 1928
.
.
5.2.5.1Fludrocortisone................................ 1914 . 6.1.3Cognitiveassessmentandphysicalperformancetests... 1928
.
.
5.2.5.2Alpha-agonists.................................. 1914 . 6.2Syncopeinpaediatricpatients............................... 1929
.
.
5.2.5.3Beta-blockers.................................. 1915 . 6.2.1Diagnosticevaluation................................. 1929
.
.
5.2.5.4Otherdrugs.................................... 1915 . 6.2.2Therapy.............................................. 1929
.
.
5.2.5.5Emergingnewtherapiesinspecificsubgroups.... 1915 . 7.Psychogenictransientlossofconsciousnessanditsevaluation.... 1929
.
.
5.2.6Cardiacpacing........................................ 1915 . 7.1Diagnosis.................................................. 1929
.
.
5.2.6.1Evidencefromtrialsinsuspectedor . 7.1.1Historicalcriteriaforattacks........................... 1929
.
.
certainreflexsyncopeandelectrocardiogram- . 7.1.2Documentationofkeyfeaturesduringanattack........ 1929
.
.
documentedasystole.................................. 1915 . 7.1.2.1Managementofpsychogenicpseudosyncope.... 1930
.
.
5.2.6.2Evidencefromtrialsinpatientswithcarotid .. 8.Neurologicalcausesandmimicsofsyncope..................... 1930
.
sinussyndrome........................................ 1915 .. 8.1Clinicalconditions.......................................... 1930
.
5.2.6.3Evidencefromtrialsinpatientswithtilt-induced .. 8.1.1Autonomicfailure .................................... 1930
.
vasovagalsyncope..................................... 1916 .. 8.1.2Epilepsyandictalasystole............................. 1930
.
5.2.6.4Evidencefromtrialsinpatientswith .. 8.1.3Cerebrovasculardisorders............................ 1930
.
adenosine-sensitivesyncope........................... 1917 .. 8.1.4Migraine.............................................. 1931
.
5.2.6.5Choiceofpacingmode......................... 1917 .. 8.1.5Cataplexy............................................ 1932
.
5.2.6.6Selectionofpatientsforpacingand .. 8.1.6Dropattacks......................................... 1932
.
proposedalgorithm................................... 1917 .. 8.2Neurologicaltests.......................................... 1932
.
5.3Treatmentoforthostatichypotensionandorthostaticintolerance .. 8.2.1Electroencephalography.............................. 1932
.
syndromes.................................................... 1919 .. 8.2.2Braincomputedtomographyandmagnetic
.
.
5.3.1Educationandlifestylemeasures....................... 1919 . resonanceimaging......................................... 1932
.
.
5.3.2Adequatehydrationandsaltintake.................... 1919 . 8.2.3Neurovascularstudies................................ 1932
.
.
5.3.3Discontinuation/reductionofvasoactivedrugs......... 1919 . 8.2.4Bloodtests........................................... 1932
.
.
5.3.4Counter-pressuremanoeuvres........................ 1920 . 9.Organizationalaspects......................................... 1932
.
.
5.3.5Abdominalbindersand/orsupportstockings........... 1920 . 9.1Syncope(transientlossofconsciousness)managementunit.. 1932
.
.
5.3.6Head-uptiltsleeping.................................. 1920 . 9.1.1Definitionofasyncopeunit........................... 1933
.
.
5.3.7Midodrine............................................ 1920 . 9.1.2Definitionofsyncopespecialist........................ 1934
.
.
5.3.8Fludrocortisone...................................... 1920 . 9.1.3Goalofasyncopeunit................................ 1934
.
.
5.3.9Additionaltherapies .................................. 1920 . 9.1.4Modelofasyncopeunit............................... 1934
.
.
5.3.10Emergingnewpharmacologicaltherapyinspecific . 9.1.5Accessandreferralstoasyncopeunit................. 1935
.
.
subgroups................................................. 1920 . 9.1.6Outcomesandqualityindicators ...................... 1935
.
.
5.4Cardiacarrhythmiasastheprimarycause ................... 1921 .. 9.2Theclinicalnursespecialistinthesyncopeunit............... 1935
. 5.4.1Syncopeduetointrinsicsinoatrialoratrioventricular .. 9.2.1Definition............................................ 1935
.
conductionsystemdisease................................. 1921 .. 9.2.2Roleandskillsoftheclinicalnursespecialist............ 1935
.
5.4.1.1Sinusnodedisease.............................. 1921 .. 10.Keymessages................................................. 1936
.
5.4.1.2Atrioventricularconductionsystemdisease...... 1921 .. 11.Gapsinevidenceandareasforfutureresearch................. 1937
.
5.4.1.3Bundlebranchblockandunexplainedsyncope... 1922 .. 12.‘Whattodo’and‘whatnottodo’messagesfromthe
.
5.4.2Syncopeduetointrinsiccardiactachyarrhythmias...... 1922 .. Guidelines....................................................... 1938
.
5.4.2.1Paroxysmalsupraventriculartachycardia......... 1923 .. 13.SupplementaryDataandWebPracticalInstructions............ 1940
.
5.4.2.2Paroxysmalventriculartachycardia.............. 1923 .. 14.Appendix .................................................... 1940
.
5.5Treatmentofsyncopesecondarytostructuralcardiac, .. 15.References................................................... 1941
.
cardiopulmonary,andgreatvesseldisease...................... 1925 ..
.
.
5.6Treatmentofunexplainedsyncopeinpatientsathighriskof .
.
suddencardiacdeath.......................................... 1925 .. Abbreviations and acronyms
.
.
5.6.1Definition............................................ 1925 .
.
.
5.6.2Leftventricularsystolicdysfunction.................... 1925 . ABPM Ambulatorybloodpressuremonitoring
.
.
5.6.3Hypertrophiccardiomyopathy........................ 1926 . AF Atrialfibrillation
.
.
5.6.4Arrhythmogenicrightventricularcardiomyopathy...... 1926 . ARVC Arrhythmogenicrightventricularcardiomyopathy
.
.
5.6.5Patientswithinheritablearrhythmogenicdisorders..... 1926 . ATP Adenosinetriphosphate
Downloaded
from
https://academic.oup.com/eurheartj/article/39/21/1883/4939241
by
guest
on
22
January
2026
--- Страница 4 ---
1886 ESCGuidelines
.
AV Atrioventricular .. VF Ventricularfibrillation
.
AVID AntiarrhythmicsversusImplantable .. VT Ventriculartachycardia
.
Defibrillatorstrial .. VVS Vasovagalsyncope
.
BBB Bundlebranchblock ..
.
BNP B-typenatriureticpeptide ..
.
BP Bloodpressure .. 1. Preamble
.
.
b.p.m. Beatsperminute .
.
CI Confidenceinterval .. Guidelinessummarizeandevaluateavailableevidencewiththeaimof
.
CI-CSS Cardioinhibitorycarotidsinussyndrome .. assisting health professionals in selecting the best management strat-
.
CPG CommitteeforPracticeGuidelines .. egies for an individual patient with a given condition. Guidelines and
.
CRT-D Cardiacresynchronizationtherapydefibrillator .. theirrecommendationsshouldfacilitatedecisionmakingofhealthpro-
.
CSM Carotidsinusmassage .. fessionalsintheirdailypractice.However,thefinaldecisionsconcerning
. CSS Carotidsinussyndrome .. anindividualpatientmustbemadebytheresponsiblehealthprofes-
.
DCM Dilatedcardiomyopathy .. sional(s)inconsultationwiththepatientandcaregiverasappropriate.
.
DDD-PM Dualchamberpacemaker .. Agreatnumberofguidelineshavebeenissuedinrecentyearsby
.
ECG Electrocardiogram/electrocardiographic .. theEuropeanSocietyofCardiology(ESC),aswellasbyothersoci-
. .
ED Emergencydepartment .. eties and organisations. Because of the impact on clinical practice,
.
EEG Electroencephalogram .. quality criteria for the development ofguidelines have been estab-
.
EFAS EuropeanFederationofAutonomicSocieties .. lishedinordertomakealldecisionstransparenttotheuser.Therec-
.
EFIM EuropeanFederationofInternalMedicine .. ommendations for formulating and issuing ESC Guidelines can be
.
EHRA EuropeanHeartRhythmAssociation .. found on the ESC website (http://www.escardio.org/Guidelines-&-
.
ENS EuropeanNeurologicalSociety .. Education/Clinical-Practice-Guidelines/Guidelines-development/Writ
.
EPS Electrophysiologicalstudy .. ing-ESC-Guidelines).ESCGuidelinesrepresenttheofficialpositionof
.
ESC EuropeanSocietyofCardiology .. theESConagiventopicandareregularlyupdated.
.
EUGMS EuropeanUnionGeriatricMedicineSociety .. MembersofthisTaskForcewereselectedbytheESC,including
.
EuSEM EuropeanSocietyofEmergencyMedicine .. representationfromitsrelevantESCsub-specialtygroups,inorder
.
HBPM Homebloodpressuremonitoring .. torepresentprofessionalsinvolvedwiththemedicalcareofpatients
.
HCM Hypertrophiccardiomyopathy .. withthispathology.Selectedexpertsinthefieldundertookacom-
.
HR Heartrate .. prehensive review of the published evidence for management of a
.
ICD Implantablecardioverterdefibrillator .. givenconditionaccordingtoESCCommitteeforPracticeGuidelines
.
ILR Implantablelooprecorder .. (CPG)policy.Acriticalevaluationofdiagnosticandtherapeuticpro-
.
ISSUE InternationalStudyonSyncopeofUnknownEtiology .. cedures was performed, including assessment of the risk–benefit
.
L-DOPA L-3,4-dihydroxyphenylalanine .. ratio.Thelevelofevidenceandthestrengthoftherecommendation
.
LOC Lossofconsciousness .. ofparticularmanagementoptionswereweighedandgradedaccord-
.
LQTS LongQTsyndrome .. ingtopredefinedscales,asoutlinedinTables1and2.
.
LVEF Leftventricularejectionfraction .. Theexpertsofthewritingandreviewingpanelsprovideddeclar-
.
MRI Magneticresonanceimaging .. ationofinterestformsforallrelationshipsthatmightbeperceivedas
.
NYHA NewYorkHeartAssociation .. realorpotentialsourcesofconflictsofinterest.Theseformswere
.
.
OH Orthostatichypotension .. compiledintoonefileandcanbefoundontheESCwebsite(http://
.
PC-Trial PhysicalCounterpressureManoeuvresTrial .. www.escardio.org/guidelines).Anychangesindeclarationsofinterest
.
PCM Physicalcounter-pressuremanoeuvres .. that arise during the writing period were notified to the ESC and
.
PNES Psychogenicnon-epilepticseizures .. updated. The Task Force received its entire financial support from
.
POST PreventionofSyncopeTrial .. theESCwithoutanyinvolvementfromthehealthcareindustry.
.
POTS Posturalorthostatictachycardiasyndrome .. TheESCCPGsupervisesandcoordinatesthepreparationofnew
.
PPS Psychogenicpseudosyncope .. Guidelines.TheCommitteeisalsoresponsiblefortheendorsement
.
RCT Randomizedcontrolledtrial .. processoftheseGuidelines.TheESCGuidelinesundergoextensive
.
SCD Suddencardiacdeath .. reviewbytheCPGandexternalexperts.Afterappropriaterevisions
.
SNRT Sinusnoderecoverytime .. theGuidelinesareapprovedbyalltheexpertsinvolvedintheTask
.
SU Syncopeunit .. Force.ThefinalizeddocumentisapprovedbytheCPGforpublica-
.
SUP SyncopeUnitProject .. tion in theEuropean HeartJournal. TheGuidelines weredeveloped
.
SVT Supraventriculartachycardia .. after careful consideration of the scientific and medical knowledge
.
TIA Transientischaemicattack .. andtheevidenceavailableatthetimeoftheirdating.
.
t.i.d. Terindie(threetimesdaily) .. ThetaskofdevelopingESCGuidelinesalsoincludesthecreationof
.
TLOC Transientlossofconsciousness .. educationaltoolsandimplementationprogrammesfortherecommen-
.
TNG Trinitroglycerin .. dationsincludingcondensedpocketguidelineversions,summaryslides,
.
VA Ventriculararrhythmia .. booklets with essential messages, summary cards for non-specialists
.
. and anelectronicversionfordigitalapplications (smartphones,etc.).
Downloaded
from
https://academic.oup.com/eurheartj/article/39/21/1883/4939241
by
guest
on
22
January
2026
--- Страница 5 ---
ESCGuidelines 1887
Table1 Classesofrecommendations
Table2 Levelsofevidence
. These versions are abridged and thus, if needed, one should always .. patientorthepatient’scaregiverwhereappropriateand/ornecessary.It
. .
refertothefull-textversion,whichisfreelyavailableviatheESCweb- . is also the health professional’s responsibility to verify the rules and
. .
siteandhostedontheEHJwebsite.TheNationalSocietiesoftheESC . regulationsapplicabletodrugsanddevicesatthetimeofprescription.
.
.
are encouraged to endorse, translate and implement all ESC .
.
.
Guidelines. Implementation programmes are needed because it has .
.
.
beenshownthattheoutcomeofdiseasemaybefavourablyinfluenced . 2. Introduction
.
.
bythethoroughapplicationofclinicalrecommendations. .
.
.
Surveysandregistriesareneededtoverifythatreal-lifedailyprac- . ThefirstESCGuidelinesforthemanagementofsyncopewerepub-
.
.
ticeisinkeepingwithwhatisrecommendedintheguidelines,thus . lishedin2001,withsubsequentversionsin2004and2009.InMarch
.
.
completingtheloopbetweenclinicalresearch,writingofguidelines, . 2015,theESCCPGconsideredthattherewereenoughnewdatato
.
.
disseminatingthemandimplementingthemintoclinicalpractice. .. justifytheproductionofnewGuidelines.
.
HealthprofessionalsareencouragedtotaketheESCGuidelinesfully .. The most important aspect characterizing this document is the
.
intoaccountwhenexercisingtheirclinicaljudgment,aswellasinthede- .. composition of the Task Force, which is truly multidisciplinary.
.
terminationandtheimplementationofpreventive,diagnostic,orthera- .. Cardiologists form a minority of the panel; experts in emergency
.
peutic medical strategies. However, the ESC Guidelines do not .. medicine, internal medicine and physiology, neurology and auto-
.
overrideinanywaywhatsoevertheindividualresponsibilityofhealth .. nomic diseases, geriatric medicine, and nursing cover all aspects of
.
professionalstomakeappropriateandaccuratedecisionsinconsider- .. managementofthe various forms ofsyncope and transientloss of
.
ation of each patient’s health condition and in consultation with that . consciousness(TLOC).
Downloaded
from
https://academic.oup.com/eurheartj/article/39/21/1883/4939241
by
guest
on
22
January
2026
--- Страница 6 ---
1888 ESCGuidelines
.
Compared with the previous versions of these Guidelines, the .. Thedocumentaimstobepatient-orientatedandfocusedonther-
.
.
2018 document contains Supplementary Data as an integral part. . apy, and to reduce the risk of recurrence and the life-threatening
.
.
Whiletheprinttextmainlyaimstogiveformalevidence-basedrec- . consequencesofsyncoperecurrence.Forthispurpose,eveninthe
.
.
ommendationsaccordingtothestandardizedrulesoftheESC,this . absence of strong evidence from trials, we give as much advice as
.
.
newweb-onlyfeatureallowsexpansionofthecontenttopractical . possibleonthemostappropriatetherapybasedonthepracticalex-
.
.
issues,andaimstofillthegapbetweenthebestavailablescientificevi- . pertiseofthemembersoftheTaskForce(‘Ourpatientsseeksolutions,
.
.
denceandtheneedfordisseminationoftheseconceptsintoclinical . not only explanations’). When possible, we provide therapeutic and
.
.
practice(‘Wehavetheknowledge,weneedtoteachit’).Thankstothe . decision-makingalgorithms.
.
.
SupplementaryDatafurtherexplanationonspecificpointsisgiven, . Finally,werecognizethatonemajorchallengeinsyncopemanage-
.
.
andthankstotheWebPracticalInstructionsadviceisgivenonhow . mentisthereductionofinappropriateadmissionsandinappropriate
.
.
toevaluatepatientswithlossofconsciousness(LOC),andhowto . useoftestswhilemaintainingthesafetyofthepatient.Wegivestrong
.
.
performandinterprettestsproperly;wheneverpossible,weprovide . focustopathwaysandorganizationalissues(‘Wehavetheknowledge;
.
. tracings,videos,flowcharts,andchecklists. . weneedtoapplyit’).Inparticular,weproposeacarepathwayforthe
Figure1 Whatisnewinthe2018syncopeGuidelines?AA=antiarrhythmic;AF=atrialfibrillation;ARVC=arrhythmogenicrightventricularcar-
diomyopathy;CSM=carotidsinusmassage;ECG=electrocardiogram;ED=emergencydepartment;LVEF=leftventricularejectionfraction;EPS=
electrophysiologicalstudy;HCM=hypertrophiccardiomyopathy;ICD=implantablecardioverterdefibrillator;ILR=implantablelooprecorder;
OH=orthostatichypotension;PCM=physicalcounter-pressuremanoeuvres;POTS=posturalorthostatictachycardiasyndrome;PPS=psycho-
genicpseudosyncope;SNRT=sinusnoderecoverytime;SU=syncopeunit;SVT=supraventriculartachycardia;VT=ventriculartachycardia.
Downloaded
from
https://academic.oup.com/eurheartj/article/39/21/1883/4939241
by
guest
on
22
January
2026
--- Страница 7 ---
ESCGuidelines 1889
Centralillustration New/revisedconceptsinthemanagementofsyncope.ECG=electrocardiogram;ED=emergencydepartment;ICD=
implantablecardioverterdefibrillator;SCD=suddencardiacdeath.
.
managementofpatientswithTLOCfromtheirarrivalintheemer- .. • TLOC isdefinedasastate ofrealor apparentLOC withlossof
.
gencydepartment(ED),andgivepracticalinstructionsonhowtoset .. awareness, characterized by amnesia for the period of uncon-
. upoutpatientsyncopeclinics(syncopeunits)aimedatreducinghos- .. sciousness,abnormal motor control,loss of responsiveness, and
.
. ashortduration.
pitalization,under-andmisdiagnoses,andcosts. .
.
.
. . ThetwomaingroupsofTLOCare‘TLOCduetoheadtrauma’
.
2.1 What is new in the 2018 version? .. and ‘non-traumatic TLOC’ (Figure 2). Traumatic TLOC will not be
.
. The changes in recommendations made in the 2018 version com- .. consideredfurtherinthisdocument,soTLOCwillbeusedtomean
.
pared with the 2009 version, the new recommendations, and the .. non-traumaticTLOC.
.
mostimportantnew/revisedconceptsaresummarizedinFigure1. .. TheclinicalfeaturescharacterizingTLOCareusuallyderivedfromhis-
.
. torytakingfrompatientsandeyewitnesses.Specificcharacteristicsthat
.
.
. aiddiagnosisareoutlinedinsection3oftheWebPracticalInstructions.
.
.
3. Definitions, classification, and .. TLOCgroupsaredefinedusingpathophysiology:thequalifyingcri-
.
.. terionforsyncopeiscerebralhypoperfusion;forepilepticseizures,it
pathophysiology .
.. isabnormalexcessivebrainactivity;andforpsychogenicTLOCitis
.
.. thepsychologicalprocessofconversion.Thesyncopedefinitionrests
3.1 Definitions .
.. onpathophysiologybecausenosetofclinicalfeaturesencompasses
.
• SyncopeisdefinedasTLOCduetocerebralhypoperfusion,char- .. all forms of syncope while also excluding all epileptic seizures and
acterizedbyarapidonset,shortduration,andspontaneouscom- ...
psychogenicTLOCevents.
pleterecovery. ..
.
. • The adjective presyncope is used to indicate symptoms and signs
.
Syncope shares many clinical features with other disorders; it .. that occur before unconsciousness in syncope. Note that the
.
thereforepresentsinmanydifferentialdiagnoses.Thisgroupofdis- .. nounpresyncopeisoftenusedtodescribeastatethatresembles
.
ordersislabelledTLOC. . theprodromeofsyncope,butwhichisnotfollowedbyLOC.
Downloaded
from
https://academic.oup.com/eurheartj/article/39/21/1883/4939241
by
guest
on
22
January
2026
--- Страница 8 ---
1890 ESCGuidelines
Generalized: Psychogenic
- Tonic pseudosyncope (PPS)
- Clonic Psychogenic non-epileptic
- Tonic-clonic seizures (PNES)
- Atonic
Figure2 Syncopeinthecontextoftransientlossofconsciousness.Non-traumatictransientlossofconsciousnessisclassifiedintooneoffour
groupings:syncope,epilepticseizures,psychogenictransientlossofconsciousness,andamiscellaneousgroupofrarecauses.Thisorderrepresents
theirrateofoccurrence.Combinationsoccur;e.g.non-traumatictransientlossofconsciousnesscausescancausefallswithconcussion,inwhichcase
transientlossofconsciousnessisbothtraumaticandnon-traumatic.TIA=transientischaemicattack;TLOC=transientlossofconsciousness.
.
.
Avarietyoftermsareusedthatgenerallydonotmatchthedefinitions . ‘vasodepressive type’ of reflex syncope, seen in the outer ring in
.
.
inthisdocumentcloselyenoughtobeusedassynonymsofthedefined . Figure3.Thesecondisafunctionalimpairment,andthethirdastruc-
.
.
terms. For example, a ‘faint’ approximately conforms to syncope but . tural impairment of the autonomic nervous system, with drug-
.
.
emphasizesvasovagalsyncope(VVS)overotherforms.Aglossaryofun- . induced,primary,andsecondaryautonomicfailureintheouterring.
.
.
certaintermsisshowninsection1oftheWebPracticalInstructions. . Inautonomicfailure,thereisinsufficientsympatheticvasoconstriction
.
.
3.2 Classification and pathophysiologyof
... inresponsetotheuprightposition.
.. Therearefourprimarycausesoflowcardiacoutput.Thefirstis
syncope and transient loss of ...
a reflex bradycardia, known as cardioinhibitory reflex syncope.
.
consciousness .. The second concerns cardiovascular causes: arrhythmia, struc-
.
3.2.1Syncope .. tural disease including pulmonary embolism, and pulmonary
.
Table 3 provides a classification ofthe principal causes ofsyncope, .. hypertension. The third is inadequate venous return due to vol-
. emphasizing groups of disorders with common pathophysiology, .. ume depletion or venous pooling. Finally, chronotropic and ino-
. presentation,andrisk.Clinicalfeatures,epidemiology,prognosis,im- .. tropic incompetence through autonomic failure may impair
. pactonqualityoflife,andeconomicissuesareshowninsection2of .. cardiacoutput.
.
theWebPracticalInstructions. .. Note that these primary mechanisms may interact in different
.
Thepathophysiological classificationcentresona fall insystemic .. ways:firstly,venouspoolingandinadequatevenousreturnisalsoa
.
bloodpressure(BP)withadecreaseinglobalcerebralbloodflowas .. factor that can trigger an inappropriate reflex in orthostatic reflex
.
.
thedefiningcharacteristicofsyncope.Figure3showslowBPandglo- . syncope;secondly,alowtotalperipheralresistancemaycauseven-
.
.
balcerebralhypoperfusionasthecentralfinalcommonpathwayof . ouspoolingofbloodbelowthediaphragm,inturndecreasingvenous
.
.
syncope.Asuddencessationofcerebralbloodflowforasshortas . returnandconsequentlycardiacoutput.
.
.
6–8 s can causecompleteLOC.A systolic BP of50–60mmHg at . Thethreemaingroupsofsyncope,i.e.reflex,cardiovascular,and
.
.
heartlevel,i.e.30–45mmHgatbrainlevelintheuprightposition,will .. secondarytoorthostatichypotension(OH),areshownoutsidethe
.
causeLOC.8,9 .. rings in Figure 3. Both reflex syncope and OH span the two main
.
SystemicBPistheproductofcardiacoutputandtotalperipheral .. pathophysiologicalmechanisms.
.
resistance;afallineithercancausesyncope.However,insyncope, ..
.
bothmechanismsoftenacttogethertoavaryingdegree. .. 3.2.2Non-syncopalformsof(realorapparent)transient
.
There are three primary causes of a low total peripheral resist- .. lossofconsciousness
.
ance. The first is decreased reflex activity causing vasodilatation .. Onlythoseformsofepilepsyinwhichnormalmotorcontrolislost,
.
through withdrawal of sympathetic vasoconstriction: this is the . sopatientsmayfall,areincludedinFigure2.Thesearetonic,clonic,
Downloaded
from
https://academic.oup.com/eurheartj/article/39/21/1883/4939241
by
guest
on
22
January
2026
--- Страница 9 ---
ESCGuidelines 1891
Table3 Classificationofsyncope
Reflex(neurallymediated)syncope
Vasovagal:
-orthostaticVVS:standing,lesscommonsitting
-emotional:fear,pain(somaticorvisceral),instrumentation,bloodphobia
Situational:
-micturition
-gastrointestinalstimulation(swallow,defaecation)
-cough,sneeze
-post-exercise
-others(e.g.laughing,brassinstrumentplaying)
Carotidsinussyndrome
Non-classicalforms(withoutprodromesand/orwithoutapparenttriggersand/oratypicalpresentation)
SyncopeduetoOH
Notethathypotensionmaybeexacerbatedbyvenouspoolingduringexercise(exercise-induced),aftermeals(postprandialhypotension),andafterprolonged
bedrest
(deconditioning).
Drug-inducedOH(mostcommoncauseofOH):
-e.g.vasodilators,diuretics,phenothiazine,antidepressants
Volumedepletion:
-haemorrhage,diarrhoea,vomiting,etc.
Primaryautonomicfailure(neurogenicOH):
-pureautonomicfailure,multiplesystematrophy,Parkinson’sdisease,dementiawithLewybodies
Secondaryautonomicfailure(neurogenicOH):
-diabetes,amyloidosis,spinalcordinjuries,auto-immuneautonomicneuropathy,paraneoplasticautonomicneuropathy,kidneyfailure
Cardiacsyncope
Arrhythmiaasprimarycause:
Bradycardia:
-sinusnodedysfunction(includingbradycardia/tachycardiasyndrome)
-atrioventricularconductionsystemdisease
Tachycardia:
-supraventricular
-ventricular
Structuralcardiac:aorticstenosis,acutemyocardialinfarction/ischaemia,hypertrophiccardiomyopathy,cardiacmasses(atrialmyxoma,tumours,
etc.),pericardialdisease/tamponade,congenitalanomaliesofcoronaryarteries,prostheticvalvedysfunction
Cardiopulmonaryandgreatvessels:pulmonaryembolus,acuteaorticdissection,pulmonaryhypertension
Remarks
• Allformsofsyncope,butmostlyreflexsyncopeandOH,aremorelikelytooccuroraremoreseverewhenvariousfactorsarepresent:medica-
tioncausinglowBP(duetovasodilatationorhypovolaemia),alcoholuse,volumedepletion(haemorrhage,lowfluidintake,diarrhoea,vomiting),
pulmonarydiseasescausingreductioninbrainoxygensupply,environmentalfactors(thermalstress).
• Therearetwomainpathophysiologicalmechanismsinreflexsyncope.“Vasodepression”referstoconditionsinwhichinsufficientsympathetic
vasoconstrictionresultsinhypotension.1,2“Cardioinhibition”isusedwhenbradycardiaorasystolepredominates,reflectingashifttowardspara-
sympatheticpredominance.Thehaemodynamicpattern,i.e.cardioinhibitory,vasodepressive,orboth,isindependentofthetriggerevokingreflex
syncope.Forexample,micturitionsyncopeandorthostaticVVSmayequallywellpresentascardioinhibitoryorasvasodepressorsyncope
• Thenon-classicalformofreflexsyncopeinvolvesaheterogeneousgroupofpatients.Thetermisusedtodescribereflexsyncopethatoccurs
withuncertainorapparentlyabsenttriggersand/oratypicalpresentation.Thediagnosisofreflexsyncopeisprobablewhenothercausesofsyn-
copeareexcluded(absenceofstructuralheartdisease)and/orsymptomsarereproducedinthetilttest.3Atpresent,thisgroupalsocontains
syncopeassociatedwithlowadenosineplasmalevels4,5
• ThecardiovascularcausesoforthostaticintoleranceincludeclassicalOH,initialOH,delayedOH,POTS,andVVS,whichinthiscontextcanbe
calledorthostaticVVS.6,7SyndromesoforthostaticintolerancethatmaycausesyncopearepresentedinWebPracticalInstructionsection2.
BP=bloodpressure;OH=orthostatichypotension;POTS=posturalorthostatictachycardiasyndrome;VVS=vasovagalsyncope.
Downloaded
from
https://academic.oup.com/eurheartj/article/39/21/1883/4939241
by
guest
on
22
January
2026
--- Страница 10 ---
1892 ESCGuidelines
Table4 Conditionsthatmaybeincorrectlydiagnosed
assyncope
Condition Characteristicfeaturesthatdistin-
guishfromsyncope
Generalizedseizures Seesection8,Table10.
Complexpartialseiz- Nofalls,yetunresponsiveandlater
ures,absenceepilepsy amnesia
PPSor DurationofapparentLOC
“pseudocoma” lastingmanyminutestohours;high
frequency,uptoseveraltimesaday
FallswithoutTLOC Nounresponsivenessoramnesia
Cataplexy Fallswithflaccidparalysisandnon-
responsive,yetnolateramnesia
Intracerebralorsub- Consciousnessmaybeprogressively
arachnoid reducedratherthanimmediately
haemorrhage lost.Accompanyingseverehead-
Figure3Pathophysiologicalbasisoftheclassificationofsyncope.
ache,otherneurologicalsigns
ANS=autonomicnervoussystem;auton.=autonomic;BP=
blood pressure; OH = orthostatic hypotension; periph. = VertebrobasilarTIA Alwaysfocalneurologicalsignsand
peripheral;resist.=resistance.
symptoms,usuallywithoutLOC;if
consciousnessislostthisusuallylasts
longerthaninTLOC.
tonic-clonic,andatonicgeneralizedseizures,andcanbeclassifiedas
CarotidTIA Consciousnessisforallpractical
primaryorsecondary.Theformsofepilepsyinwhichpeopleremain
purposesnotlostincarotidTIAs,
activelyupright,i.e.sittingorstanding(e.g.complexpartialseizures
buttherearepronouncedfocal
orabsenceepilepsy)arenotregardedasTLOC,butsometimesthey
neurologicalsignsandsymptoms
areincorrectlydiagnosedassyncope.
PsychogenicTLOCconsistsoftwoforms:oneresemblesepileptic Subclaviansteal Associatedwithfocalneurological
seizures(psychogenicnon-epilepticseizures[PNES])andone,with- syndrome signs
outgrossmovements,resemblessyncope(psychogenicpseudosyn-
Metabolicdisorders Durationmuchlongerthanin
cope[PPS]).
includinghypogly- TLOC;consciousnessmaybeim-
TherarecausesofTLOConlyseldomlycauseconfusionwiththe
caemia,hypoxia, pairedinsteadoflost
main TLOC forms, probably because in most cases they differ
hyperventilationwith
enoughclinicallytobeclearlynotsyncope.Bothvertebrobasilartran-
hypocapnia
sient ischaemic attacks (TIAs) and subclavian steal syndrome are
associated with focal neurological signs. A subarachnoid haemor- Intoxication Durationmuchlongerthanin
rhagemaypresentwithashortLOC,buttheassociatedabruptex- TLOC;consciousnessmaybeim-
tremeheadachesuggeststhecause.Incyanoticbreath-holdingspells, pairedinsteadoflost
expiratory apnoea with hypoxia is the primary mechanism.10 So-
Cardiacarrest LOCyetnospontaneousrecovery called‘pallidbreath-holdingspells’inchildrendonotconstituteapri-
maryrespiratoryproblem,butarecardioinhibitoryreflexsyncope.11
Coma DurationmuchlongerthanTLOC
Table 4 lists themainfeatures thatdistinguishsyncope fromdis-
ordersthatmaybemistakenforsyncope.
LOC=lossofconsciousness;PPS=psychogenicpseudosyncope;TIA=transient
ischaemicattack;TLOC=transientlossofconsciousness.
4. Diagnostic evaluation and
management according to risk
.
.
stratification
... withpossibleTLOC,historytakingshouldfirstestablishwhetherthere
.. wasindeedaTLOC.Often,thisallowsadistinctionbetweenthemajor
.
4.1 Initial evaluation
... TLOCgroups.TheflowdiagramfortheevaluationofTLOCisshownin
.. Figure4.Theinitialevaluationshouldanswerkeyquestions:
TheclinicalfeaturescharacterizingTLOCareusuallyderivedfromhis- ..
.
torytakingfrompatientsandeyewitnesses.Whenapatientfirstpresents . (1) WastheeventTLOC?
Downloaded
from
https://academic.oup.com/eurheartj/article/39/21/1883/4939241
by
guest
on
22
January
2026
--- Страница 11 ---
ESCGuidelines 1893
Figure4 Flowdiagramfortheinitialevaluationandriskstratificationofpatientswithsyncope.BP=bloodpressure;ECG=electrocardiogram;
H&Pexam=historyandphysicalexamination;TLOC=transientlossofconsciousness.
.
(2) IncaseofTLOC,isitofsyncopalornon-syncopalorigin? .. approximately60%ofcases.12Fornon-syncopalTLOC,refertosec-
.
.
(3) Incaseofsuspectedsyncope,isthereaclearaetiologicaldiagnosis . tions7and8. .
.
(seesection4.1.1)? . .
(4) Isthereevidencetosuggestahighriskofcardiovasculareventsor .. 4.1.1Diagnosisofsyncope .
death(seesection4.1.2)? .. ThestartingpointofthediagnosticevaluationofTLOCofsuspected
.
.. syncopalnatureistheinitialsyncopeevaluation,whichconsistsof:
TLOC has four specific characteristics: short duration, abnor- ..
.
mal motor control, loss of responsiveness, and amnesia for .. • Carefulhistorytakingconcerningpresentandpreviousattacks,as
.
. well as eyewitness accounts, in person or through a telephone
the period of LOC (for an explanation of the clinicalfeatures of .
.. interview.
TLOC see Web Table 4 in section 4.1 of the Web Practical .
.. • Physical examination, including supine and standing BP
Instructions). .
. measurements.
.
TLOCisprobablysyncopewhen:(i)therearesignsandsymptoms .
. • Electrocardiogram(ECG).
.
specificforreflexsyncope,syncopeduetoOH,orcardiacsyncope, .
.
and(ii)signsandsymptomsspecificforotherformsofTLOC(head .. Based on these findings, additional examinations may be per-
.
.
trauma, epileptic seizures, psychogenic TLOC, and/or rare causes) . formedwhenneeded(seesection4.2):
.
.
areabsent.Practicalinstructionsforhistorytakingaregiveninsec- .
.. • ImmediateECGmonitoringwhenthereisasuspicionofarrhyth-
tions3and4oftheWebPracticalInstructions. .
. micsyncope.
.
Whenepilepticseizuresorpsychogenicattacksarelikely,appro- .
. • Echocardiogram when there is previous known heart disease,
.
priatestepsshouldbetaken.Byusingadetailedclinicalhistory,phys- .. datasuggestiveofstructuralheartdisease,orsyncopesecondary
.
icians can differentiate syncope from other forms of TLOC in . tocardiovascularcause.
Downloaded
from
https://academic.oup.com/eurheartj/article/39/21/1883/4939241
by
guest
on
22
January
2026
--- Страница 12 ---
1894 ESCGuidelines
.
.
• Carotidsinusmassage(CSM)inpatientsaged>40years. . Evenifthereisnoindependentgold/referencestandardtodiag-
.
.
• Head-up tilt testing when there is suspicion of syncope due to . nose syncope, there is strong consensus that the initial evalu-
.
OHorreflexsyncope. .. ation may lead to certain or highly likely diagnosis when the
.
• Bloodtestswhenclinicallyindicated,e.g.haematocritorhaemo- ...
diagnostic criteria listed in the table of recommendations are
globin when haemorrhage is suspected, oxygen saturation and .
.. met.
bloodgasanalysiswhenhypoxiaissuspected,troponinwhencar- .
.
.
diac ischaemia-related syncope is suspected, or D-dimer when .
.
pulmonaryembolismissuspected,etc. .
Diagnosticcriteriawithinitialevaluation
Recommendations Classa Levelb
ReflexsyncopeandOH
VVSishighlyprobableifsyncopeisprecipitatedbypain,fear,orstanding,andisassociatedwithtypicalprogressiveprodrome
I C
(pallor,sweating,and/ornausea).8,13–17
Situationalreflexsyncopeishighlyprobableifsyncopeoccursduringorimmediatelyafterspecifictriggers,listedin
I C
Table3.8,13–17
SyncopeduetoOHisconfirmedwhensyncopeoccurswhilestandingandthereisconcomitantsignificantOH.18–24 I C
Intheabsenceoftheabovecriteria,reflexsyncopeandOHshouldbeconsideredlikelywhenthefeaturesthatsuggestreflex
IIa C
syncopeorOHarepresentandthefeaturesthatsuggestcardiacsyncopeareabsent(seeTable5).
Cardiacsyncope
ArrhythmicsyncopeishighlyprobablewhentheECGshows25–39:
• Persistentsinusbradycardia<40b.p.m.orsinuspauses>3sinawakestateandinabsenceofphysicaltraining;
• MobitzIIsecond-andthird-degreeAVblock;
• AlternatingleftandrightBBB; I C
• VTorrapidparoxysmalSVT;
• Non-sustainedepisodesofpolymorphicVTandlongorshortQTinterval;or
• PacemakerorICDmalfunctionwithcardiacpauses.
Cardiacischaemia-relatedsyncopeisconfirmedwhensyncopepresentswithevidenceofacutemyocardialischaemiawithor
I C
withoutmyocardialinfarction.25–39
Syncopeduetostructuralcardiopulmonarydisordersishighlyprobablewhensyncopepresentsinpatientswithprolapsing
I C
atrialmyxoma,leftatrialballthrombus,severeaorticstenosis,pulmonaryembolus,oracuteaorticdissection.
Additionaladviceandclinicalperspectives
Theinitialsyncopeevaluation,asdescribedinthisdocument,candefinethecauseofsyncopeinmostpatients.Strictadherencetotheabovedefin-
itionsofVVSandsituationalreflexsyncope,andofsyncopeduetoOH,canbeconsideredcertainorhighlylikelyirrespectiveofthepresenceof
anyotherabnormalfinding.Inyoungsubjectswithunexplainedsyncopeandnohistoryofcardiacdisease,nofamilyhistoryofsuddendeath,nosu-
pinesyncopeorsyncopeduringsleeporexercise,nounusualtriggers,andanormalECG,thechanceofcardiacsyncopeisverylow.SCDratesin
subjects<35yearsamountto1–3/100000.
AV=atrioventricular;BBB=bundlebranchblock;b.p.m.=beatsperminute;ECG=electrocardiogram;ICD=implantablecardioverterdefibrillator;OH=orthostatichypo-
tension;SCD=suddencardiacdeath;SVT=supraventriculartachycardia;VT=ventriculartachycardia;VVS=vasovagalsyncope.
aClassofrecommendation.
bLevelofevidence.
Downloaded
from
https://academic.oup.com/eurheartj/article/39/21/1883/4939241
by
guest
on
22
January
2026
--- Страница 13 ---
ESCGuidelines 1895
.
.
Whenadiagnosisisnearlycertainorhighlylikely,nofurtherevalu- . 4.1.2Managementofsyncopeintheemergency
.
.
ation is needed, and treatment—if any—can be planned. In other . departmentbasedonriskstratification
.
.
cases,theinitialevaluationmaysuggestadiagnosiswhenthefeatures . ThemanagementofTLOCofsuspectedsyncopalnatureintheED
.
.
listedinTable5are present,orotherwiseisunabletosuggestany . shouldanswerthefollowingthreekeyquestions:
.
.
diagnosis. .
.
. (1) Isthereaseriousunderlyingcausethatcanbeidentified?
.
.
. (2) Whatistheriskofaseriousoutcome?
.
Table5 Clinicalfeaturesthatcansuggestadiagnosis .
. (3) Shouldthepatientbeadmittedtohospital?
oninitialevaluation ..
.
.
. Figure5showsaflowchartforthemanagementandriskstratifica-
.
.
Reflexsyncope .. tionofpatientsreferredtotheEDforTLOCsuspectedtobesyn-
• Longhistoryofrecurrentsyncope,inparticularoccurringbe- .. cope(modifiedfromCasagrandaetal.40).
.
.
foretheageof40years .
. • Afterunpleasantsight,sound,smell,orpain .. Question 1: Is there a serious underlying cause that can be
.
• Prolongedstanding .. identifiedintheED?
.
• Duringmeal .
. Normally the presenting complaint of syncope can be established.
• Beingincrowdedand/orhotplaces ..
. TheprimaryaimforanEDclinicianisthentoestablishanunderlying
• Autonomicactivationbeforesyncope:pallor,sweating,and/ ..
. diagnosis,especiallythoseassociatedwiththepotentialforrapidclin-
ornausea/vomiting ..
• Withheadrotationorpressureoncarotidsinus(asintu-
.. icaldeterioration.41,42Itistheacuteunderlyingdiseasethatmostfre-
.
mours,shaving,tightcollars)
... quently determines short-term adverse events rather than the
• Absenceofheartdisease
.. syncopeitself.43Subsequentmanagementwillfocusontreatingthis
.
.. underlyingcause(Figure5).Many(40–45%)non-cardiovascularand
S •yn Wco hp ilee od ru ae ftt eo rsO taH
nding
....
somecardiovascularlife-threateningunderlyingconditionsareobvi-
• Prolongedstanding
... ousintheED.44Table6listshigh-riskfeaturesthatsuggestthepres-
• Standingafterexertion ... enceofaseriousunderlyingcauseandlow-riskfeaturesthatsuggest
• Post-prandialhypotension .. abenignunderlyingcause.
.
• Temporalrelationshipwithstartorchangesofdosageofvas- ..
.
odepressivedrugsordiureticsleadingtohypotension .. Question2:Whatistheriskofaseriousoutcome?
.
• Presenceofautonomicneuropathyorparkinsonism .. High-riskfeaturesareshowninTable6,andhowtousethisriskpro-
.
Cardiacsyncope
... file to guide subsequent management and disposition is shown in
• Duringexertionorwhensupine ... Figure6.
• Suddenonsetpalpitationimmediatelyfollowedbysyncope .. Riskstratificationisimportant,fortworeasons:
.
• Familyhistoryofunexplainedsuddendeathatyoungage ..
• Presenceofstructuralheartdiseaseorcoronaryartery ... (1) Torecognizepatientswithalikelylow-riskconditionabletobedis-
disease ... chargedwithadequatepatienteducation.
.
• ECGfindingssuggestingarrhythmicsyncope: . (2) Torecognizepatientswithalikelyhigh-riskcardiovascularcondition
.
.
-Bifascicularblock(definedaseitherleftorrightBBBcom- . requiringurgentinvestigation.Thismayrequireadmission.
.
binedwithleftanteriororleftposteriorfascicularblock) ..
-Otherintraventricularconductionabnormalities(QRSdur- .. High-risk patients are more likely to have cardiac syncope.
.
ation>_0.12s) .. Structuralheartdisease25–27,31,35,36,45andprimaryelectricaldisease46
.
-MobitzIsecond-degreeAVblockand1(cid:2)degreeAVblock .. are major risk factors for sudden cardiac death (SCD) and overall
.
withmarkedlyprolongedPRinterval .. mortalityinpatientswithsyncope.Low-riskpatientsaremorelikely
-Asymptomaticmildinappropriatesinusbradycardia(40–50 ... to have reflex syncope and have an excellent prognosis.47 OH is b.p.m.)orslowatrialfibrillation(40–50b.p.m.)intheab- ..
. associatedwithatwo-foldhigherriskofdeathowingtotheseverity
senceofnegativelychronotropicmedications .
-Non-sustainedVT
... ofcomorbiditiescomparedwiththegeneralpopulation.48
.
-Pre-excitedQRScomplexes ..
.
-LongorshortQTintervals . Question3:Shouldthepatientbeadmittedtohospital?
.
-Earlyrepolarization .. Approximately 50% of patients who present to the ED with
.
-ST-segmentelevationwithtype1morphologyinleads .. syncope are admitted (although the rate varies between 12–86%)
.
V1-V3(Brugadapattern) .
. (seeSupplementaryDataTable4).Theuseofclinicaldecisionrulesand
-NegativeTwavesinrightprecordialleads,epsilonwaves ..
. standardizedprotocolshasnotchangedthisratesignificantly.Thecom-
suggestiveofARVC ..
. positeestimateofoutcomesisthatinthenext7–30days,only0.8%
-Leftventricularhypertrophysuggestinghypertrophic .
.
cardiomyopathy .. dieand6.9%haveanon-fatalsevereoutcomewhilstintheED,while
.
. another 3.6% have a post-ED serious outcome (see Supplementary
.
.
.. DataTable4).Unnecessaryadmissioninlow-riskpatientscanbeharm-
.
ARVC=arrhythmogenicrightventricularcardiomyopathy;AV=atrioventricular;
... ful.87Whereasitiscrucialtoidentifythesehigh-riskpatientstoensure
BBB=bundlebranchblock;b.p.m.=beatsperminute;ECG=electrocardio- .. early,rapid,andintensiveinvestigation,notallpatientsathighriskneed
.
gram;OH=orthostatichypotension;VT=ventriculartachycardia. .. hospitalization.80
.
Downloaded
from
https://academic.oup.com/eurheartj/article/39/21/1883/4939241
by
guest
on
22 January
2026
--- Страница 14 ---
1896 ESCGuidelines
Figure 5 Themanagementofpatientspresentingtotheemergencydepartmentfortransientlossofconsciousnesssuspectedtobesyncope
(modifiedfromCasagrandaetal.40).ED=emergencydepartment;TLOC=transientlossofconsciousness.
aForexample,thisincludespulmonaryembolismpresentingwithshortnessofbreath,pleuriticchestpain,andsyncope,butnottrauma
secondarytosyncope.
Managementofsyncopeintheemergencydepartment
Recommendations Classa Levelb
Itisrecommendedthatpatientswithlow-riskfeatures,likelytohavereflexorsituationalsyncope,orsyncopeduetoOH,
I B
aredischargedfromtheED.27,35,36,49–54,58,62,69
Itisrecommendedthatpatientswithhigh-riskfeaturesreceiveanearlyintensiveandpromptevaluationinasyncopeunitor
I B
inanEDobservationunit(ifavailable),orarehospitalized.26,27,35,36,44–46,50,55–57,59,60,70–76
Itisrecommendedthatpatientswhohaveneitherhigh-norlow-riskfeaturesareobservedintheEDorinasyncopeunit
I B
insteadofbeinghospitalized.40,63–65,77
RiskstratificationscoresmaybeconsideredforriskstratificationintheED.78–86 IIb B
Additionaladviceandclinicalperspectives
• IntheED,presyncopeshouldbemanagedwiththesameaccuracyassyncopeasitcarriesthesameprognosis.66–68
• DiagnosticradiologyandlaboratorytestssuchaschestX-ray,braincomputedtomography,routinebloodhaematology,biochemistry,andD-dimerandcardiac
markershavealowdiagnosticyield,impactonriskstratificationofpatientswithsyncope,andshouldnotroutinelybeusedunlessspecificallysuggestedbyclinical
evaluation.
• Around10%ofpatientswithsyncopeintheEDwillsufferfromaseriousoutcomewithin7–30daysoftheirvisit,withjustunderhalfoccurringaftertheirstayinthe
ED(seeSupplementaryDataTable4).Itiscrucialtoidentifythesehigh-riskpatientstoensureearly,rapid,andintensiveinvestigation.
• Assyncopeunitsarebotheffectiveandefficient,thisearly,rapid,andintensiveinvestigationcanbeperformedonanoutpatientbasis(eitherinasyncopeunitoran
EDobservationunit)inmostcases.Onlypatientswithariskofashort-termseriousoutcomeshouldbeconsideredforhospitaladmission.
• Toreduceinappropriateadmissions,patientswhohaveacardiacdeviceandsyncopeshouldundergopromptdeviceinterrogation.
• RiskstratificationscoresperformnobetterthangoodclinicaljudgementandshouldnotbeusedalonetoperformriskstratificationintheED.
ED=emergencydepartment;OH=orthostatichypotension.
aClassofrecommendation.
bLevelofevidence.
Downloaded
from
https://academic.oup.com/eurheartj/article/39/21/1883/4939241
by
guest
on
22
January
2026
--- Страница 15 ---
ESCGuidelines 1897
Table6 High-riskfeatures(thatsuggestaseriouscondition)andlow-riskfeatures(thatsuggestabenigncondition)in
patientswithsyncopeatinitialevaluationintheemergencydepartment
Downloaded
from
https://academic.oup.com/eurheartj/article/39/21/1883/4939241
by
guest
on
22
January
2026
--- Страница 16 ---
1898 ESCGuidelines
AF=atrialfibrillation;ARVC=arrhythmogenicrightventricularcardiomyopathy;AV=atrioventricular;BP=bloodpressure;b.p.m.=beatsperminute;ECG=electrocardio-
gram;ED=emergencydepartment;ICD=implantablecardioverterdefibrillator;LQTS=longQTsyndrome;LVEF=leftventricularejectionfraction;SCD=suddencardiac
death;SVT=supraventriculartachycardia;VT=ventriculartachycardia.
aSomeECGcriteriaarepersediagnosticofthecauseofthesyncope(seerecommendations:Diagnosticcriteria);insuchcircumstancesappropriatetherapyisindicatedwithout
furtherinvestigations.WestronglysuggesttheuseofstandardizedcriteriatoidentifyECGabnormalitieswiththeaimofprecisediagnosisofECG-definedcardiacsyndromesin
EDpractice.61
Downloaded
from
https://academic.oup.com/eurheartj/article/39/21/1883/4939241
by
guest
on
22
January
2026
--- Страница 17 ---
ESCGuidelines 1899
if
Figure6Emergencydepartmentriskstratificationflowchart.Low-andhigh-riskfeaturesarelistedinTable6.ED=emergencydepartment;
SU=syncopeunit.
Patientswithlow-riskfeatures.ThesepatientsdonotneedfurtherdiagnostictestsintheEDastheyarelikelytohavereflex,situational,
or orthostatic syncope. They may benefit from reassurance, or counselling (see Web Practical Instructions section 9.1: ESC information
sheetforpatientsaffectedbyreflexsyncope).
Patientswithhigh-riskfeatures.ThesepatientsshouldbeclassifiedasHIGHRISK;theyrequireanintensivediagnosticapproachandmay
needurgent treatment andadmission. Thesepatients shouldbe monitored(although itis unclear for how long this should be, most
studiessuggestingupto6hoursintheEDandupto24hoursinhospital)inasettingwhereresuscitationcanbeperformedincaseof
deterioration.40,62
Patientsthathaveneitherhigh-norlow-riskfeatures.Thesepatientswillrequireexpertsyncopeopinion,whichcanprobablybesafelyman-
agedinanoutpatientsetting.63Thereisnodirectevidencethatadmittingpatientstohospitalchangestheiroutcome,whilstthereisevi-
dencethatmanagementinanEDobservationunitand/orfast-tracktoasyncopeoutpatientunitisbeneficial.64,65
aRecent studies have suggested that outcomes in patients presenting with presyncope are similar to those presenting with
syncope.66–68
bThesepatientsmaystillrequireadmissiontohospitalforassociatedillness,injuryorwelfarereasons.Low-riskpatientscanbereferred
totheoutpatientsyncopeclinicfortherapypurposes,ifneeded.
.
.
The diagnostic tests, procedures, and interventions that may re- . <_48hcoupledwithfast-trackingtoasyncopeunitreducedthead-
.
quireadmissioninpatientswithhigh-riskfeaturesarelistedinTable7. .. missionrateto29%.77Amongpatientsnotadmitted,20%weredis-
.
.
Furthermore, this Task Force believes that the implementation . chargedafterashortobservationintheED,20%werefast-trackedto
.
ofnovelcarepathwaysandorganizationalapproaches,suchasEDob- .. thesyncopeunit,and31%weredischargeddirectlyfromtheED.77
.
.
servation units and syncope in- and outpatient units (Figure 6), .
.
.
offer safe and effective alternatives to admission in the cases .. Risk stratification scores: There are several ED syncope clinical
.
listedinTable7.Basedonaconsensusdocument,40asingle-centre .. decision rules that aim to stratify patients with syncope based on
.
experienceconsistingofashortstayintheEDunderobservationof . medical history, examination, and ECG findings (see Supplementary
Downloaded
from
https://academic.oup.com/eurheartj/article/39/21/1883/4939241
by
guest
on
22
January
2026
--- Страница 18 ---
1900 ESCGuidelines
Table7 High-risksyncopepatients:criteriafavouringastayinanemergencydepartmentobservationunitand/or
fast-trackingtoasyncopeunitvs.requiringadmissiontohospital
FavourinitialmanagementinEDobservationunitand/or Favouradmissiontohospital
fast-tracktosyncopeunit
High-riskfeaturesAND: High-riskfeaturesAND:
• Stable,knownstructuralheartdisease • Anypotentiallyseverecoexistingdiseasethatrequiresadmission
• Severechronicdisease • Injurycausedbysyncope
• Syncopeduringexertion • Needoffurtherurgentevaluationandtreatmentifitcannot
• Syncopewhilesupineorsitting beachievedinanotherway(i.e.observationunit),e.g.ECGmonitoring,
• Syncopewithoutprodrome echocardiography,stresstest,electrophysiologicalstudy,angiography,
• Palpitationsatthetimeofsyncope devicemalfunction,etc.
• Inadequatesinusbradycardiaorsinoatrialblock • Needfortreatmentofsyncope
• Suspecteddevicemalfunctionorinappropriateintervention
• Pre-excitedQRScomplex
• SVTorparoxysmalatrialfibrillation
• ECGsuggestinganinheritablearrhythmogenicdisorders
• ECGsuggestingARVC
ARVC=arrhythmogenicrightventricularcardiomyopathy;ECG=electrocardiogram;ED=emergencydepartment;SVT=supraventriculartachycardia.
.
DataTable3).26,34–36,44,88NoneoftheserulesareusedwidelyinEDs .. syndrome(CSS)requiresthereproductionofspontaneoussymp-
.
.
duetopoorsensitivityandspecificityreportedfromexternalvalida- . tomsand,inaddition,thatpatientshavesyncopeofunknownori-
.
tion,orduetoalackofexternalvalidation.70,78–85Syncopeclinical .. gin compatible with a reflex mechanism. In such circumstances,
.
decisionrulesperformnobetterthanclinicianjudgmentatpredicting .. CSMusuallyshowsaperiodofasystole>6s.91Theprevalenceof
.
short-term serious outcomes.86 Clinical decision rules can predict .. CSS, as defined here, was 8.8%whenCSM was performed after
.
.
pooroutcomes,butmostsyncopedeathsandmanypooroutcomes . the initial evaluation in 1855 consecutive patients >40 years of
.
.
are associated with underlying illness rather than syncope per se,58 . age with syncope compatible with a reflex mechanism.92,93 In a
.
.
particularlyinthelongterm.56 .. multicentre study94 aimed at validation of the 2009 ESC
.
.. Guidelines, CSM was indicated after initial evaluation in 73% of
.
Evenifthequalityofevidenceismoderate,thereisstrongcon- .. 700patientsandwasdiagnosticin12%.Theprecisemethodology
.
sensusfromseveralstudiesthatcurrentlyavailableriskstratifi- .. and results of CSM are shown in section 5 of the Web Practical
. cationscoreshavenotshownbetter sensitivity, specificity, or .. Instructions.
.
prognosticyieldcomparedwithclinicaljudgmentinpredicting .. ThemaincomplicationsofCSMareneurological.Whenpooling
.
short-term serious outcomes after syncope. Therefore, they .. thedatafromfourstudies90,95–97inwhich8720patientswereana-
.
should not be used alone to perform risk stratification in .. lysed,TIAsorstrokeswereobservedin21(0.24%).
.
theED. .. The relationship between abnormal response to CSM and .
.. spontaneoussyncopeisacrucialpointthathasbeenstudiedusing
.
4.2 Diagnostic tests .. twomethods.Thefirstwasapre-postcomparisonoftherecur-
.
. 4.2.1Carotidsinusmassage . rencerateofsyncopeafterpacing.Non-randomizedstudiesdem-
.
.
Aventricularpauselasting>3sand/orafallinsystolicBPof>50 . onstratedfewerrecurrencesatfollow-upinpacedpatientsthanin
.
.
mmHg is known as carotid sinus hypersensitivity. Carotid sinus . those without pacing. These results were confirmed in two
.
hypersensitivity is a common finding in older men without syn- ... randomized trials.98,99 The second method was to analyse the
.
cope; abnormal responses are frequently observed (<_40%) in .. occurrenceofasystolicepisodesregisteredinpatientswithacar-
.
patientswithoutsyncope,especiallyiftheyareolderandaffected .. dioinhibitory response to CSM using an implanted device.
.
by cardiovascular disease.89 Carotid sinus hypersensitivity is .. Recordings of long pauses were very common in the two trials
exceptionalinpatients<40yearsofage.90Thespecificityofthe ... that employed this method.100,101 These results suggest that a
.
testincreasesifspontaneoussyncopeisreproducedduringCSM. .. positive response to CSM, reproducing symptoms, in patients
.
Syncope was induced in only 5% of asymptomatic persons aged .. withsyncopeishighlypredictiveoftheoccurrenceofspontane-
.
>65years.89Fortheabovereasons,thediagnosisofcarotidsinus . ousasystolicepisodes.
Downloaded
from
https://academic.oup.com/eurheartj/article/39/21/1883/4939241
by
guest
on
22
January
2026
--- Страница 19 ---
ESCGuidelines 1901
.
There is strong consensus that the diagnosis of CSS requires .. neous events, and indirectly by studies of efficacy of cardiac
.
boththereproductionofspontaneoussymptomsduringCSM .. pacing.Furtherresearchislikelytohaveanimportantimpact
.
andclinicalfeaturesofspontaneoussyncopecompatiblewith .. onourconfidenceintheestimationofeffectandmaychange
.
areflexmechanism.Thequalityofevidenceismoderateandis .. theestimate.
.
givenbystudiesofECGcorrelationbetweenCSMandsponta- .
Cardiacsinusmassage
Recommendations Classa Levelb
Indications
CSMisindicatedinpatients>40yearsofagewithsyncopeofunknownorigincompatiblewithareflexmechanism.92–94 I B
Diagnosticcriteria
CSSisconfirmedifCSMcausesbradycardia(asystole)and/orhypotensionthatreproducespontaneoussymptoms,and
I B
patientshaveclinicalfeaturescompatiblewithareflexmechanismofsyncope.89,90,92,93,98–102
Additionaladviceandclinicalperspectives
• HistoryofsyncopeanditsreproductionbyCSMdefinesCSS;positiveCSMwithoutahistoryofsyncopedefinescarotidsinushypersensitiv-
ity.89,90,92,93Carotidsinushypersensitivityinpatientswithunexplainedsyncopemaybeanon-specificfindingbecauseitispresentin<_40%of
olderpopulationsandshouldbeusedwithcautionfordiagnosisofthemechanismofsyncope.
• CSMshouldbeperformedwiththepatientinthesupineanduprightpositions,andwithcontinuousbeat-to-beatBPmonitoring.Thismaybe
morereadilyperformedinthetiltlaboratory.90
• Althoughneurologicalcomplicationsareveryrare,90,95–97theriskofprovocationofTIAwiththemassagesuggeststhatCSMshouldbeunder-
takenwithcautioninpatientswithpreviousTIA,stroke,orknowncarotidstenosis>70%.
BP=bloodpressure;CSM=carotidsinusmassage;CSS=carotidsinussyndrome;TIA=transientischaemicattack.
aClassofrecommendation.
bLevelofevidence.
.
4.2.2Orthostaticchallenge .. adisadvantageduetotherapidlyfallingBPduringOH.Withasphyg-
.
Changing from the supine to the upright position produces a dis- .. momanometer, more than four measurements per minute cannot
.
placementofbloodfromthethoraxtothelowerlimbsandabdomi- .. beobtainedwithoutvenousobstructioninthearm.Whenmorefre-
.
nal cavity that leads to a decrease in venous return and cardiac .. quentreadingsare required,asforinitialOH,continuousbeat-to-
.
output.Intheabsenceofcompensatorymechanisms,afallinBPmay .. beatnon-invasiveBPmeasurementisneeded.20,103,104
.
leadtosyncope.20,103,104 Thediagnostic criteriaforOHhave been ..
.
definedbyconsensus.6 .. Diagnostic criteria: Abnormal BP fall is defined as a progressive
. Currently,therearethreemethodsforassessingtheresponseto .. andsustainedfallinsystolicBPfrombaselinevalue>_20mmHgor
.
changeinposturefromsupinetoerect20,103,104:activestanding(see .. diastolic BP >_10 mmHg, or a decrease in systolic BP to <90
.
section4.2.2.1),head-uptilt(seesection4.2.2.2),and24-hambula- .. mmHg.ThisdefinitionofOHdiffersfromthe2011consensus6in
.
.
toryBPmonitoring(ABPM)(seesection4.2.3.4). . addingthe90mmHgthreshold.ThisTaskForcebelievesthatan
.
.
. absolutethresholdof90mmHgofsystolicBPisuseful,especially
.
.
4.2.2.1 Activestanding . inpatientswithasupineBP<110mmHg.AnisolateddiastolicBP
.
.
. dropisveryrareanditsclinicalrelevanceforOHdiagnosisislim-
.
.
Indications: Thistestisusedtodiagnosedifferenttypesofortho- .. ited. Orthostatic heart rate (HR) increase is blunted or absent
.
static intolerance (see Web Practical Instructions Web Table 1). A . [usuallynot>10beatsperminute(b.p.m.)]inpatientswithneuro-
.
.
sphygmomanometerisadequateforroutineclinicaltestingforclassi- . genic OH, but increases or even exaggerates with anaemia or
.
.
cal OH and delayed OH because of its ubiquity and simplicity. .. hypovolaemia.Theprobabilitythatsyncopeandorthostaticcom-
.
Automaticarm-cuffdevices,whichareprogrammedtorepeatand .. plaintsareduetoOHcanbeassessedusingtheinformationgiven
.
confirmmeasurementswhendiscrepantvaluesarerecorded,areat . inTable8.
Downloaded
from
https://academic.oup.com/eurheartj/article/39/21/1883/4939241
by
guest
on
22
January
2026
--- Страница 20 ---
1902 ESCGuidelines
Table8 Associationoforthostaticintoleranceandorthostatichypotension
Historyofsyncopeandorthostaticcomplaints
HighlysuggestiveofOH:syncopeandpre- PossiblyduetoOH:notallofthefeatures
syncopearepresentduringstanding,absent highlysuggestiveofOHarepresent
whilelying,andlesssevereorabsentwhilesit-
ting;apredilectionforthemorning;sittingor
lyingdownmusthelp;complaintsmayget
worseimmediatelyafterexercise,aftermeals
orinhightemperatures;no“autonomic
activation”
Supineandstanding SymptomaticabnormalBPfall SyncopeisduetoOH(ClassI) SyncopeislikelyduetoOH(ClassIIa)
BPmeasurement
AsymptomaticabnormalBPfall SyncopeislikelyduetoOH(ClassIIa) SyncopemaybeduetoOH(ClassIIb)
NoabnormalBPdrop Unproven Unproven
BP=bloodpressure;OH=orthostatichypotension.
Activestanding
Recommendations Classa Levelb
Indications
IntermittentdeterminationbysphygmomanometerofBPandHRwhilesupineandduringactivestandingfor3minareindi-
I C
catedatinitialsyncopeevaluation.20,103,104
Continuousbeat-to-beatnon-invasiveBPandHRmeasurementmaybepreferredwhenshort-livedBPvariationsaresus-
IIb C
pected,suchasininitialOH.20,103,104
Diagnosticcriteria
SyncopeduetoOHisconfirmedwhenthereisafallinsystolicBPfrombaselinevalue>_20mmHgordiastolicBP>_10
I C
mmHg,oradecreaseinsystolicBPto<90mmHgthatreproducesspontaneoussymptoms.6,20,103,104
SyncopeduetoOHshouldbeconsideredlikelywhenthereisanasymptomaticfallinsystolicBPfrombaselinevalue>_20
mmHgordiastolicBP>_10mmHg,oradecreaseinsystolicBPto<90mmHg,andsymptoms(fromhistory)areconsistent IIa C
withOH.6,20,103,104
SyncopeduetoOHshouldbeconsideredlikelywhenthereisasymptomaticfallinsystolicBPfrombaselinevalue>_20
mmHgordiastolicBP>_10mmHg,oradecreaseinsystolicBPto<90mmHg,andnotallofthefeatures(fromhistory)are IIa C
suggestiveofOH.6,20,103,104
POTSshouldbeconsideredlikelywhenthereisanorthostaticHRincrease(>30b.p.m.orto>120b.p.m.within10minof
IIa C
activestanding)intheabsenceofOHthatreproducesspontaneoussymptoms.6,20,103,104
SyncopeduetoOHmaybeconsideredpossiblewhenthereisanasymptomaticfallinsystolicBPfrombaselinevalue>_20
mmHgordiastolicBP>_10mmHg,oradecreaseinsystolicBPto<90mmHg,andsymptoms(fromhistory)arelessconsis- IIb C
tentwithOH.6,20,103,104
BP=bloodpressure;b.p.m.=beatspermin;OH=orthostatichypotension;HR=heartrate;POTS=posturalorthostatictachycardiasyndrome.
aClassofrecommendation.
bLevelofevidence.
Downloaded
from
https://academic.oup.com/eurheartj/article/39/21/1883/4939241
by
guest
on
22
January
2026
--- Страница 21 ---
ESCGuidelines 1903
.
.
4.2.2.2 Tilttesting . considered:(i)toconfirmadiagnosisofreflexsyncopeinpatientsin
.
Sinceitsintroductionin1986,105manyprotocolshavebeenreported .. whomthisdiagnosiswassuspectedbutnotconfirmedbyinitialeval-
.
.
with variations in the initial stabilization phase, duration, tilt angle, .. uation105–109,111, and (ii) for the assessment of autonomic
.
type ofsupport,and pharmacologicalprovocation.Themostcom- .. failure,especiallyforthereproductionofdelayedOH(whichcouldnot
.
monlyusedarethetrinitroglycerin(TNG)testusing300–400mgof .. bedetectedbyactivestandingbecauseofitsdelayedonset)23,24,112,113
.
sublingual TNG after a 20-min unmedicated phase,106,107 and the .. andposturalorthostatictachycardiasyndrome(POTS).114Tilttesting
.
low-dose intravenous isoproterenol test, which uses incremental .. maybehelpfulinseparatingsyncopefromPPS.115–117
.
dosestoincreaseaverageHRbyabout20–25%overbaseline(usu- .. Tilt testing has limited value in assessing treatment efficacy.118
.
ally<_3mg/min).108,109Inarecentsystematicliteraturereview,110the .. However,tilttestingiswidelyacceptedasausefultooltodemon-
.
overallpositivityrateinpatientswithsyncopewas66%fortheTNG .. strate susceptibility of the patient to reflex syncope, especially a
.
protocoland61%fortheisoproterenolprotocol;therespectivepos- .. hypotensive(vasodepressive)tendency,andtherebytoinitiatetreat-
.
itivity rate in subjects without syncope (controls) ranged from .. ment(e.g.physicalmanoeuvres,seesection5).119–121
.
11–14%;andthetestdifferentiatedpatientswithsyncopefromcon- .. The endpoint of tilt testing is the reproduction of
.
trolswithanoddsratioof12.Themethodologyandclassificationof .. symptoms along with the characteristic circulatory pattern of
.
responsesaredescribedinsection6oftheWebPracticalInstructions. .. theindicationmentionedabove,namelytheinductionofreflexhypo-
.
.
Addingvideorecordingtoatilttablepermitsobjectiveandrepeated . tension/bradycardia, OH, POTS, or PPS. The typical tilt test result
. .
reviewofclinicalsignsinrelationtoBPandHR,andhelpstoassess . patternsareshownintheWebPracticalInstructionssection6.
.
.
therelativecontributionofbradycardiaandhypotensiontosyncope . .
.
(see section 5.2.6.3 and the explanatory video in Web Practical . Interpretationoftilttestingresultsinpatientswithreflexsyncope:
.
Instructionssection6.3.15),andtodistinguishbetweenVVSandPPS .. Somestudies122,123comparedtheresponsetotilttestingwithsponta-
.
.
(seesection4.2.5). . neoussyncoperecordedbyanimplantablelooprecorder(ILR).While
.
.
The clinical situationcorrespondingtotilt-induced syncopeisthat . apositivecardioinhibitoryresponsetotilttestingpredicts,withahigh
.
.
which is triggered by prolonged standing. The test should be . probability, an asystolic spontaneous syncope, the presence of a
Tilttesting
Recommendations Classa Levelb
Indications
Tilttestingshouldbeconsideredinpatientswithsuspectedreflexsyncope,OH,POTS,orPPS.23,24,105–109,111–117 IIa B
Tilttestingmaybeconsideredtoeducatepatientstorecognizesymptomsandlearnphysicalmanoeuvres.119–121 IIb B
Diagnosticcriteria
Reflexsyncope,OH,POTS,orPPSshouldbeconsideredlikelyiftilttestingreproducessymptomsalongwiththecharac-
IIa B
teristiccirculatorypatternoftheseconditions.23,24,105–109,111–117
Additionaladviceandclinicalperspectives
• Anegativetilttableresponsedoesnotexcludeadiagnosisofreflexsyncope.
• WhilesensitivityandspecificityareatacceptablelevelswhenmeasuredinpatientswithVVSandhealthycontrols,inusualclinicalsettingsofsyncope
ofuncertainorigintilttestingsuggeststhepresenceofahypotensivesusceptibility,whichmayexistnotonlyinreflexsyncopebutalsowithother
causesofsyncopeincludingsomeformsofcardiacsyncope.Theconceptofhypotensivesusceptibilityratherthandiagnosishasimportantpractical
utility,becausethepresenceorabsenceofhypotensivesusceptibilityplaysamajorroleinguidingpacemakertherapyinpatientsaffectedbyreflex
syncopeandinthemanagementofhypotensivetherapies,whicharefrequentlypresentintheelderlywithsyncope(seesections5.1and5.2).
• Apositivecardioinhibitoryresponsetotilttestingpredicts,withhighprobability,asystolicspontaneoussyncope;thisfindingisrelevantforthera-
peuticimplicationswhencardiacpacingisconsidered(seesection5.2.6).Conversely,thepresenceofapositivevasodepressor,amixed
response,orevenanegativeresponsedoesnotexcludethepresenceofasystoleduringspontaneoussyncope.122,123
• Tilttestingmaybehelpfulinseparatingsyncopewithabnormalmovementsfromepilepsy.137
• Tilttestingmayhavevalueindistinguishingsyncopefromfalls.23
• TilttestingmaybehelpfulinseparatingsyncopefromPPS.InsuspectedPPS,thetilttestshouldpreferablybeperformedtogetherwithEEGmon-
itoring;anormalEEGhelpstoconfirmthediagnosis.116,117IntheabsenceofanEEG,avideorecordingwillbehelpfulinconfirmingthediagnosis.
• Tilttestingshouldnotbeusedtoassesstheefficacyofadrugtreatment.118
EEG =electroencephalogram; OH =orthostatic hypotension; POTS =postural orthostatic tachycardia syndrome; PPS =psychogenic pseudosyncope;VVS =vasovagal
syncope.
aClassofrecommendation.
bLevelofevidence.
Downloaded
from
https://academic.oup.com/eurheartj/article/39/21/1883/4939241
by
guest
on
22
January
2026
--- Страница 22 ---
1904 ESCGuidelines
.
.
. VVS.Thisconcepthaspracticalimplicationsfortherapy(seesec-
.
.
. tions5.1and5.2).
.
.
.
.
.
.
.
.
.. 4.2.3Basicautonomicfunctiontests
.
.. Autonomicfunctionassessmenthelpstoidentifyautonomicfailureas
.
.. theunderlyingcauseofsyncope.
.
.
.
.
.. 4.2.3.1Valsalvamanoeuvre
.
.. ThemethodologyoftheValsalvamanoeuvreisdescribedinsection
.
.. 7.1.1 of the Web Practical Instructions and in Web Video 2. There is
.
.. strongevidencethattheabsenceofaBPovershootandanabsence
. .. ofaHRincreaseduringtheValsalvaispathognomonicforneurogenic
.
.. OH,occurringinprimaryandsecondaryautonomicfailure,andthe
.
.. degree of hypotension and/or lack of compensation during forced
.
.. expirationusuallycorrelatewiththedegreeofautonomicdysfunc-
. .. tionandrelatedsymptoms.138–143Incontrast,apronouncedBPfall
.
.
. beyond what is normally expected during forced expiration, but a
.
.
. normalchronotropicresponseduringthemanoeuvre,mayoccurin
.
.
. patients with suspected situational syncope, i.e. syncope occurring
.
.
Figure7 Ratesoftilttestingpositivityindifferentclinicalcondi- . duringsomeformsofsituationalsyncope,e.g.coughing,brassinstru-
.
tions. These studies used the Westminster protocol for passive .. mentplaying,singing,andweightlifting.144
.
tilt,125 the Italian protocol for trinitroglycerin tilt,106 and the clo- ..
.
mipramine protocol,124 for a total of 1453 syncope patients and .. 4.2.3.2Deepbreathing
.
407 controls without syncope. Studies using other tilt protocols, .
. Themethodologyofthedeep-breathingtestisdescribedinsection
.
e.g.isoproterenolchallenge,werenotincluded.Clom= clomipr- .
. 7.1.2oftheWebPracticalInstructions.Underphysiologicalconditions,
.
amine;TNG=trinitroglycerin;VVS=vasovagalsyncope. .
.. HRrisesduringinspirationandfallsduringexpiration.HRvariability
.
.. duringdeepbreathing(alsocalledtheexpiratory/inspiratoryindexor
.
.. E/I index) is >_15 b.p.m. in healthy individuals aged >50 years.145
.
positivevasodepressor,mixedresponse,orevenanegativeresponse, .. Thereisstrongconsensusthatbluntedorabolishedvariationissug-
.
does not exclude the presence of asystole during spontaneous .. gestiveofparasympatheticdysfunction.142,143,146,147
.
syncope.122,123 ..
.
Tilt testing has an acceptable sensitivity124 and specific- .. 4.2.3.3Otherautonomicfunctiontests
.
ity106,124,125 whenthese are calculated inpatientswithtrue VVS .. Furtherteststoevaluatecardiovascularsympatheticfunctioninclude
.
orwithoutahistoryofsyncope.However,thereisaninabilityto .. calculationofthe 30:15ratio, the cold pressuretest, the sustained
.
apply the test to populations with syncope of uncertain cause .. hand grip test, and mental arithmetic. There is weak evidence that
.
where it is hoped that tilt testing might prove decisive. In these .. thesetestsmaybeuseful.13,142,143,147
.
clinical settings, tilt testing fails to deliver (Figure 7). Indeed, tilt ..
.
.
testingwaspositivein51–56%ofpatientswithatypicalclinicalfea- . 4.2.3.4Twenty-four-hourambulatoryandhomebloodpressure
. tures suggesting a reflex mechanism,106,124–128 in 30–36% with .. monitoring
. unexplainedsyncopeafterfullinvestigation,124,129andin45–47% .. Twenty-four-hour ABPM and home BP monitoring (HBPM) are
. with true cardiac arrhythmic syncope.130,131 In other words, tilt .. increasinglyusedtodiagnoseandmonitorthetreatmentofhyperten-
.
testingofferslittlediagnosticvalueinpatientsforwhomitismost .. sion.148ThereisstrongevidencethatOHisfrequentlyassociatedwith
.
.
needed.Inthesepatients,apositivetilttestrevealsasusceptibility . a nocturnal ‘non-dipping’ or even ‘reverse-dipping’ BP pattern in
.
toorthostaticstress.132Thishypotensivesusceptibilityplaysarolein .. patientswithautonomicfailure,withrelevanttherapeuticandprognos-
.
causing syncope irrespective of the aetiology and mechanism of .. ticimplications140,148–151(seeWebPracticalInstructionssection7.1.3).In
.
.
syncope.Forexample,inarrhythmicsyncopecausedbyparoxys- . thesepatients,ABPMallowstheassessmentofnocturnalhypertension,
.
.
mal atrial tachyarrhythmias, the mechanism is a combination of . postprandial hypotension, and exercise- and drug-induced hypoten-
.
.
onset of the arrhythmia itself and hypotensive susceptibility, . sion,aswellasmonitoringforsideeffectsofantihypotensiveregimens
.
.
corroboratedbypositivetilttesting.130,131Similarly,multifactorial .. andpointingtoadditionaldisorderssuchassleepapnoea.152Thereis
.
mechanismsarelikelyinothertypesofcardiacsyncope,e.g.aortic .. weakevidencethatABPMmayalsodetectthedegreeofOHindaily
.
stenosis,133 hypertrophic cardiomyopathy (HCM),134 and .. lifebetterthansingleofficeBPmeasurements.153
.
sicksinussyndrome.135,136Thepresenceorabsenceofsuscepti- .. HBPMmaybeusedtoinvestigatethecauseoforthostaticintoler-
.
bility explains the occurrence of syncope in some and not in .. ance,i.e. to clarifywhethersymptoms are duetoOH ortoother
.
others affected by the same severity of arrhythmia or structural .. causes,suchasvertigoormotorimbalanceinParkinson’sdiseaseor
.
defect. Tilt testing should now be considered a means of .. multiplesystematrophy.Theevidenceisweak.Finally,HBPMcanbe
.
exposing a hypotensive tendencyrather thanbeing diagnostic of . usedtoclarifythatBPisnotlowduringepisodesofPPS.154
Downloaded
from
https://academic.oup.com/eurheartj/article/39/21/1883/4939241
by
guest
on
22
January
2026
--- Страница 23 ---
ESCGuidelines 1905
Basicautonomicfunctiontests
Recommendations Classa Levelb
Valsalvamanoeuvre
Valsalvamanoeuvreshouldbeconsideredfortheassessmentofautonomicfunctioninpatientswithsuspectedneurogenic
IIa B
OH.138–143
Valsalvamanoeuvremaybeconsideredforconfirmingthehypotensivetendencyinducedbysomeformsofsituationalsyn-
IIb C
cope,e.g.coughing,brassinstrumentplaying,singing,andweightlifting.144
Deep-breathingtest
Deep-breathingtestsshouldbeconsideredfortheassessmentofautonomicfunctioninpatientswithsuspectedneurogenic
IIa B
OH.142,143,146,147
Otherautonomicfunctiontests
Otherautonomicfunctiontests(30:15ratio,coldpressuretest,sustainedhandgriptest,andmentalarithmetictest)may
IIb C
beconsideredfortheassessmentofautonomicfunctioninpatientswithsuspectedneurogenicOH.13,142,143,147
ABPM
ABPMisrecommendedtodetectnocturnalhypertensioninpatientswithautonomicfailure.140,148–151 I B
ABPMshouldbeconsideredtodetectandmonitorthedegreeofOHandsupinehypertensionindailylifeinpatientswith
IIa C
autonomicfailure.152,153
ABPMandHBPMmaybeconsideredtodetectwhetherBPisabnormallylowduringepisodessuggestiveoforthostatic
IIb C
intolerance.
Additionaladviceandclinicalperspectives
• Wheneverpossible,reproductionofthetriggersituation(e.g.coughing,swallowing,laughing,bassinstrumentplaying,weightlifting)underbeat-
to-beatnon-invasiveHRandBPmeasurementshouldbeperformedinpatientswithsuspectedsituationalsyncope.
• Theeffectsofageandsexshouldbeconsideredwheninterpretingautonomicfunctiontests.145,155–157
• Compliancewithautonomicfunctiontestsmaybelimitedinpatientswithdementia.PatientswithtremororParkinsonismmaynotsucceedin
performingthesustainedhandgriptest.ThecoldpressuretestmaybeuncomfortableinpatientswithRaynaud’sphenomena.147
ABPM=ambulatorybloodpressuremonitoring;BP=bloodpressure;HBPM=homebloodpressuremonitoring;HR=heartrate;OH=orthostatichypotension.
aClassofrecommendation.
bLevelofevidence.
.
.
4.2.4Electrocardiographicmonitoring(non-invasiveand . 4.2.4.2Holtermonitoring
.
. invasive) . Since,inmostpatients,symptomsdonotrecurduringmonitoring,the
.
.
TheroleofECGmonitoringcannotbedefinedinisolation.Asarule, . trueyieldofHoltermonitoringinsyncopemaybeaslowas1–2%in
.
.
ECGmonitoringisindicatedonlywhenthereisahighpre-testproba- . anunselectedpopulation.In15%ofpatients,symptomswerenotasso-
.
bility of identifying an arrhythmia associated with syncope, such as .. ciatedwitharrhythmia.161Thus,inthesepatients,arhythmdisturbance
.
.
thoselistedinTable5. . couldpotentiallybeexcludedasacauseofsyncope.Holtermonitoring
.
.
. in syncope is inexpensive in terms of set-up costs, but expensive in
.
.
4.2.4.1 In-hospitalmonitoring .. termsofcostperdiagnosis.162Holtermonitoringinsyncopemaybeof
.
In-hospital monitoring (in bed or by telemetry) is warranted in .. morevalueifsymptomsarefrequent.Dailysingleormultipleepisodes
.
patientswithhigh-riskclinicalfeatures(definedinTable6)suggesting .. ofLOCmightincreasethepotentialforsymptom–ECGcorrelation.
.
arrhythmic syncope, especiallyif themonitoringis applied immedi- ..
.
atelyaftersyncope.AlthoughthediagnosticyieldofECGmonitoring .. 4.2.4.3Prospectiveexternaleventrecorders
.
varies from 1.9–17.6%,158–160 it is justified by the need to avoid .. Eventrecordersareexternaldevicesthatareappliedbythepatient
.
immediaterisktothepatient. . when symptoms occur. Whereas these recorders can be useful in
Downloaded
from
https://academic.oup.com/eurheartj/article/39/21/1883/4939241
by
guest
on
22
January
2026
--- Страница 24 ---
1906 ESCGuidelines
.
theinvestigationofpalpitations,163theyhaveamarginalroleinthe .. There are several areas of interest other than unexplained syn-
.
.
evaluationofsyncope. . copeinwhichILRshavebeeninvestigated:
.
.
.
.. • Patients with bundle branch block (BBB) in whom paroxysmal
4.2.4.4 Smartphoneapplications .
.. atrioventricular (AV) block is likely despite negative complete
Becauseuptonowsmartphoneapplicationshaverecordedreal-time .
.. EPS:anarrhythmiawasobservedin41%ofthesepatients(being
ECG,theircurrentroleinsyncopeislimitedforthesamereasonas ..
paroxysmal AV block in 70%) under ILR observation, based on
.
for prospective event recorders.164,165 However, home video .. pooleddatafromthreestudies174,187,188(seeSupplementaryData
.
recordsareveryusefulinallformsofTLOC(seesection4.2.5.2). .. Table6).
.
.. • Patients in whom epilepsy was suspected butthe treatmenthas
.
4.2.4.5 Externallooprecorders .. proven ineffective: in pooled data, an attack could have
.
Ingeneral,externallooprecordershaveahigherdiagnosticyieldthan .. beendocumentedbyILRin62% ofpatients,withanarrhythmic
Holter monitoring.162 External loop recorders can be useful in ... causebeingresponsiblein26%137,189–191(seeSupplementaryData
patientswithrelativelyfrequentsyncopeepisodes.166–168Inarecent ... Table7).
multicentreinternationalregistry,thediagnosticyieldinsyncopewas
... • Patients with unexplained falls: in pooled data, an attack could
. have been documented by ILR in 70% of patients, with an
24.5%, with the most common findingbeingbradyarrhythmias; the ...
arrhythmic cause being responsible in 14%191–194 (see
strongerpredictorfordiagnosticfindingswasearlymonitoringafter ..
. SupplementaryDataTable8). theindexevent.166 ...
• Patients with HCM, arrhythmogenic right ventricular cardiomy-
.
.. opathy(ARVC),orprimaryelectricaldiseases(seesection5.4).
.
4.2.4.6 Remote(athome)telemetry .
.
.
Most recently, external and implantable device systems have been .. 4.2.4.8Diagnosticcriteria
.
developed that provide continuous ECG recording or 24-h loop .. Thegoldstandardforthediagnosisofarrhythmicsyncopeiswhen
.
memory withwireless transmission(realtime) to a service centre. .. there isacorrelationbetweenthesymptomsand anECGrecord-
.
Somerecentstudieshaveshownthatimplementingremotemonitor- .. ing.195,196 The presence of asymptomatic significant arrhythmias—
.
ingincreasesthediagnosticyieldandachievesdiagnosisearlierthan .. defined as prolonged asystole (>_3 s), rapid supraventricular
withoutremotemonitoring.169–171 ...
tachycardias (SVTs)(i.e. >160 b.p.m.for >32beats), orventricular
.
.. tachycardias(VTs)—hasbeenconsideredbyseveralauthorstobea
.
4.2.4.7 Implantablelooprecorders .. diagnostic finding.185,188,197–199 On the other hand, although the
.
Inameta-analysisoffiverandomizedcontrolledtrials(RCTs),172–176 .. absence ofdocumentation ofan arrhythmia during a syncopal epi-
.
660patientswithunexplainedsyncopewererandomizedtoacon- .. sode cannot be considered to be a specific diagnosis, it allows the
.
ventionalstrategyconsistingofanexternallooprecorder,tilttesting, .. exclusionofanarrhythmiaasthemechanismofthesyncope.Most
.
andanelectrophysiologicalstudy(EPS),ortoprolongedmonitoring .. evidenceinsupportoftheabovediagnosticcriteriaisindirectlybased
.
withanILR.TheresultsshowedthatinitialimplantationofanILRin .. onthebenefitofspecifictherapiesguidedbyECGmonitoringinpre-
.
the workup provided a 3.7 [95% confidence interval (CI) 2.7–5.0] .. ventingsyncopalrecurrences.172,184–186,188,200
.
increasedrelativeprobabilityofadiagnosiscomparedwiththecon- .. Evenifthequalityofevidenceismoderate,thereisstrongcon-
.
ventional strategy (see Supplementary Data Table 5). ILR was more .. sensusbasedonevidencefromseveralcontrolledtrialsthata
.
cost-effectivethanaconventionalstrategy.172,173,177,178 ..
correlationbetweensymptomsandadocumentedarrhythmia,
.
In pooled data from nine studies179 performed in 506 .. orthepresenceofsomeasymptomaticsignificantarrhythmias
.
patients with unexplained syncope at the end of complete nega- .. (definedabove),isdiagnosticofthecauseofsyncopeandspe-
.
tive work-up, a correlation between syncope and ECG was ... cifictreatmentmustbeprescribed.
.
found in 176 patients (35%); of these, 56% had asystole (or .
.. The principal limitation of any ECG monitoring device is the
bradycardia in a few cases) at the time of the recorded event, .
.. inability to record BP together with ECG. In reflex syncope, the
11% had tachycardia, and 33% had no arrhythmia. Presyncope .
.. documentationofbradycardia/asystoleduringasyncopalepisode
was much less likely to be associated with an arrhythmia than .
.. doesnotruleoutthepossibilitythatahiddenhypotensivereflex
syncope. Similar findings were subsequently observed with ILR .
.. istheprincipalcauseforsyncope,andthatbradycardia/asystoleis
use expanded in an early phase of evaluation in patients with .
.. a secondary late event. This issue has important implications for
recurrent syncope of uncertain origin, in the absence of high- .
risk criteria and structural heart disease,176,180–183 and in sus-
... therapy (see section 5). A classification of ECG recordings with
pected reflex syncope.184–186 In particular, an asystolic pause
... theirprobablerelatedpathophysiologyisavailableinWebTable6
.. andWebPracticalInstructionssection8.
was present during syncope in about 50% of these patients. .
Downloaded
from
https://academic.oup.com/eurheartj/article/39/21/1883/4939241
by
guest
on
22
January
2026
--- Страница 25 ---
ESCGuidelines 1907
Electrocardiographicmonitoring
Recommendations Classa Levelb
Indications
Immediatein-hospitalmonitoring(inbedorbytelemetry)isindicatedinhigh-riskpatients(definedinTable6). I C
Holtermonitoringshouldbeconsideredinpatientswhohavefrequentsyncopeorpresyncope(>_1episodeperweek).161 IIa B
Externallooprecordersshouldbeconsidered,earlyaftertheindexevent,inpatientswhohaveaninter-symptominterval<_4
IIa B
weeks.162,166,168,201
ILRisindicatedinanearlyphaseofevaluationinpatientswithrecurrentsyncopeofuncertainorigin,absenceofhigh-risk
criteria(listedinTable6),andahighlikelihoodofrecurrencewithinthebatterylifeofthedevice.175,176,181–184,202, I A
SupplementaryDataTable5
ILRisindicatedinpatientswithhigh-riskcriteria(listedinTable6)inwhomacomprehensiveevaluationdidnotdemon-
strateacauseofsyncopeorleadtoaspecifictreatment,andwhodonothaveconventionalindicationsforprimarypreven- I A
tionICDorpacemakerindication.174,180,187,188,195,SupplementaryDataTables5and6
ILRshouldbeconsideredinpatientswithsuspectedorcertainreflexsyncopepresentingwithfrequentorseveresyncopal
IIa B
episodes.184–186
ILRmaybeconsideredinpatientsinwhomepilepsywassuspectedbutthetreatmenthasprovenineffective.137,189–191,
IIb B
SupplementaryDataTable7
ILRmaybeconsideredinpatientswithunexplainedfalls.191–194,SupplementaryDataTable8 IIb B
Diagnosticcriteria
Arrhythmicsyncopeisconfirmedwhenacorrelationbetweensyncopeandanarrhythmia(bradyarrhythmiaortachyar-
I B
rhythmia)isdetected.172,184–186,188,200
Intheabsenceofsyncope,arrhythmicsyncopeshouldbeconsideredlikelywhenperiodsofMobitzIIsecond-orthird-
degreeAVblockoraventricularpause>3s(withthepossibleexceptionofyoungtrainedpersons,duringsleeporrate- IIa C
controlledatrialfibrillation),orrapidprolongedparoxysmalSVTorVTaredetected.185,188,197–199
Additionaladviceandclinicalperspectives
• Beawarethatthepre-testselectionofthepatientsinfluencesthesubsequentfindings.Includepatientswithahighlikelihoodofarrhythmic
events.Theduration(andtechnology)ofmonitoringshouldbeselectedaccordingtotheriskandthepredictedrecurrencerateof
syncope.158–160,183
• ExcludepatientswithaclearindicationforICD,pacemaker,orothertreatmentsindependentofadefinitediagnosisofthecauseofsyncope.
• Includepatientswithahighprobabilityofrecurrenceofsyncopeinareasonabletime.Owingtotheunpredictabilityofsyncoperecurrence,be
preparedtowaitupto4yearsormorebeforeobtainingsuchacorrelation.203
• Intheabsenceofadocumentedarrhythmia,presyncopecannotbeconsideredasurrogateforsyncope,whereasthedocumentationofasignifi-
cantarrhythmiaatthetimeofpresyncopecanbeconsideredadiagnosticfinding.199
• Theabsenceofarrhythmiaduringsyncopeexcludesarrhythmicsyncope.
AV=atrioventricular;ICD=implantablecardioverterdefibrillator;ILR=implantablelooprecorder;SVT=supraventriculartachycardia;VT=ventriculartachycardia.
aClassofrecommendation.
bLevelofevidence.
.
.
4.2.5Videorecordinginsuspectedsyncope .. relationtoBPandHRobjectivelyandrepeatedly,thushelpingtodis-
.
4.2.5.1 In-hospitalvideorecording .. tinguishVVSfromPPS.Thisapproachhasrevealednewpathophysio-
.
For PNES, a video-electroencephalogram (EEG) forms the highest .. logical insights in syncope.9 Attaching the camera to the tilt table
.
levelofdiagnosticprobability.204ForsyncopeandPPS,videocanplay .. allows detailed study of the face and head, which is useful when
.
a similar, probably underused, role (see section 7). Adding video .. assessing the start and end of LOC.9,205 Video recording of tilt-
.
recordingtoatilttabletestaddstheabilitytoreviewclinicalsignsin . inducedPPS116ensuresthatapparentTLOCoccurswhileBPandHR
Downloaded
from
https://academic.oup.com/eurheartj/article/39/21/1883/4939241
by
guest
on
22
January
2026
--- Страница 26 ---
1908 ESCGuidelines
.
.
are not low; adding an EEG increases the diagnostic probability of . sinoatrialblock,usuallydocumentedby12-leadECGorECGmoni-
.
.
PPSevenfurther.Themethodhasbeenproventoshowthecom- . toring.Theprognosticvalueofaprolongedsinusnoderecoverytime
.
binedpresenceofVVSandPPS.117 .. (SNRT)isnotwelldefined.Anabnormalresponseisdefinedas>_1.6
.
.. or2sforSNRT,or>_525msforcorrectedSNRT.210Oneobservatio-
.
.
4.2.5.2 Homevideorecording . nalstudyshowedarelationshipbetweenthepresenceofprolonged
.
Homevideorecords(bymeansofsmartphonetechnology)arevery .. SNRTatEPSandtheeffectofpacingonsymptoms.211Anothersmall
.
.
usefulinallformsofTLOCtoallowsignsofanattacktobestudied. . prospectivestudyshowed thata corrected SNRT>_800mshadan
.
.
Patientsandtheirrelativesshouldbeurgedtorecordattacks,ifpossi- . eight-foldhigherriskofsyncopethanaSNRTbelowthisvalue.212
.
.
ble,incasesofdiagnosticuncertainty.Inepilepsy,advancesaremade ..
.
towards prolonged video and EEG recording in patients’ .. 4.2.6.2Syncopeinbifascicularbundlebranchblock(impendinghigh-
.
homes.206,207ForsyncopeorPPS,experiencesuggeststhatthechan- .. degreeatrioventricularblock)
.
cesofobtainingavideorecordarehigherforPPSthanforsyncope, .. Patientswithbifascicularblockandsyncopeareathigherriskofdevel-
. whichisprobablytheeffectofahighfrequencyandlongdurationof .. opinghigh-degreeAVblock.213AprolongedHVinterval>_70ms,or
.
attacksinPPS.Itisrareforthebeginningofeventstoberecorded.206 .. inductionofsecond-orthird-degreeAVblockbypacingorbyphar-
.
Homevideorecordsallowcomplexeventssuchassyncope-induced .. macologicalstress(ajmaline,procainamide,ordisopyramide),identi-
.
epilepticseizurestobediagnosed.208 .. fiesagroupathigherriskofdevelopingAVblock.Bycombiningthe
. .. above-mentionedpartsoftheelectrophysiologicalprotocol,apositive
.
.. EPSyieldedapositivepredictivevalueashighas>_80%fortheidentifi-
.
Videorecordinginsuspectedsyncope .. cation of patients who will develop AV block in old studies.214–216
.
.. This finding has been indirectly confirmed by recent studies that
.
.
Recommendations Classa Levelb .. showed a significant reduction in syncopal recurrences in patients
.
. with prolonged HV implanted with a pacemaker compared with a
.
Homevideorecordingsofspontaneous .. controlgroupofuntreatedpatientswithanegativeEPS188,orwitha
.
eventsshouldbeconsidered.Physicians .. controlgroupwhoreceivedanempiricpacemaker.217Theseresults
.
shouldencouragepatientsandtheirrel- IIa C .. justifyanupgradeoftherecommendationforEPS-guidedtherapy(i.e.
.
ativestoobtainhomevideorecordings .. cardiacpacing)inpatientswithapositiveEPSfromclassIIatoclassI.
.
ofspontaneousevents.206,208 ..
.
.
. Evenifthequalityofevidenceismoderate,thereisstrongcon-
Addingvideorecordingtotilttesting .
.
. sensusthatapositiveEPSindicatesthatthelikelymechanism
maybeconsideredinordertoincrease .
.
IIb C . ofsyncopeisparoxysmalAVblock.
thereliabilityofclinicalobservationof .
.
inducedevents.9,116,117,205 .. Conversely,approximatelyone-thirdofpatientswithanegativeEPSin
.
.. whomanILRwasimplanteddevelopedintermittentorpermanentAV
.
aClassofrecommendation.
... blockonfollow-up.187Thus,EPShasalownegativepredictivevalue.
bLevelofevidence. .. MortalityishighinpatientswithsyncopeandBBB.However,neither
.
.. syncopenorprolongedH-Vintervalwereassociatedwithahigherrisk
.
.. ofdeath,andpacemakertherapydidnotdecreasethisrisk.213
.
. .
.
4.2.6 Electrophysiologicalstudy .. 4.2.6.3Suspectedtachycardia
.
.. Inpatientswithsyncopeprecededbyasuddenonsetofbriefpalpita-
. Indications: In an overview of eight studies, including 625 patients .. tionssuggestingSVTorVT,anEPSmaybe indicatedtoassessthe
. withsyncopeundergoingEPS,209positiveresultsoccurredpredomi- .. exactmechanism,especiallywhenacurativecatheterablationproce-
. nantly in patients with structuralheart disease. In recent years, the .. dureisconsideredtobebeneficial.
.
developmentofpowerfulnon-invasivemethods,i.e.prolongedECG .. Inpatientswithapreviousmyocardialinfarctionandpreservedleft
.
monitoring, showing a higher diagnostic value, has decreased the .. ventricular ejection fraction (LVEF), induction of sustained mono-
.
importanceofEPSasadiagnostictest.Inclinicalpractice,registrydata .. morphic VT is strongly predictive of the cause of syncope,218
.
.
show that approximately 3% of patients with unexplained syncope . whereastheinductionofventricularfibrillation(VF)isconsidereda
.
evaluated by cardiologists undergo EPS and even fewer if they are .. non-specific finding.37 The absence of induction of ventricular
.
evaluatedbyotherspecialists.71Nevertheless,EPSremainsusefulfor .. arrhythmiasidentifiesagroupatlowerriskofarrhythmicsyncope.219
.
.
diagnosis in the following specific clinical situations: asymptomatic . The role of EPS and the use of pharmacological challenge by
.
.
sinusbradycardia(suspectedsinusarrestcausingsyncope),bifascicu- . class I antiarrhythmic drugs in patients with syncope and sus-
.
.
lar BBB (impending high-degree AV block), and suspected . pectedBrugadasyndromeiscontroversial.Inarecentmeta-analy-
.
tachycardia. .. sis,220 the risk of arrhythmic events was slightly increased in
.
.
. patientswithahistoryofunexplainedsyncopeoraspontaneous
.
.
Diagnostic criteria: 4.2.6.1 Asymptomatic sinus bradycardia: sus- .. type 1 pattern, and who had induction of VT or VF with one or
.
pectedsinusarrestcausingsyncope .. twoextrastimuli.However,theabsenceofinductioninsuchindi-
.
The pre-test probability of bradycardia-related syncope is relatively .. vidualsdoesnotnecessarilyprecludearrhythmiarisk,particularly
.
high when there is asymptomatic sinus bradycardia (<50 b.p.m.) or . inpatientswithhigh-riskfeatures.
Downloaded
from
https://academic.oup.com/eurheartj/article/39/21/1883/4939241
by
guest
on
22
January
2026
--- Страница 27 ---
ESCGuidelines 1909
Electrophysiologicalstudy
Recommendations Classa Levelb
Indications
Inpatientswithsyncopeandpreviousmyocardialinfarction,orotherscar-relatedconditions,EPSisindicatedwhensyn-
I B
coperemainsunexplainedafternon-invasiveevaluation.218
InpatientswithsyncopeandbifascicularBBB,EPSshouldbeconsideredwhensyncoperemainsunexplainedafternon-inva-
IIa B
siveevaluation.188,214–217,221
Inpatientswithsyncopeandasymptomaticsinusbradycardia,EPSmaybeconsideredinafewinstanceswhennon-invasive
IIb B
tests(e.g.ECGmonitoring)havefailedtoshowacorrelationbetweensyncopeandbradycardia.210–212
Inpatientswithsyncopeprecededbysuddenandbriefpalpitations,EPSmaybeconsideredwhensyncoperemainsunex-
IIb C
plainedafternon-invasiveevaluation.
EPS-guidedtherapy
InpatientswithunexplainedsyncopeandbifascicularBBB,apacemakerisindicatedinthepresenceofeitherabaselineH-V
intervalof>_70ms,second-orthird-degreeHis-Purkinjeblockduringincrementalatrialpacing,orwithpharmacological I B
challenge.188,214–217,221
Inpatientswithunexplainedsyncopeandpreviousmyocardialinfarction,orotherscar-relatedconditions,itisrecom-
I B
mendedthatinductionofsustainedmonomorphicVTismanagedaccordingtothecurrentESCGuidelinesforVA.46
Inpatientswithoutstructuralheartdiseasewithsyncopeprecededbysuddenandbriefpalpitations,itisrecommendedthat
theinductionofrapidSVTorVT,whichreproducehypotensiveorspontaneoussymptoms,ismanagedwithappropriate I C
therapyaccordingtothecurrentESCGuidelines.46,222
Inpatientswithsyncopeandasymptomaticsinusbradycardia,apacemakershouldbeconsideredifaprolongedcorrected
IIa B
SNRTispresent.210–212
Additionaladviceandclinicalperspectives
• Ingeneral,whereasapositiveEPSpredictsthecauseofsyncope,anegativestudyisunabletoexcludeanarrhythmicsyncopeandfurtherevalua-
tioniswarranted.
• TheinductionofpolymorphicVTorVFinpatientswithischaemiccardiomyopathyorDCMcannotbeconsideredadiagnosticfindingofthe
causeofsyncope.
• EPSisgenerallynotusefulinpatientswithsyncope,normalECG,noheartdisease,andnopalpitations.
BBB=bundlebranchblock;DCM=dilatedcardiomyopathy;ECG=electrocardiogram;EPS=electrophysiologicalstudy;ESC=EuropeanSocietyofCardiology;SNRT=sinus
noderecoverytime;SVT=supraventriculartachycardia;VA=ventriculararrhythmia;VF=ventricularfibrillation;VT=ventriculartachycardia.
aClassofrecommendation.
bLevelofevidence.
.
.
4.2.7Endogenousadenosineandotherbiomarkers . and VVS. In parallel, the adenosine/adenosine triphosphate
.
.
EstablishedcardiacbiomarkerssuchastroponinandB-typenatriu- . (ATP)provocationtesthasbeenperformedtodemonstratethe
.
.
reticpeptidehavebeenusedtodistinguishcardiacfromnon-cardiac . utility of adenosine sensitivity and paroxysmal cardioinhibitory
.
.
syncopeandidentifystructuralheartdisease.223–225 .. propensity for the selection of appropriate pacemaker candi-
.
.. dates.4,227,228 The test requires rapid (<2s) injection of a 20 mg
.
4.2.7.1 Adenosine(triphosphate)testandplasmaconcentration .. bolusofATP/adenosineduringECGmonitoring.Theinductionof
.
The purinergic signalling system, including adenosine and its .. AV block with ventricular asystole lasting >6 s, or the induction
.
receptors, has been proposed to be involved in unexplained .. of AV block lasting >10 s, is considered abnormal. ATP testing
.
syncopewithoutprodrome.4,226Alowplasmaadenosinelevelis .. was positive in most patients with syncope of unknown origin
.
associated with paroxysmal AV block or CSS, whereas a high .. (especially syncope without prodrome and without structural
.
levelisseeninthosewithahypotensive/vasodepressivetendency . heartdisease4)butnotincontrols,suggestingthatparoxysmalAV
Downloaded
from
https://academic.oup.com/eurheartj/article/39/21/1883/4939241
by
guest
on
22
January
2026
--- Страница 28 ---
1910 ESCGuidelines
.
.
block could be the cause of unexplained syncope. Although car- . 4.2.7.3Immunologicalbiomarkers
.
.
diacpacingmayleadtosubstantialreductionofsyncopalattacks . AutoantibodiesagainstadrenergicreceptorsinOHandPOTShave
.
in elderly patients with unexplained syncope and a positive ATP .. beenreported,butfurtherstudiesareneeded.232–234
.
test,229 previous studies showed no correlation between ..
.
.
AVblockinducedbyATPandECGfindings(documentedbyILR) .
.
during spontaneous syncope.122,123,227 Thus, the low predictive .. 4.2.8Echocardiography
.
. Forpatientswithsuspectedheartdisease,echocardiographyserves
value of the test does not support its routine use in selecting .
.
. toconfirmorrefutethesuspicionsinequalproportionsandplaysan
patients for cardiac pacing, but rather its positivity suggests that ...
importantroleinriskstratification.235,236Echocardiographyidentifies
it can be used to confirm the suspicion of asystolic syncope ..
. thecauseofsyncopeinveryfewpatientswhennomoretestsare
bymeansofprolongedECGmonitoring.Theroleofendogenous ..
. needed (i.e. severe aortic stenosis, obstructive cardiac tumours or
adenosine release in triggering a special form of asystolic ...
thrombi,pericardialtamponade,oraorticdissection).237–239Inalit-
syncope (so-called adenosine-sensitive syncope) remains under ..
. eraturereview,rightandleftatrialmyxomapresentedwithsyncope investigation. ...
in<20%ofcases.240–244
.
.
.
4.2.7.2 Cardiovascularbiomarkers ..
Somecardiovascularbiomarkersareincreasedinautonomicdysfunc-
... 4.2.8.1Exercisestressechocardiography
tion underlying syncope, such as elevated copeptin (vasopressin),
... Uprightorsemi-supineexercisestress echocardiography to detect
endothelin-1, and N-terminal pro-B-type natriuretic peptide in
... provocableleftventricularoutflowtractobstructionshouldbecon-
OH,113,230,231 whereasatrialnatriuretic peptide may be reduced in
... sideredinpatientswithHCMthatcomplainofexertionalorpostural
POTS.113 At present, the use of cardiovascular biomarkers in the
... syncope,particularlywhenitrecursduringsimilarcircumstances(e.g.
.. whenrushingupstairsorstraining).Agradientof>_50mmHgisusu-
diagnosisofsyncopeawaitsmoreevidenceandverificationininde- .
.. allyconsideredtobethethresholdatwhichleftventricularoutflow
pendentcohorts. .
. tractobstructionbecomeshaemodynamicallyimportant.245–249
Echocardiography
Recommendations Classa Levelb
Indications
Echocardiographyisindicatedfordiagnosisandriskstratificationinpatientswithsuspectedstructuralheartdisease.235,236 I B
Two-dimensionalandDopplerechocardiographyduringexerciseinthestanding,sitting,orsemi-supinepositiontodetect
provocableleftventricularoutflowtractobstructionisindicatedinpatientswithHCM,ahistoryofsyncope,andaresting I B
orprovokedpeakinstantaneousleftventricularoutflowtractgradient<50mmHg.245–249
Diagnosticcriteria
Aorticstenosis,obstructivecardiactumoursorthrombi,pericardialtamponade,andaorticdissectionarethemostprob-
I C
ablecausesofsyncopewhentheelectrocardiogramshowsthetypicalfeaturesoftheseconditions.237–244
Additionaladviceandclinicalperspectives
• Forpatientswithoutsuspectedcardiacdiseaseafterhistorytaking,physicalexamination,andelectrocardiography,theelectrocardiogramdoes
notprovideadditionalusefulinformation,suggestingthatsyncopealoneisnotanindicationforechocardiography.
• ComputedtomographyorMRIshouldbeconsideredinselectedpatientspresentingwithsyncopeofsuspectedcardiacstructuraloriginwhen
echocardiographyisnotdiagnostic.
HCM=hypertrophiccardiomyopathy;MRI=magneticresonanceimaging.
aClassofrecommendation.
bLevelofevidence.
Downloaded
from
https://academic.oup.com/eurheartj/article/39/21/1883/4939241
by
guest
on
22
January
2026
--- Страница 29 ---
ESCGuidelines 1911
4.2.9Exercisestresstesting
Exercise-induced syncope is infrequent, and the literature is lim- Coronaryangiography
ited to case reports. Exercise testing should be performed in
patients who have experienced episodes of syncope during or Recommendations Classa Levelb
shortly after exertion. Syncope can occur during or immediately
Indications
after exercise. These two situations should be considered sepa-
rately. Indeed, syncope occurring during exercise is likely due to Inpatientswithsyncope,thesameindica-
cardiaccauses(eventhoughsomecasereportshaveshownthatit tionsforcoronaryangiographyshouldbe
IIa C
mightbeamanifestationofanexaggeratedreflexvasodilatation), consideredasinpatientswithout
whereassyncopeoccurringafterexerciseisalmostinvariablydue syncope.258
to a reflex mechanism.250–252 Tachycardia-related exercise-
Additionaladviceandclinicalperspectives
inducedsecond-andthird-degreeAVblockhasbeenshowntobe
locateddistaltotheAVnode253andpredictsprogressiontoper- Angiographyaloneisnotdiagnosticofthecauseofsyncope.
manentAVblock.254,255ArestingECGfrequentlyshowsintraven-
tricular conduction abnormalities,253,254 but cases with a normal aClassofrecommendation.
bLevelofevidence.
resting ECG have also been described.256,257 There are no data
supporting an indication for exercise testing in a general popula-
.
tionwithsyncope. .. 5. Treatment
.
.
.
.
.
. 5.1 General principles of treatment of
.
.
Exercisetesting .. syncope
.
.
.. The general framework of treatment is based on risk stratification
.
Recommendations Classa Levelb .. andtheidentificationofspecificmechanismswhenpossible(Figure8).
.
.. Thefollowingthreegeneralprinciplesshouldbeconsidered:
Indications .
.
.
. • The efficacy of therapy aimed at preventing syncope recurrence
.
Exercisetestingisindicatedinpatientswho .
. is largely determined by the mechanism of syncope rather than
.
experiencesyncopeduringorshortlyafter I C .. its aetiology. Bradycardia is a frequent mechanism of syncope.
.
exertion. .. Cardiacpacingisthemostpowerfultherapyforbradycardiabut
.
. its efficacy is less if hypotension coexists (see Table 9 and
Diagnosticcriteria ..
. SupplementaryDataTable9).Thetreatmentofsyncopeduetoa
.
Syncopeduetosecond-orthird-degreeAV .. hypotensivereflexortoOHismorechallengingbecausespecific
.
b dl eo vc ek lois psco dn ufi rir nm ge ed xew rh ce isn e,t eh ve eA nV wb itl ho oc uk
t
I C
......
•
Othe ftr ea np ,ie ts hea rr ae pl yes ts oef pfe rc et vi eve n.
t recurrence differs from that for the
. underlying disease. The management of patients at high risk of
syncope.253–257 ..
. SCD requires careful assessment of the individual patient’s risk
.
Reflexsyncopeisconfirmedwhensyncope .. (seesection5.5).
. isreproducedimmediatelyafterexercisein I C .. • Syncopalrecurrencesoftendecreasespontaneouslyaftermedical
.
thepresenceofseverehypotension.250–252 .. assessment,evenintheabsenceofaspecifictherapy;ingeneral,
.
. syncope recurs in <50% of patients within 1–2 years (see
. Additionaladviceandclinicalperspectives .. Supplementary Data Table 10). The decrease seems to be more
. Therearenodatasupportingroutineexercisetestinginpatients .. evident when there is a lack of a clear anatomical substrate for
. withsyncope. .. syncope, such as in the case of reflex syncope and unexplained
.
.. syncope. The reason for this decrease is not known. Several
.
. potential clinical, statistical, and psychological explanations have
AV=atrioventricular. ..
aClassofrecommendation. .. been provided and all probably play a role (see Supplementary
bLevelofevidence. .. DataTable10).Whateverthereason,thepossibilityofspontane-
.
.. ous improvement has major practical importance for treatment
.
. that can be postponed in low-risk conditions. The consequence
.
.
. ofthespontaneousdecreaseisthatanytherapyforsyncopepre-
.
.
. vention appears to be more effective than it actually is, which
4.2.10Coronaryangiography .
.. makestheresultsof observationaldata ontherapyquestionable
Inpatientspresentingwithsyncopeandobstructivecoronaryartery .
.. intheabsenceofacontrolgroup.
disease,percutaneouscoronaryinterventionisnotassociatedwitha ..
.
significant reduction in readmission for syncope.258 Angiography ..
.
alone isnot diagnostic ofthecauseof syncope. Therefore, cardiac ..
catheterizationtechniquesshouldbecarriedoutinsuspectedmyo- ... 5.2 Treatment of reflex syncope
.
cardial ischaemia or infarction with the same indications as for .. Despite its benign course, recurrent and unpredictable reflex syn-
.
patientswithoutsyncope. . cope may be disabling. The cornerstone of management of these
Downloaded
from
https://academic.oup.com/eurheartj/article/39/21/1883/4939241
by
guest
on
22
January
2026
--- Страница 30 ---
1912 ESCGuidelines
Figure 8 Generalframeworkoftreatmentisbasedonriskstratificationandtheidentificationofspecificmechanismswhenpossible.ARVC=
arrhythmogenicrightventricularcardiomyopathy;CAD=coronaryarterydisease;DCM=dilatedcardiomyopathy;ECG=electrocardiographic;
HCM=hypertrophiccardiomyopathy;ICD=implantablecardioverterdefibrillator;LQTS=longQTsyndrome;SCD=suddencardiacdeath.
Table9 Expectedsyncoperecurrencerateswithapermanentpacemakerindifferentclinicalsettings(formore
detailsseeSupplementaryData Table9).
Clinicalsetting Expected2-yearsyncoperecurrencerate
withcardiacpacing
Syncopeduetoestablishedbradycardiaandabsenceofhypotensivemechanism Highefficacy(<_5%recurrencerate)
Syncopeduetoestablishedbradycardiaandassociatedhypotensivemechanism Moderateefficacy(5–25%recurrencerate)
Syncopeduetosuspectedbradycardiaandassociatedhypotensivemechanism Lowefficacy(>25%recurrencerate)
.
patients is non-pharmacological treatment, including education, .. 5.2.1Educationandlifestylemodifications
.
lifestylemodification,andreassuranceregardingthebenignnatureof .. Education and lifestyle modifications have not been evaluated in
.
thecondition. .. randomizedstudies,butthereisaconsensusforimplementingthem
.
Additionaltreatmentmaybenecessaryinpatientswithsevereforms, .. as first-linetherapy in all cases. Thesecomprisereassuranceabout
.
as defined in Web Practical Instructions section 2.3, in particular: when .. thebenignnatureofthedisease,educationregardingawarenessandthe
.
very frequent syncope alters quality of life; when recurrent syncope .. possible avoidance of triggers and situations (e.g. dehydration and/or
.
without,orwithaveryshort,prodromeexposesthepatienttoariskof .. hot crowded environments), and theearly recognition of prodromal
.
trauma;andwhensyncopeoccursduringahigh-riskactivity(e.g.driving, .. symptoms in order to sit or lie down and activate counter-pressure
.
machineoperation,flying,orcompetitiveathletics,etc.).Only14% of .. manoeuvres without delay. If possible, triggers should be addressed
.
.
thehighlyselectedpopulationwithreflexsyncopewhoarereferredto . directly,suchascoughsuppressionincoughsyncope,micturitioninthe
.
specializedsyncopeunitsmayneedsuchadditionaltreatment.186Ingen- .. sittingposition,etc.Increasedintakeoforalfluidsisalsoadvised.Salt
.
.
eral,notherapyisappropriateforeveryformofreflexsyncope.The . supplementation at a dose of 120 mmol/day of sodium chloride has
.
mostimportantdiscriminantforthechoiceoftherapyisage.Adecision .. beenproposed.259Ingeneral,>50%ofpatientswithrecurrentsyncopal
.
.
pathwayfortheselectionofaspecifictherapyaccordingtoage,severity . episodesinthe1or2yearsbeforeevaluationdonothavesyncopal
.
.
ofsyncope,andclinicalformsissummarizedinFigure9. . recurrencesinthefollowing1or2yearsand,inthosewithrecurrences,
Downloaded
from
https://academic.oup.com/eurheartj/article/39/21/1883/4939241
by
guest
on
22
January
2026
--- Страница 31 ---
ESCGuidelines 1913
Figure9 Schematicpracticaldecisionpathwayforthefirst-linemanagementofreflexsyncope(basedonpatient’shistoryandtests)accordingto
age,severityofsyncope,andclinicalforms.Youngerpatientsarethoseaged<40yearswhileolderpatientsare>60years,withanoverlapbetween40
and60years.Severityofreflexsyncopeisdefinedinthetext.Thedurationofprodromeislargelysubjectiveandimprecise.Avalueof<_5sdistinguishes
arrhythmicfromreflexsyncope49;inpatientswithoutstructuralheartdisease,aduration>10scandistinguishreflexsyncopefromcardiacsyncope.38
Inpractice,theprodromeis‘absentorveryshort’ifitdoesnotallowpatientsenoughtimetoact,suchastositorliedown.Theheading’lowBPphe-
notype’identifiespatientswithchroniclowBPvalues(ingeneral,systolicaround110mmHg,whohaveaclearhistoryoforthostaticintoleranceand
orthostaticVVS).Thegroup‘dominantcardioinhibition‘identifiespatientsinwhomclinicalfeaturesandresultsoftestssuggestthatsuddencardioinhibi-
tionismainlyresponsibleforsyncope.Onesuchclueislackofprodrome,sopatientswithoutprodromesmay,afteranalysis,fallintothiscategory.
Remark:
(cid:3) Overlapbetweensubgroupsisexpected.
(cid:3) Inselectedcases,pacingmaybeusedinpatientsaged<40years.ThisTaskForcecannotgiverecommendationsduetothelackof
sufficientevidencefromstudies.
(cid:3) Inselectedcases,fludrocortisonemaybeusedinpatientsaged>60years.ThisTaskForcecannotgiverecommendationsdueto
thelackofsufficientevidencefromstudies.
(cid:3) Midodrinecanbeusedatanyageevenifexistingstudieswereperformedinyoungpatients.
(cid:3) Patients with short or no prodrome should continue investigations to identify the underlying mechanism and guide subsequent
therapy.
(cid:3) SometimesanILRstrategyshouldalsobeconsideredinpatientsaged<40years.
BP=bloodpressure;ILR=implantablelooprecorder;VVS=vasovagalsyncope.
aSpontaneousorprovokedby,sequentially,carotidsinusmassage,tilttesting,orILR.
.
.
the burden of syncope decreases by >70% compared with the . Despitethelackofcontrolledstudies,thereisstrongconsensus
.
.
preceding period. The effect of education and reassurance is . thateducationandlifestylemodificationshaveahighimpact
.
.
probably the most likely reason for the decrease in syncope . inreducingrecurrenceofsyncope.
.
.
(seeSupplementaryDataTable10).Anexampleofapatientinstruction .
.
.
sheetcanbefoundintheWebPracticalInstructionssection9.1:European .. 5.2.2Discontinuation/reductionofhypotensivetherapy
.
SocietyofCardiologyinformationsheetforpatientsaffectedbyreflex .. Carefulavoidance ofagentsthatlowerBP, i.e.anyantihyperten-
.
syncope. . sive agents, nitrates, diuretics, neuroleptic antidepressants, or
Downloaded
from
https://academic.oup.com/eurheartj/article/39/21/1883/4939241
by
guest
on
22
January
2026
--- Страница 32 ---
1914 ESCGuidelines
.
.
dopaminergicdrugs,iskeyinthepreventionofrecurrenceofsyn- . Thereissufficientevidencefrommultipletrialsthattilttrain-
.
cope. In a small randomized trial260 performed in 58 patients .. ing has little efficacy in reducing recurrence of syncope in
.
.
(mean age 74 ± 11 years) affected by vasodepressor reflex syn- . youngpatientswithlong-lastingrecognizableprodromalsymp-
.
.
copediagnosedbytilttestingorCSM,whoweretakingonaverage . toms.Furtherresearchisunlikelytohaveanimportantimpact
.
.
2.5hypotensivedrugs,discontinuationorreductionofthevasoac- . onourconfidenceintheestimate.
.
.
tive therapy caused a reduction of the rate of the primary com- .
.
.
binedendpointofsyncope,presyncope,andadverseeventsfrom .
.
.
50to19%(hazardratio0.37)comparedwithacontrolgroupwho .. 5.2.5Pharmacologicaltherapy
.
continuedhypotensivetherapyduringafollow-upof9months.In .. Pharmacological therapy may be considered in patients who have
.
theSystolicBloodPressureInterventionTrial,261patientsathigh .. recurrent syncope despite education and lifestyle modifications
.
cardiovascularriskwhowerealreadyusingantihypertensivedrugs .. includingtraininginPCM.Manydrugshavebeentestedinthetreat-
.
targeting a systolic BP of 120 mmHg had an approximately two- .. mentofreflexsyncope,forthemostpartwithdisappointingresults.
. foldriskofsyncopevs.thecontrolgrouptargetingasystolicBPof .. Whileresultshavebeensatisfactoryinuncontrolledtrialsorshort-
.
140mmHg.Inashort-termrandomizedtrial262conductedin32 .. termcontrolledtrials,severallong-termplacebo-controlledprospec-
.
patients affected by CSS, withdrawal of vasodilator therapy .. tivetrialshavenotshownabenefitoftheactivedrugoverplacebo,
.
reduced the magnitude of the vasodepressor reflex induced by .. withsomeexceptions.
. CSM. ..
.
.
. 5.2.5.1Fludrocortisone
.
Thereismoderateevidencethatdiscontinuation/reductionof .. Fludrocortisone, by increasing renal sodium reabsorption and
.
hypotensive therapy targeting a systolic BP of 140 mmHg .. expandingplasmavolume,maycounteractthephysiologicalcascade
.
shouldbeeffectiveinreducingsyncopalrecurrencesinpatients .. leading to the orthostatic vasovagal reflex.273 The mechanism of
.
.
with hypotensive susceptibility. Further research is likely to . actioncanbecomparedwiththatofsalineinfusion,whichhasalso
.
haveanimportantimpactonourconfidenceintheestimate. .. proved effective in acute tilt test studies.274 The Prevention of
.
.. SyncopeTrial(POST)2275enrolled210young(medianage30years)
.
.
. patientswithlow–normalvaluesofarterialBPandwithoutcomor-
5.2.3Physicalcounter-pressuremanoeuvres ..
. bidities,andrandomizedthemtoreceivefludrocortisone(titratedat
IsometricmusclecontractionsincreasecardiacoutputandarterialBP ..
during the phase of impending reflex syncope. Three clinical stud-
... adosageof0.05–0.2mgonceperday)orplacebo.Theprimaryend-
ies119,120,263 and one prospective multicentre randomized trial121
... pointshowedonlyamarginalnon-significantreductioninsyncopein
.. thefludrocortisonegroupcomparedwiththeplacebogroup(hazard
assessedtheeffectivenessofphysicalcounter-pressuremanoeuvres .
.. ratio0.69,95%CI0.46–1.03;P=0.069),whichbecamemoresignifi-
(PCM)ofthelegsorarmsandshowedthattheyallowedthepatient .
.. cantwhentheanalysiswasrestrictedtopatientswhoachieved0.2
toavoidordelaylosingconsciousnessinmostcases.InthePhysical .
CounterpressureManoeuvresTrial(PC-Trial),121223patientsaged
... mg/daydosestabilizationat2weeks.Theclinicalbenefitoffludrocor-
.. tisonetherapywasmodest:at12months,44%ofpatientsintheflu-
38±15yearswithrecurrentreflexsyncopeandrecognizablepro- .
.. drocortisone arm continued to suffer syncope, a rate only slightly
dromalsymptomswererandomizedtoreceivestandardizedconven- .
.. lowerthanthe60.5%rateobservedintheplaceboarm.Inthemean-
tional therapy alone or conventional therapy plus training in PCM. .
.. time,asimilarnumberofpatientsdiscontinuedfludrocortisonether-
Actuarial recurrence-free survival was better in the PCM group .
.. apy owing to side effects, thus equating the benefit/risk ratio.
(log-rankP=0.018),resultinginarelativeriskreductionof39%(95% .
.. Fludrocortisoneshouldnotbeusedinpatientswithhypertensionor
CI 11–53). No adverse events were reported. A limitation of this .
.
. heartfailure.Fludrocortisonewasineffectiveinasmallrandomized
treatmentisthatitcannotbeusedinpatientswithshortorabsent . .. double-blindtrialinchildren.276
prodromeandthatPCMarelesseffectiveinpatientsolderthan60 ..
.
years.264AninstructionsheetonhowtoperformPCMcanbefound ..
. Thereismoderateevidencethatfludrocortisonemaybeeffec-
intheWebPracticalInstructionssection9.2. ..
. tive in reducing syncopal recurrences in young patients with
.
.
. lownormal values of arterial BP and without comorbidities.
ThereismoderateevidencethatPCMiseffectiveinreducing ..
. Furtherresearchislikelytohaveanimportantimpactonour
syncopal recurrences in patients <60 years old with long- ..
. confidenceintheestimateofeffect.
lastingrecognizableprodromalsymptoms. ..
.
.
.
. 5.2.5.2Alpha-agonists
.
.
5.2.4Tilttraining . Asfailuretoachievepropervasoconstrictionoftheperipheralves-
.
.
In highly motivated young patients with recurrent vasovagal symp- .. selsiscommoninreflexsyncope,alpha-agonistvasoconstrictors(eti-
.
tomstriggeredbyorthostaticstress,theprescriptionofprogressively .. lefrineandmidodrine)havebeenused.Etilefrinehasbeenstudiedin
.
prolongedperiodsofenforceduprightposture(so-calledtilttraining) .. alargerandomizedplacebo-controlleddouble-blindtrial.277During
.
has been proposed toreducesyncope recurrence.265 Whilesome .. follow-up,patientstreatedtwicedailywithetilefrine25mgorpla-
.
studies suggested modestbenefit withoutpatienttilttraining,266,267 .. ceboshowednodifferenceinthefrequencyofsyncopeorthetime
.
most controlled trials reported no significant effect.268–272 .. torecurrence.Midodrine[usually2.5–10mg,threetimesdaily(t.i.d)]
.
Moreover, this treatment is hampered by the low compliance of .. hasprovedeffectiveinsmallstudiesbutnonesatisfiedthecriteriaof
.
patientsincontinuingthetrainingprogrammeforalongperiod. . a pivotal clinical trial. A recent systematic review of these trials278
Downloaded
from
https://academic.oup.com/eurheartj/article/39/21/1883/4939241
by
guest
on
22
January
2026
--- Страница 33 ---
ESCGuidelines 1915
.
showedthattheconfidenceinestimateswasmoderatebecauseof .. orthostaticVVS.287Norepinephrinetransportinhibitors(reboxetine
.
.
imprecisionandpublicationbias.Themostfrequentsideeffectsthat . andsibutramine)leadtoaselectiveincreaseinsympathetictonedur-
.
.
ledtodiscontinuationofmidodrineweresupinehypertension,pilo- . ingstressbyinhibitingthereuptakeofnorepinephrineinsympathetic
.
.
motorreactions,andurinaryproblems(urinaryretention,hesitancy, . neuronal synapses. In double-blind, randomized, crossover fashion,
.
.
or urgency). The major limitation of midodrine is frequent dosing, . reboxetineandsibutramineblockorattenuatethevasovagalreflex
.
whichlimitslong-termcompliance.Overall,thesedatasuggestthat .. during tilt testing.288 In an open-label prospective clinical study in
.
.
chronicpharmacologicaltreatmentwithalpha-agonistsalonemaybe . sevenverysymptomaticpatientswhohadnotrespondedtoanypre-
.
.
oflittleuseinreflexsyncopeandthatlong-termtreatmentcannotbe . vioustreatment,sibutramineachieved94%suppressionofsyncopal
.
.
advisedforoccasionalsymptoms. .. episodesat6months.289
.
.. Ganglionicplexusablation.Radiofrequencyablationofvagalganglia
.
There are contrastingresultsfrommultiple trials that alpha- .. locatedclosetothesinusnodeandAVnodewasreportedtoabolish
.
agonistsmaybeeffectiveinreducingsyncopalrecurrencesin .. thevagalefferentoutputduringVVSinsomeobservationalstudies
. patientswiththeorthostaticformofVVS.Furtherresearchis .. andcase reports.290,291 However,owingto a weakrationale,small
.
likely to have an important impact on our confidence in the .. populations, weak documentation of follow-up results, procedural
.
estimate. .. risks,andlackofcontrolgroups,thecurrentevidenceisinsufficient
.
.. toconfirmtheefficacyofvagalgangliaablation.
. 5.2.5.3 Beta-blockers ..
.
Beta-blockershavebeenpresumedtolessenthedegreeofventricu- ..
.
lar mechanoreceptor activation owing to their negative inotropic .. 5.2.6Cardiacpacing
.
effectinreflexsyncope.Thistheoryhasnotbeensupportedbythe .. Permanentpacemakertherapymaybeeffectiveifasystoleisadomi-
.
.
outcomeofclinicaltrials.Beta-blockersfailedtobeeffectiveinVVS . nant feature of reflex syncope. Establishing a relationship between
.
in two randomized double-blindcontrolled trials.279,280A rationale .. symptomsandbradycardiashouldbethegoaloftheclinicalevalua-
.
.
fortheuseofbeta-blockersinotherformsofneutrally-mediatedsyn- . tionofpatientswithsyncopeandanormalbaselineECG.Theefficacy
.
.
cope is lacking. It should be emphasized that beta-blockers may . of pacing depends on the clinical setting. A comparative table of
.
.
enhancebradycardiainCSS. . results in different settings is reported in the Supplementary Data
.
.
. Table 9. Figure 10 summarizes the recommended indication for
.
.
There is sufficient evidence from multiple trials that beta- .. pacing.
.
blockersarenotappropriateinreducingsyncopalrecurrences. .
.
.
Desirableandundesirableeffectsarecloselybalanced. .. 5.2.6.1Evidencefromtrialsinsuspectedorcertainreflexsyncopeand
.
.. electrocardiogram-documentedasystole
.
5.2.5.4 Otherdrugs .. Intwoobservationalstudies,cardiacpacingreducedsyncopeburden
.
Paroxetine,aselectiveserotoninreuptakeinhibitor,waseffectivein .. inpatientswithdocumentedasystolicsyncopeby92184and83%,200
.
one placebo-controlled trial, which included highly symptomatic .. but did not prevent all syncopal events. In the randomized
.
patientsfromoneinstitution.281Thisfindinghasnotbeenconfirmed .. double-blind Third International Study on Syncope of Uncertain
.
in other studies and has no experimental support. Conversely, .. Etiology(ISSUE)-3 trial,185 77patients who haddocumentation,by
.
humanstudieswithdifferentsubtypesofserotonin-receptorantago- .. meansofILR,ofsyncopewith>_3-sasystoleor>_6-sasystolewithout
.
nists demonstrated a decreased tolerance to tilt.1,282 In a small .. syncopewererandomlyassignedtoreceiveeitherdual-chamberpac-
.
randomizedtrial,benzodiazepinewasaseffectiveasmetoprolol.283 .. ingwithratedropresponseorsensingonly.Duringfollow-up,the2-
.
Asomatostatinanalogue(octreotide)284wasusedinafewpatients .. yearestimatedrateofsyncoperecurrencewas57%withpacemaker
. affectedbyorthostaticintoleranceanditseffectcannotbeproperly .. off and 25% with pacemaker on (log-rank P¼0.039). The risk of
. evaluated. .. recurrencewasreducedby57%.IntheILRsubgroupofthemulti-
. .. centreSyncopeUnitProject(SUP)2study,292theestimatedratesof
.
.
5.2.5.5 Emergingnewtherapiesinspecificsubgroups . syncoperecurrencewithpacingwere11%at1year,24%at2years,
.
.
Low-adenosine phenotype. In a series of case reports, theophylline . and24%at3years,andweresignificantlylowerthanthecorrespond-
.
.
appearedeffectiveinpatientswithrecurrentsuddenonset(pre)syn- . ingratesobservedinuntreatedcontrolpatients.Theaboveevidence
.
.
cope who presented with the common biological characteristic of . supportsaclassIIarecommendation
.
lowcirculatingadenosinelevels.285,286Theophyllineisanon-selective ..
.
.
adenosine receptor antagonist that is potentially effective when . Thereissufficientevidencethatdual-chambercardiacpacing
.
.
adenosineissuspectedtobeinvolvedinthemechanismofsyncope. . should be considered to reduce recurrence of syncope when
.
.
An intra-patient comparison between a period with and a period .. thecorrelation between symptomsand ECG isestablished in
.
without theophylline therapy, with the support of prolonged ECG .. patients(cid:4)40yearsofagewiththeclinicalfeaturesofthosein
.
monitoring,showedthatsymptomsdisappearedandthenumberof .. theISSUEstudies.
.
prolongedasystolicpauseswasimpressivelyreducedfromamedian .
.
.
of1.11permonthduring13monthsofnotreatmentto0permonth .. 5.2.6.2Evidencefromtrialsinpatientswithcarotidsinussyndrome
.
during20monthsoftheophyllinetreatment. .. The evidence supporting the benefit of cardiac pacing in patients
.
Low-norepinephrine phenotype. A mismatch between sympathetic .. affectedbycardioinhibitoryCSSislimitedtoafewsmallcontrolled
.
nerveactivityandnorepinephrinespilloverispresentinpatientswith . trialsandretrospectiveobservationalstudies.Inareview293including
Downloaded
from
https://academic.oup.com/eurheartj/article/39/21/1883/4939241
by
guest
on
22
January
2026
--- Страница 34 ---
1916 ESCGuidelines
Figure10Summaryofindicationsforpacinginpatientswithreflexsyncope.CI-CSS=cardioinhibitorycarotidsinussyndrome.
.
.
12studiesforatotalof601pacedand305unpacedpatients,thesyn- . 5.2.6.3Evidencefromtrialsinpatientswithtilt-inducedvasovagal
.
.
copalrecurrencerateduringfollow-uprangedfrom0–20%withpac- . syncope
.
.
ing, whereas the recurrence of syncope was always higher in . Effectiveness of pacing in patients with tilt-induced VVS has been
.
untreatedpatients,whoshowedaratebetween20–60%.Inameta- .. studiedinfivemulticentreRCTs.296–300Whencombiningtheresults
.
analysis of the three studies293 with a control group of untreated .. ofthesetrials,318patientswereevaluated;syncoperecurredin21%
.
.
patients,syncoperecurredin9%of85pacedpatientsandin38%of . ofthepacedpatientsandin44%ofunpacedpatients(P<0.001).A
.
.
91controls(relativerisk0.24,95%CI0.12–0.48).Inasingle-centre . meta-analysisofallstudiessuggestedanon-significant17%reduction
.
.
registry of 169 consecutive patients treated with pacemakers, the . insyncopefromthedouble-blindstudies,andan84% reductionin
.
actuarialestimateofsyncopalrecurrencewas7%at1year,16%at .. thestudieswherethecontrolgroupdidnotreceiveapacemaker.301
.
.
3years,and20%at5years.90IntheCSSsubgroupofthemulticentre .. Ingeneral,pacingwasineffectiveintrialsthatenrolledpatientswith-
.
SUP2study,292theestimatedsyncoperecurrencerateswithpacing .. outanasystolictiltresponse.299,300Allofthesestudieshavelimita-
.
were9%at1year,18%at2years,and20%at3years,andweresignif- .. tions, and a direct comparison is somewhat difficult because of
.
icantly lower than the corresponding rates observed in untreated .. important differences in study design, largely focused on patient
. controls, which were 21%, 33%, and 43%, respectively. Given the .. selection.Overall,intypicalvasovagalpopulations,pacingseemsto
. similaroutcomeofpatientswithreflexspontaneousasystolicpauses .. havemarginalefficacy.
. andthosewithCSS,thisTaskForcevotedtodowngradetherecom- .. Therationalefortheefficacyofcardiacpacingisthatthecardioin-
.
mendationforpacinginpatientswithCSSfromclassI(asinthe2013 .. hibitoryreflexisdominantinsomepatients,asthereisnorolefor
.
ESCPacingGuidelines294)toclassIIa. .. pacinginthepreventingvasodilatationandhypotension.Inasubstudy
.
.. oftheISSUE-3trial,302anasystolicresponseduringtilttestingpre-
.
DespitethelackoflargeRCTs,thereissufficientevidencethat .. dictedasimilarasystolicformduringspontaneousILR-documented
.
dual-chamber cardiac pacing should be considered to reduce .. syncope,withapositivepredictivevalueof86%.Inthetiltsubgroup
.
syncopal recurrences in patients affected by dominant cardi- .. oftheSUP2study,292among38patientswithdominantcardioinhibi-
.
oinhibitoryCSS. .. toryreflex(withameanasystolicpauseof22±16s)theestimated
.
.
. ratesofsyncoperecurrencewithpacingwere3%at1year,17%at2
.
.
Twovariablesarewellknowntohampertheefficacyofpacingther- . years,and23%at3years;thesefiguresweresignificantlylowerthan
.
apyinCSS:themixedforms93,98(seealsoWebPracticalInstructions .. the corresponding rates observed in untreated controls, and were
.
.
section5)andtheassociationwithpositivityoftilttesting.Patients . similar to those observed in patients with CSS or with ECG-
.
.
whohavepositivetilttestshave a three-foldgreaterprobability of . documented asystole. In a recent multicentre crossover RCT per-
.
.
syncoperecurrenceafterdualchamberpacingthanthosewithnega- . formedin46patientsaged>40years,affectedbyseverelyrecurrent
.
tivetilttests293,295;thus,whentilttestingispositive,cautionmustbe .. (>5 episodes during life) cardioinhibitory VVS,303 during 24-month
.
.
recommendedoverpacemakerimplantation. . follow-up,syncoperecurredin4(9%)patientstreatedwithadual-
Downloaded
from
https://academic.oup.com/eurheartj/article/39/21/1883/4939241
by
guest
on
22
January
2026
--- Страница 35 ---
ESCGuidelines 1917
.
.
chamberpacemakerwithclosed-loopstimulationcomparedwith21 . dual-chambercardiacpacingsignificantlyreducedthe2-yearsyncope
.
.
(46%)patientswhohadreceivedashampacemakerprogrammedoff . recurrenceratefrom69%inthecontrolgroupto23%intheactive
.
.
(P=0.0001). .. group.
.
Adding video recording to tilt testing, Saal et al.205 recently ..
.
showed, in patients with asystole, that asystole occurred 3 s .. There is weak evidence that dual-chamber cardiac pacing
.
beforesyncopeorlaterinone-thirdofpatients,inwhomcardioinhi- .. maybeusefulinreducingrecurrencesofsyncopeinpatients
.
bition wastoo late to have primarily caused syncope; in the other .. with the clinical features of adenosine-sensitive syncope.
.
two-thirds of asystolic tilt responses, the cause must have been .. Thedocumentationofpossiblebradyarrhythmiainsponta-
.
mainly cardioinhibition or a combination of cardioinhibition and .. neoussyncoperemainsthepreferredeligibilitycriterionfor
.
vasodepression. .. pacing.
.
The clinical presentation is probably as important as tilt test ..
.
positivity when selecting patients who can benefit from cardiac .. 5.2.6.5Choiceofpacingmode
.
pacing.The SUP 2studypopulationwas characterized by higher .. In CSS, a few small controlled studies304,305 and one registry306
.
mean age, history of recurrent syncope beginning in middle or .. showedthatdual-chamberpacingisbetterthanthesinglechamber
.
.
older age, and frequent injuries, probably due to presentation . ventricularmodeincounteractingBPfallduringCSMandinprevent-
.
withoutwarning.292 .. ing symptom recurrences. Even if the quality of evidence is weak,
. .
. dual-chamberpacingiswidelypreferredinclinicalpractice.
.
.
Owingtothecontrastingresultsoftherandomizedtrials,the . InpatientswithVVS,dual-chamberpacingwasusedmostlywith .
.
estimated benefit of dual-chamber pacing in cardioinhibitory . a rate drop response feature that instituted rapid dual-chamber
.
.
tilt-positive patients is weak. Divergence of opinion exists . pacingifthedevicedetectedarapiddecreaseinHR.Acompari-
.
.
among experts. Further research is very likely to have an . son between dual-chamber closed-loop stimulation and conven-
.
.
important impact on recommendations. Conversely, there is . tional dual-chamber pacing has been performed by means of a
.
.
strong consensus that pacing cannot be offered to patients . crossoverdesignintwosmallstudies;thesestudiesshowedfewer
.
.
with non-cardioinhibitory tilt-positive response, and further . syncope recurrences with closed-loop stimulation, both in the
.
.
tests(e.g.ILR)arewarrantedtodocumentthemechanismof . acutesettingduringrepeatedtilttesting307andduring18-month
.
.
thespontaneousreflex. .. clinicalfollow-up.308
.
.
.
.
5.2.6.4 Evidencefromtrialsinpatientswithadenosine-sensitivesyncope .. 5.2.6.6Selectionofpatientsforpacingandproposedalgorithm
.
Under this term, classified as a non-classical form of reflex syn- .. Thefactthatpacingiseffectivedoesnotmeanthatitisalwaysneces-
.
cope in Table 3, different clinical conditions are included, which .. sary.Inpatientswithreflexsyncope,cardiacpacingshouldbethelast
.
have a supposed role of adenosine in the genesis of syncope in .. choiceandshouldonlybeconsideredinhighlyselectedpatients,i.e.
.
common. .. those>_40yearsofage(mostly>60years),affectedbysevereforms
.
A new clinical entity, called idiopathic AV block, has recently .. of reflex syncope with frequent recurrences associated with a
.
been described inpatients with a long history of syncope and in .. highriskofinjury,oftenduetothelackofprodrome.186Whilethere
.
whomparoxysmalAVblockcouldberecordedatthetimeofsyn- .. isgrowingscepticismoverthediagnosticaccuracyoftilttestingfor
.
coperecurrence.5Thesepatientshadanotherwisenormalheart .. syncopediagnosis,emergingevidencesupportstheuseoftilttesting
.
andnosignofconductiondiseaseonECGandEPS;theyhadvery .. fortheassessmentofreflexhypotensivesusceptibility132,whichmaybe
.
. lowplasmaadenosinelevelsandahighinductionrateoftransient . considered to identify patients with an associated hypotensive
.
.
complete heart block during exogenous injections of adenosine. . responsewhowouldbelesslikelytorespondtopermanentcardiac
.
No syncope recurrence was observed after permanent cardiac .. pacing(seesection4.2.2.2).Inameta-analysis309ofindividualpatient
. .
pacingoververylongperiodsoffollow-upandtherewasnoper- . data from four studies performed in patients with asystolic reflex
. .
manentAVblock. . syncope documented by an ILR, the estimated 3-year recurrence
.
.
Similarly, the entity of ‘low-adenosine syncope’ has recently . rateofsyncopewas2%(95%CI±4%)intilt-negativepatientsand
.
.
been described in patients who have an otherwise unexplained . 33% (95% CI ± 20%) in tilt-positive patients; a positive tilt test .
.
syncope with sudden onset without prodrome, a normal heart, . response was the only significant predictor of syncope recurrence
.
andnormalECG.4Theclinical,laboratory,andbiologicalfeatures .. with a hazard ratio of 4.3. Patients with hypotensive susceptibility
.
.
of these patients are similar to those observed in patients . shouldneedmeasuresdirectedtocounteracthypotensivesuscepti-
.
.
affected by idiopathic paroxysmal AV block. Unlike in VVS, tilt .. bilityinadditiontocardiacpacing,e.g.thediscontinuation/reduction
.
testing is usually negative.4,226 No syncope recurrence was .. of hypotensive drugs and the administration of fludrocortisone or
.
observedafterpermanentcardiacpacingin 10patientswhohad .. midodrine.
.
ECGdocumentationofasystolicpauseduetosinusarrestorAV .. ThealgorithmshowninFigure11hasrecentlybeenprospectively
.
block.286 .. validated in a multicentre pragmatic study, which showed a low
.
Inasmallmulticentretrial227performedin80highlyselectedeld- .. recurrencerateofsyncopewithpacingof9%at1yearand15%at2
.
erlypatientswithunexplainedunpredictablesyncopewhohadapos- .. years, significantly lower than the 22% and 37%, respectively,
.
itiveresponsetointravenousinjectionofabolusof20mgofATP, . observedinunpacedcontrols.186
Downloaded
from
https://academic.oup.com/eurheartj/article/39/21/1883/4939241
by
guest
on
22
January
2026
--- Страница 36 ---
1918 ESCGuidelines
Treatmentofreflexsyncope
Recommendations Classa Levelb
Educationandlifestylemodifications
Explanationofthediagnosis,theprovisionofreassurance,andexplanationoftheriskofrecurrenceandtheavoidanceof
I B
triggersandsituationsareindicatedinallpatients.SupplementaryDataTable10
Discontinuation/reductionofhypotensivetherapy
Modificationordiscontinuationofhypotensivedrugregimenshouldbeconsideredinpatientswithvasodepressorsyncope,
IIa B
ifpossible.260–262
Physicalmanoeuvres
IsometricPCMshouldbeconsideredinpatientswithprodromeswhoare<60yearsofage.119–121,263,264 IIa B
Tilttrainingmaybeconsideredfortheeducationofyoungpatients.265–272 IIb B
Pharmacologicaltherapy
FludrocortisonemaybeconsideredinyoungpatientswiththeorthostaticformofVVS,low–normalvaluesofarterialBP,
IIb B
andtheabsenceofcontraindicationtothedrug.275
MidodrinemaybeconsideredinpatientswiththeorthostaticformofVVS.278 IIb B
Beta-adrenergicblockingdrugsarenotindicated.279,280 III A
Cardiacpacing
Cardiacpacingshouldbeconsideredtoreducesyncopalrecurrencesinpatientsaged>40years,withspontaneousdocu-
mentedsymptomaticasystolicpause(s)>3sorasymptomaticpause(s)>6sduetosinusarrest,AVblock,orthecombina- IIa B
tionofthetwo.184,185,200,292
Cardiacpacingshouldbeconsideredtoreducesyncoperecurrenceinpatientswithcardioinhibitorycarotidsinussyn-
IIa B
dromewhoare>40yearswithrecurrentfrequentunpredictablesyncope.90,292,293
Cardiacpacingmaybeconsideredtoreducesyncoperecurrencesinpatientswithtilt-inducedasystolicresponsewhoare
IIb B
>40yearswithrecurrentfrequentunpredictablesyncope.292,297,298,303
Cardiacpacingmaybeconsideredtoreducesyncoperecurrencesinpatientswiththeclinicalfeaturesofadenosine-sensi-
IIb B
tivesyncope.5,227,286
Cardiacpacingisnotindicatedintheabsenceofadocumentedcardioinhibitoryreflex.299,300 III B
Additionaladviceandclinicalperspectives
• Ingeneral,notherapycancompletelypreventsyncoperecurrenceduringlong-termfollow-up.Adecreaseofthesyncopeburdenisareasonable
goaloftherapy.
• Thefactthatpacingmaybeeffectivedoesnotmeanthatitisalsoalwaysnecessary.Itmustbeemphasizedthatthedecisiontoimplantapace-
makerneedstobemadeintheclinicalcontextofabenignconditionthatfrequentlyaffectsyoungpatients.Thus,cardiacpacingshouldbelimited
toahighlyselectedsmallproportionofpatientsaffectedbyseverereflexsyncope.Patientssuitableforcardiacpacingareolderwithahistoryof
recurrentsyncopebeginninginmiddleorolderageandwithfrequentinjuries,probablyduetopresentationwithoutwarning.Syncoperecur-
renceisstillexpectedtooccurdespitecardiacpacinginaminorityofpatients.
• Tilttestresponseisthestrongestpredictorofpacemakerefficacy.309Patientswithanegativetilttestresponsewillhaveariskofsyncoperecur-
renceofaslowasthatobservedinpatientspacedforintrinsicAVblock.Furtherresearchisveryunlikelytochangetheconfidenceintheesti-
mateofeffect.Onthecontrary,patientswithapositivetilttestresponsewillhaveahigherriskofrecurrenceofsyncopewithalargeconfidence
range,whichmakesanyestimateofthebenefitofpacinguncertain.Furtherresearchiswarranted.
AV=atrioventricular;BP=bloodpressure;PCM=physicalcounter-pressuremanoeuvres;VVS=vasovagalsyncope.
aClassofrecommendation.
bLevelofevidence.
Downloaded
from
https://academic.oup.com/eurheartj/article/39/21/1883/4939241
by
guest
on
22
January
2026
--- Страница 37 ---
ESCGuidelines 1919
No
No
Asystolic
tilt testing?
No
No
Figure11 Decisionpathwayforcardiacpacinginpatientswithreflexsyncope.CI-CSS=cardioinhibitorycarotidsinussyndrome;CSM=carotid
sinusmassage;DDDPM=dual-chamberpacemaker;ILR=implantablelooprecorder.
. 5.3 Treatment of orthostatic hypotension .. chloride.310Rapidingestionofcoolwaterisreportedtobeeffectivein
.
and orthostatic intolerance syndromes
... combatingorthostaticintoleranceandpostprandialhypotension.311
.
.
CurrentmanagementstrategiesforOHaresummarizedinFigure12. ..
.
.
.
. 5.3.3Discontinuation/reductionofvasoactivedrugs
.
5.3.1Educationandlifestylemeasures .. Several studies that have evaluated the association of vasoactive
.
Educationregardingthenatureoftheconditioninconjunctionwiththe .. drugs(i.e.anyantihypertensiveagents,nitrates,diuretics,neuroleptic
.
lifestyle advice outlined in section 5.2.1 can markedly improve ortho- .. antidepressants, or dopaminergic drugs) with OH and falls
.
staticsymptoms,eventhoughtheriseinBPisrelativelysmall(10–15 .. have yielded contrasting results.312 However, intensely prescribed
.
mmHg);raisingstandingBPtojustwithintheautoregulatoryzonecan .. antihypertensivetherapycanincreasetheriskofOH.Intensiveanti-
.
makeasubstantialfunctionaldifference.AmbulatoryBPrecordingsmay ... hypertensivetreatmentcanbedefinedashigherdosesofantihyper-
behelpfulinidentifyingabnormaldiurnalpatterns.Theserecordingsmay ... tensive medications, an increased number of antihypertensive
alsohelpidentifysupineornocturnalhypertensionintreatedpatients. ... drugs, or lowering BP to a target <140/90 mmHg. The total
.
.. numberofBP-loweringmedications313ortheuseofthreeormore
.
5.3.2Adequatehydrationandsaltintake .. antihypertensive drugs may be a significant predictor of OH.314
.
The expansion of extracellular volume is an important goal. In the .. Angiotensin-converting enzyme inhibitors, angiotensin receptors
.
absenceofhypertension,patientsshouldbeinstructedtohaveasufficient .. blockers,andcalciumchannelblockersarelesslikelytobeassociated
.
saltandwaterintake,targeting2–3Loffluidsperdayand10gofsodium . withOHcomparedwithbeta-blockersandthiazidediuretics.315–318
Downloaded
from
https://academic.oup.com/eurheartj/article/39/21/1883/4939241
by
guest
on
22
January
2026
--- Страница 38 ---
1920 ESCGuidelines
Figure12Schematicpracticalguideforthetreatmentoforthostatichypotension.
.
The principal treatment strategy in drug-induced autonomic .. 5.3.8Fludrocortisone
.
failure is eliminating the offending agent. The quality of evi- .. Fludrocortisone(0.1–0.3mgoncedaily)isamineralocorticoidthat
.
denceismoderate.Longer-termfutureRCTsarelikelytohave .. stimulatesrenalsodiumretentionandexpandsfluidvolume.327The
.
animportantimpactondeterminingthenetrisk2benefitratio .. evidenceinfavouroffludrocortisoneisfromtwosmallobservational
.
ofthewithdrawalofculpritmedications. .. studies(incombinationwithhead-upsleeping)andonedouble-blind
.
.. trialin60patients;theobservationalstudiesshowedhaemodynamic
.
5.3.4Counter-pressuremanoeuvres .. benefitand,inthetrial,treatedpatientswerelesssymptomaticwith
.
PCM such as leg crossing and squatting should be encouraged in
.. higherBP.322,327,328
.
.
patientswithwarningsymptomswhoareabletoperformthem.319 .
.. Thedesirableeffectsoffludrocortisoneoutweightheundesirable
.
.. effects.Thequalityofevidenceismoderateandfurtherresearch
.
5.3.5Abdominalbindersand/orsupportstockings .. islikelytohaveanimportantimpactontheestimateofbenefit.
.
Gravitational venous pooling in older patients can be treated with .
.
abdominalbindersorcompressionstockings.23,320,321 ..
.
. 5.3.9Additionaltherapies .
.
. Additionalandlessfrequentlyusedtreatments,aloneorincombina- 5.3.6Head-uptiltsleeping ..
Sleepingwiththeheadofthebedelevated(>10degrees)prevents
... tion, include desmopressin in patients with nocturnal polyuria,
nocturnalpolyuria,maintainsamorefavourabledistributionofbody
... octreotide in postprandial hypotension, erythropoietin in anaemia,
fluids,andamelioratesnocturnalhypertension.104,322,323
... pyridostigmine, the use ofwalking sticks,frequent small meals,and
.. thejudiciousexerciseoflegandabdominalmuscles,especiallyswim-
.
.. ming.Theirefficacyislessestablished.104
5.3.7Midodrine .
.
.
Thealpha-agonistmidodrineisausefuladditiontofirst-linetreatment .
.
.
inpatientswithchronicautonomicfailure.Itcannotberegardedasa . 5.3.10Emergingnewpharmacologicaltherapyinspecific
.
.
cure, nor isit helpful inall affected patients, butit is veryuseful in . subgroups
.
.
some. There is no doubt that midodrine increases BP both in the .. Droxidopa,aprecursorofnorepinephrine,isacentrallyandperiph-
.
supine anduprightposture, andamelioratesthe symptomsofOH. .. erallyactingalpha/beta-agonistapprovedbytheUSFoodandDrug
.
Midodrine (2.5–10 mg t.i.d) was shown to be effective in three .. Administration for the treatment of symptomatic neurogenic OH.
.
randomizedplacebo-controlledtrials.324–326 .. Droxidopahasrecentlybeeninvestigatedforthetreatmentofneu-
.
.. rogenic OH in four short-term RCTs329–332 with a total of 485
.
The desirable effects of midodrine outweigh the undesirable .. patients.TheyshowedamodestincreaseinstandingsystolicBPand
.
effects.Thequalityofevidenceismoderateandfurtherresearch .. the symptom benefit of droxidopa over placebo regarding some
.
islikelytohaveanimportantimpactontheestimateofbenefit. . itemsofqualityoflifeafter2weeksoftreatment,butitsbenefitwas
Downloaded
from
https://academic.oup.com/eurheartj/article/39/21/1883/4939241
by
guest
on
22
January
2026
--- Страница 39 ---
ESCGuidelines 1921
.
.
. 5.4.1.1Sinusnodedisease
.
Treatmentoforthostatichypotension .. In general, cardiac pacemaker therapy is indicated and has proved
.
.
. effectiveinintrinsicsinusnodediseasewhenintermittentsinusarrest
.
.
Recommendations Classa Levelb .. orsinoatrialblockhasbeendemonstratedtoaccountforsyncopeby
.
.. means ofECG documentationduringspontaneous syncope.334–338
Explanationofthediagnosis,theprovision .
.. A frequent situation is that of patients who have prolonged sinus
ofreassurance,andexplanationoftherisk .
I C .. pause following the termination of tachycardia in bradycar-
ofrecurrenceandtheavoidanceoftriggers ...
dia-tachycardia syndrome due to the abnormally prolonged time
andsituationsareindicatedinallpatients. ...
needed for the recovery of automaticity by a diseased sinus node.
.
Adequatehydrationandsaltintakeare .. Permanentpacingdoesnotaffectsurvival.
indicated.310,311
I C ...
.
.. When the correlation between symptoms and ECG is estab-
Modificationordiscontinuationofhypoten- ...
lished,thereisgeneralconsensusthatcardiacpacingiseffec-
sivedrugregimensshouldbe IIa B ...
tiveandusefulforsymptomrelief.
considered.312–318 ...
Intheabsenceoftheabovesituations,despiteadequatepacing,syn-
.
IsometricPCMshouldbeconsidered.319 IIa C ... cope recurs in approximately 15–28% of patients at 5 years339–341
.
. (seeSupplementaryData Table9).Thisisduetothefrequentassocia-
.
Abdominalbindersand/orsupportstockings .
. tionofavasodepressorreflexmechanismwithsinusnodedisease.In .
toreducevenouspoolingshouldbe IIa B .
. patientswithsinusnodediseaseandsyncope,carotidsinushypersen-
considered.23,320,321 ..
. sitivityandapositiveresponsetotiltarepresentin<_50%ofpatients.
.
.
Head-uptiltsleeping(>10degrees)to .. Thus, an increased susceptibility to neurally mediated bradycardia/
increasefluidvolumeshouldbe IIa C
... hypotensionisoftenthecauseofsyncope.135,136Areflexmechanism
.
considered.104,322,323 .. ofsyncopefitswellwiththeunpredictablenaturalhistoryofsyncope
.
. recurrence.Physiciansshouldbeawarethateffectivenessoftherapyis
.
Midodrineshouldbeconsideredifsymp-
IIa B
...
notwelldocumentedinsuchcases.Fromapracticalperspective,car-
tomspersist.324–326 ...
diacpacingmaybeareasonablesolutioninpatientsaffectedbysinus
.
Fludrocortisoneshouldbeconsideredif
.. nodedisease,whohavehaddocumentationofanasymptomaticven-
symptomspersist.322,327,328
IIa C ...
tricularpause>3s(withexceptionsforyoungtrainedpersons,during
.
.. sleep, and medicated patients), when a competitive diagnosis, i.e.
Additionaladviceandclinicalperspectives ... hypotension,canberuledout.294AnabnormalSNRTenhancesthe
• InindividualswithestablishedOHandriskfactorsforfalls, ... probabilityofefficacyofcardiacpacing(seesection4.2.6.1).210–212
.
aggressiveBP-loweringtreatmentshouldbeavoided;their .
.
.
treatmenttargetsshouldberevisedtoasystolicBPvalueof .. When the correlation between symptoms and ECG is not
.
140–150mmHgandmedicationwithdrawalshouldbe .. established,cardiacpacingmaybereasonableinpatientswith
.
considered. .. intrinsic sinus node disease, syncope, and documentation of
.
• TheBP-loweringagents(angiotensin-convertingenzyme .. asymptomaticpause(s).
.
inhibitors,angiotensinreceptorblockers,andcalciumchannel .. Theeliminationofdrugsthatmayexacerbateorunmaskanunderly-
.
blockers)shouldbeusedpreferentially,especiallyamong .. ingsusceptibilitytobradycardiaisanimportantelementinpreventing
.
patientsathighriskoffalls,asdiureticsandbeta-blockersare .. syncope recurrence. Percutaneous cardiac ablative techniques for
.
associatedwithOHandfallsandshouldbeavoidedinat-risk .. the control of atrial tachyarrhythmia have become of increasing
. individuals. .. importance in selected patients with the bradycardia-tachycardia
. .
. formofsicksinussyndrome,butareinfrequentlyusedforthepre-
.
.
BP=bloodpressure;OH=orthostatichypotension;PCM=physicalcounter- . ventionofsyncope.
.
pressuremanoeuvres. .
. aClassofrecommendation. ..
bLevelofevidence. .. 5.4.1.2Atrioventricularconductionsystemdisease
.
. Cardiacpacingisthetreatmentofsyncopeassociatedwithsympto-
.
.
. maticAVblock(Figure13).AlthoughformalRCTsofpacinginthird-
lostafter8weeks.333Thus,currentevidenceisinsufficienttoconfirm ..
. orsecond-degreetype2AVblockhavenotbeenperformed,some
.
theefficacyofdroxidopaforlong-termuse. .
.. observationalstudiessuggestthatpacingishighlyeffectiveinprevent-
.
.. ingsyncoperecurrenceswhenAVblockisdocumented.Langenfeld
5.4 Cardiac arrhythmias as the primary .
.. etal.341observeda declineintherateofsyncopefrom44to3.4%
cause ...
over5-yearfollow-upin115patientspacedforAVblock;therecur-
.
5.4.1Syncopeduetointrinsicsinoatrialor .. renceratewas7%inthesubgroupwithsyncopebeforepacemaker
.
atrioventricularconductionsystemdisease .. implantation.Morerecently,Sudetal.200reportednosyncoperecur-
.
Current management strategies in patients with syncope due to .. rence,andAsteetal.255reportedarecurrenceof1%at5yearsafter
.
intrinsiccardiacbradycardiaaresummarizedinFigure13. . pacemaker implantation among 73 patients with documented
Downloaded
from
https://academic.oup.com/eurheartj/article/39/21/1883/4939241
by
guest
on
22
January
2026
--- Страница 40 ---
1922 ESCGuidelines
° °
Figure13 Summaryofindicationsforpacinginpatientswithsyncopeduetointrinsiccardiacbradycardia.AF=atrialfibrillation;asympt.=asymp-
tomatic;AV=atrioventricular;BBB=bundlebranchblock;ECG=electrocardiogram;EPS=electrophysiologicalstudy;HR=heartrate;ILR=
implantablelooprecorder;SB=sinusbradycardia;SND=sinusnodedysfunction;sympt.=symptomatic.
.
.
persistentorintermittentdocumentedAVblock(seeSupplementary .. Evenifthequalityofevidenceismoderate,thereisstrongcon-
.
DataTable9). .. sensusthatinpatientswithbifascicularBBBwithapositiveEPS
.
.. or documentation of paroxysmal AV block during prolonged
.
5.4.1.3 Bundlebranchblockandunexplainedsyncope .. ECGmonitoring,cardiacpacingishighlyeffectiveinpreventing
.
ThepresenceofbifascicularBBBsuggeststhatthecauseofsyncope .. syncoperecurrence.Theevidenceofefficacyofempiricalpac-
.
may be complete heart block. Nevertheless, less than half of the .. ingstrategyisweakandtheestimateofbenefitisuncertain.
.
patientswithbifascicularBBBandsyncopewillhaveafinaldiagnosis .. Althoughsyncopeisnotassociatedwithanincreasedincidenceofsud-
.
ofAVblock,asimilarpercentagewillhaveafinaldiagnosisofreflex .. dendeathinpatientswithpreservedcardiacfunction,ahighincidence
.
syncope, and, in approximately 15%, the cause will remain unex- .. oftotaldeaths(aboutone-thirdsudden)wasobservedinpatientswith
.
plained at the end of a complete workup.342 In addition, among .. BBBandheartfailure,previousmyocardialinfarction,orlowejection
.
patients receiving an ILR, approximately half remained free of syn- .. fraction.345–347Indeed,thehightotalandsuddenmortalityseemstobe
. cope for >2 years after the implantation.187,188,342,343 Conversely, .. mainly related to underlying structural heart disease and ventricular
. .
implantation of a pacemaker without documentation of AV block . tachyarrhythmias.Inthislattersituation,syncopeisariskfactor,rather
. (empiricalpacing)exposedpatientstotheriskofrecurrenceofsyn- .. than the cause, of death.218 Unfortunately, ventricular programmed
.
.
copeinaboutone-quarterofcasesduringlong-termfollow-upand . stimulationdoesnotseemtoidentifythesepatientscorrectly,andthe
.
wasunnecessaryinanotherhalf.217,344Thus,onlyoneinfourpace- .. finding of inducible ventricular arrhythmia (VA) should therefore be
.
makerswillfinallybeappropriate.Finally,pacemakertreatmenthas .. interpretedwithcaution.345,346Therefore,animplantablecardioverter
.
.
notbeenproventohaveasurvivalbenefit.Theaboveconsiderations . defibrillator(ICD)oracardiacresynchronizationtherapydefibrillatoris
.
justifyaclassIIbindicationintheESCGuidelinesonpacing.294 .. indicated in patients with BBB, congestive heart failure, or previous
.
Toovercometheaboveproblems,ESCGuidelinesonpacing294— .. myocardialinfarctionanddepressedsystolicfunctionforthepreven-
.
.
inpatientswithLVEF>35%—recommendastrategyofEPSfollowed . tionofSCD,butmaybeunabletopreventtherecurrenceofsyncope,
.
.
byILRiftheEPSfindingsareunremarkable.Withthisstrategy,apace- . whichisoftenduetonon-arrhythmiccausessuchasOHorvasode-
.
.
makerwasimplantedinapproximatelyhalfofthepatientsandthese .. pressorreflex.Thestrategyforthemanagementofpatientswithunex-
.
patients had syncope recurrence after pacemaker implantation in .. plainedsyncopeandBBBissummarizedinFigure14.
.
0–7%ofcases188,217.Thisstrategywassafe;however,thisTaskForce ..
.
recognizesthat in the‘realworld’, anempiricalpacemaker maybe ..
.
acceptableinselectedpatients athighriskoftraumaticrecurrence .. 5.4.2Syncopeduetointrinsiccardiactachyarrhythmias
.
(e.g.elderlypatientswithunpredictablesyncopes)andthatanindivid- .. Current management strategies in patients with syncope due to
.
ualrisk–benefitevaluationiswarranted(Figure14). . intrinsiccardiactachyarrhythmiaaresummarizedinFigure15.
Downloaded
from
https://academic.oup.com/eurheartj/article/39/21/1883/4939241
by
guest
on
22
January
2026
--- Страница 41 ---
ESCGuidelines 1923
Figure14 Therapeuticalgorithmforpatientspresentingwithunexplainedsyncopeandbundlebranchblock.BBB=bundlebranchblock;CRT-D
=cardiacresynchronizationtherapydefibrillator;EPS=electrophysiologicalstudy;ICD=implantablecardioverterdefibrillator;ILR=implantable
looprecorder;PM=pacemaker.
Figure15 Choiceoftherapyforpatientspresentingwithsyncopeduetocardiactachyarrhythmiasastheprimarycause.AA=antiarrhythmic;
ICD=implantablecardioverterdefibrillator;SVT=supraventriculartachycardia;VT=ventriculartachycardia.
.
.
5.4.2.1 Paroxysmalsupraventriculartachycardia .. 5.4.2.2Paroxysmalventriculartachycardia
.
InpatientswithparoxysmalAVnodalre-entranttachycardia,AVre- .. Syncope due to torsade de pointes isnotuncommonand is,inits
.
entrant tachycardia, typical atrial flutter, and ectopic tachycardia .. acquired form, the result of drugs that prolong the QT interval.
.
associated with syncope, catheter ablation is the first-choice treat- .. Treatmentistheimmediatediscontinuationofthesuspecteddrug.
.
ment.Inthesepatients,theroleofdrugtherapyislimitedtobeinga .. Catheter ablation or drug therapy is recommended in patients
.
bridgetoablationorbeingusedwhenablationhasfailed.Inpatients .. with syncope due to VT in the presence or absence of structural
.
with syncope associated with atrial fibrillation or atypical left atrial .. heart disease in order to prevent syncope recurrence (Figure 15).
.
flutter,thedecisionshouldbeindividualized. . Detailed guidelines regarding antiarrhythmic drug usage in patients
Downloaded
from
https://academic.oup.com/eurheartj/article/39/21/1883/4939241
by
guest
on
22
January
2026
--- Страница 42 ---
1924 ESCGuidelines
.
.
withVTcanbefoundinthe2015ESCGuidelinesforVAandthepre- . patientswithsyncopeandpreviousmyocardialinfarctionwhohave
.
ventionofSCD.46 .. VTinducedduringEPS346(seesection4.2.6).
.
.
AnICDisindicatedinpatientswithsyncopeanddepressedcardiac . Inpatientswithpreservedsystolicfunction,theindicationforICD
.
.
function, and VT or VF without correctable cause. Although ICD . is weaker because trials have not addressed this specific issue.
.
maynotpreventsyncoperecurrenceinthesepatients,31,348itisindi- .. However,whenVTcausessyncope,thisTaskForcebelievesthatan
.
.
catedtoreducetheriskofSCD(refertothe2015ESCGuidelines . ICD is warranted if catheter ablation and pharmacological therapy
.
for VA and the prevention of SCD46). An ICD is also indicated in .. havefailedorcouldnotbeperformed(Figure15).
Treatmentofsyncopeduetocardiacarrhythmias
Recommendations Classa Levelb
Bradycardia(intrinsic)
Cardiacpacingisindicatedwhenthereisanestablishedrelationshipbetweensyncopeandsymptomaticbradycardiadueto:
• Sicksinussyndrome.210–212,334–338 I B
• IntrinsicAVblock.200,255,341 I B
Cardiacpacingisindicatedinpatientswithintermittent/paroxysmalintrinsicthird-orsecond-degreeAVblock(including
I C
AFwithslowventricularconduction),althoughthereisnodocumentationofacorrelationbetweensymptomsandECGs.
Cardiacpacingshouldbeconsideredwhentherelationshipbetweensyncopeandasymptomaticsinusnodedysfunctionis
IIa C
lessestablished.135,136,210–212,339,340
Cardiacpacingisnotindicatedinpatientswhentherearereversiblecausesforbradycardia. III C
BifascicularBBB
Cardiacpacingisindicatedinpatientswithsyncope,BBB,andapositiveEPSorILR-documentedAVblock.188,217 I B
CardiacpacingmaybeconsideredinpatientswithunexplainedsyncopeandbifascicularBBB.217,255,344 IIb B
Tachycardia
CatheterablationisindicatedinpatientswithsyncopeduetoSVTorVTinordertopreventsyncoperecurrence.46 I B
AnICDisindicatedinpatientswithsyncopeduetoVTandanejectionfraction<_35%.46 I A
AnICDisindicatedinpatientswithsyncopeandpreviousmyocardialinfarctionwhohaveVTinducedduringEPS.218 I C
AnICDshouldbeconsideredinpatientswithanejectionfraction>35%withrecurrentsyncopeduetoVTwhencatheter
IIa C
ablationandpharmacologicaltherapyhavefailedorcouldnotbeperformed.46
Antiarrhythmicdrugtherapy,includingrate-controldrugs,shouldbeconsideredinpatientswithsyncopeduetoSVTorVT. IIa C
Additionaladviceandclinicalperspectives
• Themajorfactorspredictingtheefficacyofpacinginpreventingsyncoperecurrenceareanestablishedrelationshipbetweensymptomsandbra-
dycardiaandtheabsenceofassociatedhypotensivesusceptibility(Table8andSupplementaryDataTable9).Whenthisrelationshipislessestab-
lished,orsomehypotensivemechanismispresent,syncopecanrecurinaminorityofpatients.
• Pacingisnotindicatedinunexplainedsyncopewithoutevidenceofanyconductiondisturbance.
• LessthanhalfofthepatientswithbifascicularBBBandsyncopehaveafinaldiagnosisofcardiacsyncope,albeittheprobabilityisdifferentamongthetypes
ofBBB.Werecommendconductinganyusefulinvestigation(e.g.CSM,EPS,orILR)toprovoke/documentthemechanismofsyncopebeforedecidingto
implantapacemakerorselectingthecorrecttherapy.
• ElderlypatientswithbifascicularBBBandunexplainedsyncopeafterareasonableworkupmightbenefitfromempiricalpacemakerimplantation,
especiallyifsyncopeisunpredictable(withnoorshortprodromes)orhasoccurredinthesupinepositionorduringeffort.
• Whenindicated,ICDpreventsSCDbutitmaybeunabletopreventsyncopeduetoVTrecurrence.31,348Thus,whensyncopeisduetoVT
(includingwhenthediagnosisisestablishedbytheinductionofVTduringEPS),catheterablationshouldbealwaysattemptedwhenfeasiblein
additiontoICDimplantation.
AF=atrialfibrillation;AV=atrioventricular;BBB=bundlebranchblock;CSM=carotidsinusmassage;ECG=electrocardiogram;EPS=electrophysiologicalstudy;ICD=
implantablecardioverterdefibrillator;ILR=implantablelooprecorder;SCD=suddencardiacdeath;SVT=supraventriculartachycardia;VT=ventriculartachycardia.
aClassofrecommendation.
bLevelofevidence.
Downloaded
from
https://academic.oup.com/eurheartj/article/39/21/1883/4939241
by
guest
on
22
January
2026
--- Страница 43 ---
ESCGuidelines 1925
.
.
5.5 Treatment of syncope secondary to . 5.6.2Leftventricularsystolicdysfunction
.
.
structural cardiac, cardiopulmonary, and .. ThebenefitofanICDtoreducetheriskofdeathisestablished.Thus,
.
great vessel disease
.. patientswithunexplainedsyncopewhohaveanestablishedICDindi-
.
.. cation per current Guidelines46 must receive an ICD before, and
Cardiacsyncopeisdiagnosedwhensyncopepresentsinpatientswith .
.. independentlyof,theevaluationofthemechanismofsyncope,evenif
severe aortic stenosis, acute myocardial infarction/ischaemia, HCM, .
.. themechanismofsyncopeisunknownoruncertainattheendofa
cardiac masses (atrial myxoma, ball thrombus, etc.), pericardial dis- .
.. complete workup. While this strategy may help to prolong life,
ease/tamponade,congenitalanomaliesofthecoronaryarteries,pros- .
.. patientsoftenremainatriskofrecurrentsyncope,implyinganeed
theticvalvedysfunction,pulmonaryembolus,acuteaorticdissection, ...
forprecise identificationofthe mechanismofsyncope and specific
andpulmonaryhypertension(seesection4.1.1).Structuralcardiacor ...
treatmentwhenpossible.
cardiopulmonary disease canbe presentinsome patientswithsyn- ...
Fewdataexistconcerningtheprevalenceandtheprognosticimpli-
cope,anditsincidenceincreasesinolderpatients.Themerepresence ...
cationsofunexplainedsyncopeinunselectedpatientswithleftven-
ofheartdiseasedoesnotimplythatsyncopeisrelatedtotheunderly- ...
tricular dysfunction or non-ischaemic dilated cardiomyopathy with
ingcardiacdisorder.Someofthesepatientshavetypicalreflexsyn- .
cope;inothers,suchasthosewithinferiormyocardialinfarctionor
aorticstenosis,theunderlyingcardiacdiseasemayplayaroleintrig-
Implantablecardioverterdefibrillatorindicationsin
geringorpotentiatingareflexmechanism,and—finally—theunderly- patientswithunexplainedsyncopeaandleftventricular
ingcardiacdiseasemaybethesubstrateforconductiondisturbances, systolicdysfunction
supraventriculararrhythmia,orVAthatcausessyncope.
Recommendations Classb Levelc
Evenintheabsenceofspecifictrials,thereisstrongconsensus
that with syncope secondary to structural cardiac disease, the ICDtherapyisrecommendedtoreduce
goaloftreatmentisnotonlytopreventsyncopalrecurrence,but SCDinpatientswithsymptomaticheartfail-
totreattheunderlyingdiseaseanddecreasetheriskofdeath. ure(NYHAclassII–III)andLVEF<_35%after
I A
>_3monthsofoptimalmedicaltherapy,who
5.6 Treatment of unexplained syncope in areexpectedtosurvive>_1yearwithgood
patients at high riskof sudden cardiac
functionalstatus.46
death AnICDshouldbeconsideredinpatients
Theunderlyingclinicalsituationisthatofapatientbeingevaluatedfor
withunexplainedsyncopeawithsystolic
ICDimplantationbecausetheyareaffectedbysyncope(s)supposedly impairment,butwithoutacurrentindication IIa C
duetotransientself-terminatingventriculartachyarrhythmias(fastVTor forICD,toreducetheriskofsudden
VF),whichhavenotyetbeendocumentedbecauseoftheirshortdura-
death.27,28,359,360
tion.349SyncopeduetodocumentedVT/VFisoutsidethescopeofthis
InsteadofanICD,anILRmaybeconsidered
section;pleaserefertosection5.4.2.Generalguidancemaybesoughtin
inpatientswithrecurrentepisodesofunex-
the2015ESCGuidelinesforVAandthepreventionofSCD.46 IIb C
plainedsyncopeawithsystolicimpairment,
butwithoutacurrentindicationforICD.
5.6.1Definition
Additionaladviceandclinicalperspectives
In general, a history of syncope in patients with structural heart
• Thepresenceofsyncopeincreasesmortalityregardlessofits
disease orinheritable arrhythmiasyndromes isassociatedwitha
two- to four-fold increased risk of death,348,350–353 but varies
cause.348Thus,syncopeisariskfactorforlife-threatening
between specific conditions.354–356 Moreover, there have been events.
• ThedecisiontoimplantanICDortocompletethe
veryfewstudiesonICDsinpatientswithsyncopeassociatedwith
left ventricular dysfunction,31,348 cardiomyopathy, or inheritable investigation(e.g.ILRimplantation)inpatientswithunex-
arrhythmia syndromes.357 In these Guidelines, we complement plainedsyncopedependsonaglobalclinicalevaluation
previousESCGuidelinesforVAandthepreventionofSCD46by ofthepatient’sconditions,thepotentialbenefitandharm
ofsuchtherapy,andthepresenceofotherriskfactors
providingaprecisedefinitionofunexplainedsyncope,andmaking
forSCD.
recommendationsforitsinvestigationandmanagementindiffer-
entclinicalsettings.
• For this section, ‘unexplained syncope‘ is defined as syncope that
ICD=implantablecardioverterdefibrillator;ILR=implantablelooprecorder;
does not meet any class I diagnostic criterion defined in the LVEF=leftventricularejectionfraction;NYHA=NewYorkHeartAssociation;
tablesofrecommendationsinsection4.Inthepresenceofclini- SCD=suddencardiacdeath.
calfeaturesdescribedinthissection,unexplainedsyncopeiscon-
aUnexplainedsyncopeisdefinedassyncopethatdoesnotmeetaclassIdiagnos-
ticcriteriondefinedinthetablesofrecommendationsinsection4.Inthepres-
sidereda‘suspectedarrhythmicsyncope’.
ence of clinical features described in this section, unexplained syncope is
consideredariskfactorforventriculartachyarrhythmias.
Whenthemechanismofsyncopeisnon-arrhythmic,themanage-
bClassofrecommendation.
mentofpatientsathighriskofSCDisthesameasforpatientswith- cLevelofevidence.
outsyncope.
Downloaded
from
https://academic.oup.com/eurheartj/article/39/21/1883/4939241
by
guest
on
22
January
2026
--- Страница 44 ---
1926 ESCGuidelines
.
lessseveresystolicimpairmentwhodonotmeetthecurrentindica- .. 5.6.4Arrhythmogenicrightventricular
.
tionforICD.358Datafromobservationalstudiesinselectedcohorts .. cardiomyopathy
.
showahighrateofoccurrenceofventriculararrhythmias,ICDdis- .. Althoughlimitedanddiverse,currentdatasuggestthatunexplainedsyn-
.
charge,anddeathinpatientswithahistoryofunexplainedsyncope .. copeisamarkerofarrhythmicriskinpatientswithARVC.46,351,362,363
.
but,owingtoalackofcontrolgroups,areunabletoshowthebenefit .. The decision to implant an ICD should take into account the other
.
ofanICD.27,28,359,360ThisTaskForcebelievesthatanICDshouldbe .. knownriskfactorsforarrhythmicevents46:frequentnon-sustainedVT,
.
consideredinpatientswithunexplainedsyncopewithsystolicimpair- .. family history of premature sudden death, extensive right ventricular
.
mentbutwithoutacurrentindicationforICDtoreducetheriskof .. disease, marked QRS prolongation, late gadolinium enhancement on
.
suddendeath. .. magnetic resonance imaging (MRI) (including left ventricular involve-
.
.. ment),leftventriculardysfunction,andVTinductionduringEPS.46
.
.
5.6.3Hypertrophiccardiomyopathy
Unexplained syncope is an independent predictor for SCD and
appropriateICDdischarge.Inasystematicreview,theaveragehaz- Implantablecardioverterdefibrillatorindicationsin
patientswithunexplainedsyncopeaandarrhythmogenic
ardratioofunexplainedsyncope(irrespectiveofdefinition)was2.68
rightventricularcardiomyopathy
(95% CI 0.97–4.38).361 In the largest multicentre study to date
(>3600patientswithHCM),syncopewasanindependentpredictor
ofthecompositeofSCDandICDdischarge(hazardratio2.05,95% Recommendations Classb Levelc
CI 1.48–2.82).350 A prophylactic ICD is appropriate in individuals
ICDimplantationmaybeconsideredin
withotherfeaturesindicativeofahighriskofSCDthatareusedto
patientswithARVCandahistoryofunex- IIb C
estimatethe5-yearriskofSCDusingtheHCMRisk-SCDmodel245;
plainedsyncope.a,46
they include: age, family history of SCD, maximum left ventricular
wallthickness,leftatrialdiameter,andnon-sustainedVT. InsteadofanICD,anILRshouldbeconsid-
eredinpatientswithrecurrentepisodesof
unexplainedsyncopewhoareatlowriskof
IIa C
Implantablecardioverterdefibrillatorindicationsin SCD,basedonamultiparametricanalysis
patientswithunexplainedsyncopeaandhypertrophic
thattakesintoaccounttheotherknown
cardiomyopathy
riskfactorsforSCD.
Recommendations Classb Levelc
ARVC=arrhythmogenicrightventricularcardiomyopathy; ICD =implantable
cardioverterdefibrillator;ILR=implantablelooprecorder;SCD=suddencar-
ItisrecommendedthatdecisionsforICD
diacdeath.
implantationinpatientswithunexplained aUnexplained(oruncertain)syncopeisdefinedanysyncopethatdoesnotmeet
I B
syncopeaaremadeaccordingtotheESC classIdiagnosticcriteriadefinedinthetablesofrecommendationsinsection4.In
thepresenceofclinicalfeaturesdescribedinthissection,unexplainedsyncopeis
HCMRisk-SCDscore.d,245
consideredariskfactorforventriculartachyarrhythmias.
bClassofrecommendation.
InsteadofanICD,anILRshouldbeconsid- cLevelofevidence.
eredinpatientswithrecurrentepisodesof
unexplainedsyncopeawhoareatlowriskof IIa C
SCD,accordingtotheHCMRisk-SCD
score.d,245 5.6.5Patientswithinheritablearrhythmogenicdisorders
5.6.5.1LongQTsyndrome
Additionaladviceandclinicalperspectives SyncopaleventsinlongQTsyndrome(LQTS)areassociatedwithan
ThedecisiontoimplantanICDortocompletetheinvestigation increasedriskofsubsequentcardiacarrest.TheannualrateofSCDin
(e.g.ILRimplantation)inpatientswithunexplainedsyncope patientswithuntreatedLQTSisaround0.9%overalland5%forthose
dependsonaglobalclinicalevaluationofthepatient’scondition, withsyncope.352,364Beta-blockertherapysubstantiallyreducestherisk
thepotentialbenefitandharmofsuchtherapy,andthepresence ofsyncopeandSCD,butpresentationwithcardiacarrestandrecur-
ofotherriskfactorsforSCD. rentsyncopeduringbeta-blockertherapyisassociatedwiththesame
riskoffataleventsasinuntreatedpatients.46Forthisreason,ICDtreat-
ESC=EuropeanSocietyofCardiology;HCM=hypertrophiccardiomyopathy; mentshouldbeconsideredinpatientswithLQTSandrecurrentunex-
ICD=implantablecardioverterdefibrillator;ILR=implantablelooprecorder; plained syncope despite beta-blocker therapy, especially in cases of
SCD=suddencardiacdeath.
aUnexplainedsyncopeisdefinedassyncopethatdoesnotmeettheclassIdiag- good treatment compliance, in the absence of precipitating factors,
nosticcriteriondefinedinthetablesofrecommendationsinsection4.Inthe andinLQT2andLQT3syndromes.Leftcardiacsympatheticdenerva-
presenceofclinicalfeaturesdescribedinthissection,unexplainedsyncopeiscon- tionshouldalsobeconsideredinthissituation,particularlyinLQT1.46
sideredariskfactorforventriculartachyarrhythmias.
bClassofrecommendation.
cLevelofevidence. 5.6.5.2Brugadasyndrome
dAweb-basedcalculatoroftheHCMriskscorecanbefoundat:http://www.
Ahistoryofsyncopemayincreasetheriskofarrhythmiceventsupto
doc2do.com/hcm/webHCM.html. It can also be found in the ESC Pocket
GuidelinesAppfoundinallappstores. two-tothree-foldcomparedwiththatinasymptomaticpatients.In
thelargestregistry(1029patients),theincidenceofarrhythmicevents
Downloaded
from
https://academic.oup.com/eurheartj/article/39/21/1883/4939241
by
guest
on
22
January
2026
--- Страница 45 ---
ESCGuidelines 1927
.
.
(sustainedVTorVF,appropriateICDtherapy,orsuddendeath)in . riskfactorsforarrhythmicevents,includingspontaneoustype1Brugada
.
.
patientswithBrugadasyndromewas7.7% peryearinthosewitha . ECGpattern,familyhistoryofsuddendeath,VFinducibilitywithoneor
.
.
history of sudden cardiac arrest, 1.9% per year with syncope, and .. two ventricular premature beats during EPS, fractionated QRS, early
.
0.5% per year in asymptomatic patients.353 However, in a second ... repolarizationintheperipheralleads,increasedT peak–T endinterval,and
study,therateofappropriateICDshockswassimilarinasymptomatic .. long PRinterval.220,367–371 A drug-induced type 1ECGpattern has a
.
patientsandinthosewithsyncope,adifferencepossiblyexplainedby .. lowerriskofsuddendeaththanaspontaneoustype1response.
.
patientselectionandahighrateofnon-arrhythmicsyncope.355
Implantablecardioverterdefibrillatorindicationsin
Implantablecardioverterdefibrillatorindicationsin patientswithunexplainedsyncopeaandBrugada
patientswithunexplainedsyncopeaandlongQT syndrome
syndrome
Recommendations Classb Levelc
Recommendations Classb Levelc
ICDimplantationshouldbeconsideredin
ICDimplantationinadditiontobeta-blockers patientswithaspontaneousdiagnostic
IIa C
shouldbeconsideredinLQTSpatientswho IIa B type1ECGpatternandahistoryof
experienceunexplainedsyncopeawhile unexplainedsyncope.a,46,353,355,365,366
receivinganadequatedoseofbeta-blockers.46
InsteadofanICD,anILRshouldbeconsid-
Leftcardiacsympatheticdenervationshould eredinpatientswithrecurrentepisodesof
beconsideredinpatientswithsymptomatic unexplainedsyncopeawhoareatlowriskof
LQTSwhen: SCD,basedonamultiparametricanalysis IIa C
(1) beta-blockersarenoteffective,nottol- thattakesintoaccounttheotherknown
erated,orarecontraindicated; IIa C riskfactorsforSCD.
(2) ICD therapy is contraindicated or
refused;or
ECG=electrocardiogram;ICD=implantablecardioverterdefibrillator;ILR=
(3) whenpatientsonbeta-blockerswithan implantablelooprecorder;SCD=suddencardiacdeath.
ICDexperiencemultipleshocks.46 aUnexplained (oruncertain) syncopeis defined asany syncopethat does not
meettheclassIdiagnosticcriteriadefinedinsection4.Inthepresenceofclinical
InsteadofanICD,anILRshouldbeconsid- featuresdescribedinthissection,unexplainedsyncopeisconsideredariskfactor
forventriculartachyarrhythmias.
eredinpatientswithrecurrentepisodesof
bClassofrecommendation.
unexplainedsyncopeawhoareatlowriskof cLevelofevidence.
IIa C
SCDbasedonamultiparametricanalysis
thattakesintoaccounttheotherknown
riskfactorsforSCD.
5.6.5.3Otherforms
Additionaladvice
Duetoalackofstudiesexaminingunexplainedsyncopeinotherforms
Beta-blockersarerecommendedinallpatientswithaclinicaldiagno-
ofinheritablearrhythmicdiseasessuchascatecholaminergicpolymor-
sisofLQTS,withthepossibleexceptionofthosewithLQTS3form.
phicVT,earlyrepolarizationsyndrome,andshortQTsyndrome,this
TaskForceisunabletogivespecificrecommendationsfortheinvesti-
ICD=implantablecardioverterdefibrillator;ILR=implantablelooprecorder; gationandtreatmentofunexplainedsyncope.Forfurtherinformation
LQTS=longQTsyndrome;SCD=suddencardiacdeath. refertothe2015ESCGuidelinesforVAandthepreventionofSCD.46
aUnexplained(or uncertain) syncope isdefinedas anysyncope that doesnot
meetclassIdiagnosticcriteriadefinedinthetablesofrecommendationsinsec-
tion4.Inthepresenceofclinicalfeaturesdescribedinthissection,unexplained
syncopeisconsideredariskfactorforventriculartachyarrhythmias. 6. Special issues
bClassofrecommendation.
cLevelofevidence.
6.1 Syncope in patients with comorbidity
and frailty
Onbalance,thisTaskForcebelievesthatitisreasonabletocon- Theapproachtotheassessmentandmanagementofanolderpatient
sideranICDinthecaseofunexplainedsyncope.Newstudies356,365 withsyncopeissimilartothatofotheragegroups;however,there
publishedafterthe2015ESCGuidelinesforVAandthepreventionof areanumberofadditionalfeaturespertinenttoage-relatedcomor-
SCD46showedthatnon-arrhythmicsyncope isfrequentinBrugada bidityandfrailtythatwarrantspecialattention.372–374
syndrome and appears to be more benign; thus, ICD should be
avoided in patients with non-arrhythmic syncope that is established 6.1.1Comorbidityandpolypharmacy
accordingtothedefinitionreportedinthissection.ILRisincreasingly Comorbidity influences the diagnosis of syncope and management
usedindoubtfulcasestoexcludeaVAasthecauseofsyncope.365,366 decisions.33,375Olderpatientsfrequentlyhaveabnormalfindingson
Thefinal decisionto implantanICDinpatientswithBrugadasyn- morethanoneinvestigationandmayhavemorethanonepossible
dromeandunexplainedsyncopeshouldalsotakeintoaccountother cause of syncope.372,374,376 Conversely, coincidental findings of
Downloaded
from
https://academic.oup.com/eurheartj/article/39/21/1883/4939241
by
guest
on
22
January
2026
--- Страница 46 ---
1928 ESCGuidelines
.
cardiovasculardiagnosessuchasaorticstenosisoratrialfibrillation377 .. 6.1.3Cognitiveassessmentandphysicalperformancetests
.
maynotnecessarilybetheattributablecauseofevents.378–380 .. Age-relatedmemoryimpairmentormoreestablishedformsofcog-
.
.
Theprescriptionofpolypharmacy,cardiovascularmedications,and . nitive impairment are frequently associated with poor recall and
.
.
psychotropic (neuroleptics and antidepressants) and dopaminergic . thereforethelackofanaccuratehistoryofevents.Insuchcircum-
.
drugs alsoincreases the risk of syncope and falls.381–385 Conversely, .. stances, details of prodromal symptoms, whether or not LOC
.
.
thediscontinuationorreductionofhypotensivetherapyreducessuch . occurred, and symptoms after the event may be unre-
.
risk.260 Negative dromotropic and chronotropic medications should .. liable.373,389,391–394 Cognitiveassessmentto informtheaccuracy of
.
.
becarefullyevaluatedinolderpatientspresentingwithsyncopeorfalls. .. historicaldata,andgeneralphysicalassessmenttoidentifycomorbid
.
Focalneurologicaleventscanoccasionallyoccurduetohypoten- .. disordersthatinfluencediagnosisandresponsetotreatments(such
.
sionand syncope, eveninpatientswithoutsignificantcarotidartery .. as Parkinson’s disease, gait and balance abnormalities, previous
.
stenosis (so called ‘hypotensive TIA’). Although these neurological .. stroke,andpolyneuropathies,etc.),arerecommended.
.
eventsoccurinonly6%ofpatientswithrecurrentsyncope,theirmis- ..
. diagnosisisparticularlyimportantbecausetheymayleadtoalowering .. Despitethelackoflargecontrolledtrialsandanoverallmodest
.
ofBPwithantihypertensivemedications(e.g.iffocalneurologyismis- .. qualityofstudies,thereisstrongconsensusthattheassessment
.
takenlyattributedtovascularpathologyratherthanhypotension),and .. ofolderpatientswithsyncopeorunexplainedfallsmayrequire
.
toafurtherincreaseoftheriskofsyncopeandneurologicevents.386 .. cognitiveassessmentandphysicalperformancetestsinaddition
. .. to syncope evaluation. Further research is likely to have an
.
Despitethelackoflargecontrolledtrialsandanoverallmod- .. importantimpactonourconfidenceintheestimateofeffect.
.
estqualityofstudies,thereisstrongconsensusthatreduction
ordiscontinuationofhypotensivedrugsandpsychotropicdrugs
Syncopeinpatientswithcomorbidityandfrailty
clearlyoutweighs the undesirable effects (e.g. complications)
of high BP. Further research is likely to have an important
Recommendations Classa Levelb
impactonourconfidenceintheestimateofeffect.
Multifactorialevaluationandinterventionis
recommendedinolderpatientsbecausemore
I B
6.1.2Falls thanonepossiblecauseforsyncopeandunex-
Syncopal events may be unwitnessed in over half of older patients
plainedfallmaybepresent.33,372–374,376–380
meaningthatcollateralhistoriesmaynotavailable,whichmakesdiscrim-
Cognitiveassessmentandphysicalperform-
inationbetweenfallsandsyncopechallenging.387Ifunwitnessedfallsare
ancetestsareindicatedinolderpatientswith I C
not due to mechanical slips or trips (i.e. are unexplained or non- syncopeorunexplainedfall.373,389,391–394
accidental),itislikelythatthepatientexperiencedasyncopaleventand
displayedlackofawarenessforLOC(Figure16).388,389Managementof Modificationordiscontinuationofpossibleculprit
fallsinsuchcircumstancesisthesameasthatforsyncope.191,194,390 medications,particularlyhypotensivedrugsand
IIa B
psychotropicdrugs,shouldbeconsideredinolder
Despite the lack of controlled trials and an overall modest patientswithsyncopeorunexplainedfall.260,381–385
qualityofstudies,thereisstrongconsensusthatthemanage-
Inpatientswithunexplainedfall,thesame
mentofunexplainedfallsshouldbethesameasthatforunex-
assessmentasforunexplainedsyncopeshould IIa C
plainedsyncope.
beconsidered.191,194,387–390
Additionaladviceandclinicalperspectives
• Insomefrailelderlypatients,therigourofassessmentwilldepend
oncompliancewithtestsandonprognosis.Otherwise,theevalu-
ationofmobile,non-frail,cognitivelynormalolderadultsmustbe
performedasforyoungerindividuals.393,395
• OrthostaticBPmeasurements,CSM,andtilttestingarewelltol-
erated,eveninthefrailelderlywithcognitiveimpairment.96,396,397
• Notinfrequently,patientswhopresentwithunexplainedfalls—
althoughorthostaticBPmeasurements,CSM,andtilttestingrepro-
ducesyncope—maydenyTLOC,thusdemonstratingamnesiafor
TLOC.388,389
• FailureoforthostaticBPtostabilizeispresentinupto40%of
community-dwellingpeople>80yearsofagewhenBPismeas-
uredusingphasicBPtechnology.398SuchfailureofsystolicBPto
stabilizeisariskfactorforsubsequentfallsandsyncope.
• Intheabsenceofawitnessaccount,thedifferentialdiagnosis
betweenfalls,epilepsy,TIA,andsyncopemaybedifficult.
Figure 16 Flow diagram for the identification of unexplained
falls. BP=bloodpressure;CSM=carotidsinusmassage;TIA=transientischaemic
attack;TLOC=transientlossofconsciousness.
aClassofrecommendation.
bLevelofevidence.
Downloaded
from
https://academic.oup.com/eurheartj/article/39/21/1883/4939241
by
guest
on
22
January
2026
--- Страница 47 ---
ESCGuidelines 1929
.
6.2 Syncope in paediatric patients .. • Children with a history suggesting VVS, a normal ECG, and no
.
6.2.1Diagnosticevaluation
... family history of arrhythmia should not undergo further cardiac
Diagnosticevaluationinpaediatricpatientsissimilartothatinadults.
... investigations.
. • The cornerstone of therapy for young patients with reflex syn-
Twospecificconditions399occurinearlychildhood: ..
. copeincludeseducationandreassurance.
.
.
• Infantile reflex syncopal attacks (also called pallid breath-holding ..
.
spells or reflex anoxic seizures), elicited by a brief unpleasant .
.
stimulus,causedbyvagallymediatedcardiacinhibition. .. 7. Psychogenic transient loss of
.
• Cyanotic breath-holding spells, characterized by stopping ...
consciousness and its evaluation
breathing during crying, leading to cyanosis and usually ..
.
TLOC. ..
. InpsychogenicTLOCthereisnogrosssomaticbraindysfunction,
.
.
Careful taking of personal and family history and a standard . buttheattacksfulfilthecriteriaforTLOC(seesection3.1).There
.
. ECG are the most important methods of distinguishing benign . are two types: PPS and PNES. In PPS movements are absent, so
.
.
reflex syncope (also including reflex anoxic seizure or breath- . PPSresemblessyncopeorlonger-lastingLOC,whereasinPNES
.
.
holdingspells)fromothercauses.Ifthefamilyhistoryispositive, . impressive limb movementsmeantheattacksresemble epileptic
.
.
geneticcausesofelectricaldiseaseoftheheartshouldbeconsid- .. seizures. PPS and PNES differ pathophysiologically from the
. eredfirst.Somechildrenwithreflexsyncopealsohaveapositive .. TLOCformsthattheyresemble:inPPS,BPandHRarenormalor
.
familyhistory.400Tilttestingseemstohavehighfalse-negativeand .. high rather than low, and the EEG is normal instead of showing
.
false-positive rates and should be used with caution for the pri- .. theslowingorflatteningtypicalofsyncope;incontrasttoepileptic
.
mary identification of reflex syncope. Since tilt protocols com- .. seizures, the EEG in PNES shows no epileptiform brain activity
.
monlyusedinadultsmaylackspecificityinteenagers,inonestudy, .. duringanattack.9,116
.
ashortertilttestdurationof10minat60or70degreeswasused .. The frequency of PPS and PNES probably depends on the
.
andshowedaspecificityof>85%.401 .. setting. The rate of PPS varies from 1% of patients referred to
.
Inyoungpatients,syncopecanrarelybetheinitialmanifestationof .. generalsyncopeclinics94to8%ofpatientsreferredtospecialist
.
unusualbutlife-threateningconditionssuchasLQTS,Kearns–Sayre .. neurological clinics,116 but PPS is probably insufficiently
.
syndrome (external ophthalmoplegia and progressive heart block), .. recognized.154
.
Brugada syndrome, catecholaminergic polymorphic VT, ..
.
.
Wolff-Parkinson-Whitesyndrome,ARVC,HCM,pulmonaryarterial . 7.1 Diagnosis
.
.
hypertension,myocarditis,arrhythmiaafterrepairedcongenitalheart .. 7.1.1Historicalcriteriaforattacks
.
disease,andanomalousoriginofacoronaryartery. .
. The presence ofa psychological trauma is not a prerequisite for a
.
Some aspects of the history can suggest a cardiac origin, and .
. diagnosisofconversion.ThediagnosisofPPSrestsonpositiveclues
.
shouldpromptcardiacevaluation. .
. takenfromthepatient’shistoryandfromdocumentingnormalEEG
.
.
• Family history: premature SCD at age <40 years and/or familial .. results, HR, or BP during an attack. History taking in PPS usually
heartdisease.
... revealsacombinationofthefollowingfeatures116,154,403:
.
• Knownorsuspectedheartdisease. .
.
. (1) Inmostcases,thedurationofPPSisasshortasinsyncope,buta
• Event triggers: loud noise, fright, and/or extreme emotional .
.
. muchlongerdurationisausefuldiagnosticfinding:patientsmaylie stress. .
.
• Syncopeduringexercise,includingswimming. .. immobileonthefloorfor15–30min.
.
• Syncope without prodromes, while supine or sleeping, or pre- .. (2) Theeyesareusuallyopeninepilepticseizuresandsyncopebutare
. cededbychestpainorpalpitations. . usuallyclosedinpsychogenicTLOC.
.
. . (3) Theattackfrequencyishigh,withseveralattacksoccurringovera
.
.
6.2.2.Therapy .. weekorinaday.
.
Thetherapeuticapproachisthesameasinadults.However,itshould .. (4) Thereisusuallynorecognisabletrigger,andnosweating,pallor,or
.
bestressedthattheeffectivenessofpharmacologicalagentsandtilt .. nauseabeforehand.
.
trainingforrecurrentreflexsyncopeisundeterminedintheabsence .. (5) InjurydoesnotexcludePNESorPPS.
.
ofwell-designedpaediatrictrials.Furthermore,eveninthepresence ..
. Thesefeaturesshouldoccurtogetherinmostattacks.Thepres-
ofVVSwithprolongedasystole,pacemakersshouldbeavoideddue ..
. enceofanotherpatternoffeaturessuggestingatruesyncopetype,
totherelativelytransientandbenignnatureofthesyndrome.402 ..
. usuallyVVS,doesnotargueagainstadiagnosisofPPS.
Insummary,thekeypointsfortheevaluationofsyncopeinpaedi- ..
.
.
atricsareasfollows: .
.
.. 7.1.2Documentationofkeyfeaturesduringanattack
• Syncope in childhood is common, the majority being of reflex ...
Thefollowingfeaturesarerelevantduringanattack:
origin, with only a minority having a potentially life-threatening .
.
.
cause. . • Video recordingor clinicalobservation, including provocationof
.
• Discriminating benign from serious causes is made primarily by .. anattackduringtilttesting.Primaryfeatures:sleep-likebodyposi-
.
history,physicalexamination,andECGresults. . tionwithclosedeyesandlackofresponsetospeechortouch,if
Downloaded
from
https://academic.oup.com/eurheartj/article/39/21/1883/4939241
by
guest
on
22
January
2026
--- Страница 48 ---
1930 ESCGuidelines
.
tested. Secondary features: subtle signs incompatible with LOC .. 8. Neurological causes and mimics
.
such as eyelid flicker, eyeball movements, swallowing, intact ...
of syncope
muscletone,normalmovementsabsentintrueunconsciousness, ..
.
andresistancetoeyeopening. ..
. This section discusses neurological disorders causing syncope or
• BP:normalorelevatedduringTLOC. .
.
• EEG: normal waking eye-closed EEG pattern, i.e. usually with .. resemblingit,andteststobeperformedinpatientswithsyncope.
.
alphaactivity,duringTLOC. ..
.
. 8.1 Clinical conditions
.
ThegoldstandardforPPSisdocumentinganattackwithahome ..
. 8.1.1Autonomicfailure
videorecorderorwithatilttestingduringwhichBP,HR,andEEG ..
. Neurological evaluation should be considered in OH due to auto-
arenormal.116,204,404ThegoldstandardforPNESisdocumentingan ..
. nomicfailure.Warningsignsareearlyimpotence,disturbedmicturi-
attackwithvideo-EEGmonitoring.204,404 ..
. tion, hyposmia, rapid eye movement, sleep behaviour
.
.. disorders,408,409Parkinsonism,ataxia,cognitiveimpairment,andsen-
7.1.2.1 Managementofpsychogenicpseudosyncope ..
. sorydeficits.Amultidisciplinaryapproachmayberequiredinsecon-
Announcing a psychological diagnosis to patients may be considered ..
. dary autonomicfailureand indrug-induced OH, dependingon the
difficult,butisnecessaryforreasonsofhonestyandasthefirststepof ..
. underlyingdisease.
treatment.404Itshouldbedonebythesomaticspecialistwhodiagnoses ..
. PPS.116,404Importantaspectsaretoassurepatientsthattheyaretaken ..
.
. 8.1.2Epilepsyandictalasystole
seriouslyandthatattacksareasinvoluntaryassyncopeoranepileptic .
.
. Table10providesanumberofcluesthataidthedifferentiationof
seizure.Acceptanceofthediagnosisbypatientsmaybecriticalforther- .
apy.Inoneobservationalstudy,405communicatingandexplainingthe ... syncope from epileptic seizures.9,50,410,411 Epilepsy and syncope
.
. may evoke one another on rare occasions, resulting in epileptic
diagnosisresultedinanimmediatereductionofattackfrequency,with .
.
. seizurestriggeringsyncopeaswellassyncopetriggeringanepilep-
39%ofpatientsbeingasymptomaticduringameanfollow-upperiodof .
.
. ticseizure.Thefirstformconcernsictalasystole.Whereasapprox-
4years.SomeadviceonhowtoinformthepatientisprovidedinWeb .
.
PracticalInstructionssection10:EuropeanSocietyofCardiologyinformation
.. imately 90% of all epileptic seizures are accompanied by
.
sheetforpatientsaffectedbypsychogenicpseudosyncope.
.. tachycardia, ictal bradycardia and asystole occur in 0.3–0.5% of
.
CognitivebehaviouraltherapyistheusualtreatmentofPNESand
.. seizures.412,413 Bradycardia precedes asystole and AV block may
.
PPS,ifattacksremainpresentafterexplanation.Onepilotrandom-
... occur, resembling the ECG pattern of reflex syncope.412,414
izedtreatmenttrial,conductedinPNES,406showedthatpsychologi- ... Epilepticasystoleoccursduringpartialcomplexseizures,notdur-
cal therapy provided more attack reduction than no treatment or
... inggeneralizedseizures.Epilepticasystoleoccursinonlyafraction
treatmentwithsertraline.TherearecurrentlynotrialsonPPS.
... of the seizures of one person, and then occurs after a variable
.. interval of 5–100s from seizure onset.415,416If asystole lasts for
.
.. morethanabout8s,syncopeensues.416Atypicalhistoryisfora
.
.. partialcomplexseizuretoprogressasusualforthatpatient,and
Diagnosisandmanagementofpsychogenic ...
thenthepatientsuddenlyfallsflaccidly,withorwithoutbriefmyo-
pseudosyncope .
.. clonicjerking.416,417Ictalbradycardia,asystole,andictalAVblock
.
.. are likely self-terminating,412 and are due to vagal activation
Recommendations Classa Levelb ..
. broughtaboutbytheseizure.Cessationofcorticalactivitydueto .
.
Diagnosis .. syncopal cerebral hypoperfusion will end the seizure. Therapy
.. requires anti-epileptic drugs and possibly a pacemaker.418
.
Therecordingofspontaneousattackswith . . Ictalasystoleisprobablynotinvolvedinsuddendeathinepilepsy,
.
avideobyaneyewitnessshouldbeconsid- IIa C . . as this typically occurs in patients after unwitnessed nocturnal
.
eredfordiagnosisofPPS.116,154 . . generalized tonic-clonic seizures, i.e. another type of epi-
.
Tilttesting,preferablywithconcurrentEEG ... lepsy.414,419 Note that most cases of sudden cardiac arrest in
.
recordingandvideomonitoring,maybe IIb C .. patientswithepilepsyareduetocardiovasculardiseaseandnotto
.
consideredfordiagnosisofPPS.116,403,407 .. ictalasystole.420
.
.. The second form concerns a syncopal epileptic seizure.
Management ... Hypoxiacantriggerepilepticseizures.208,421Suchsyncopalepilep-
.
DoctorswhodiagnosePPSshouldpresent
.. tic seizures have been described in infants with reflex syncope
thediagnosisofPPStothepatient.116,404
IIa C ....
or cyanotic breath-holding spells. A typical syncopal spell
.. suddenly transforms into prolonged clonic movements that
.
Cognitivebehaviouraltherapymaybecon- .. lastforminutes;notethatshorterepilepticseizuresmayremain
.
sideredinthetreatmentofPPSifattacks IIb C .. unnoticed.
.
persistafterexplanation. .
.
.
.
.. 8.1.3Cerebrovasculardisorders
E aCEG las= soe fle rc et cr oo men mc ee np dh aa tlo iog nr .am;PPS=psychogenicpseudosyncope. ....
Ingeneral,aTIAconcernsafocalneurologicaldeficitwithoutLOC,
bLevelofevidence. .. andsyncopetheopposite.Subclavianstealreferstothereroutingof
.
. bloodflowtothearmthroughthevertebralarteryduetoproximal
Downloaded
from
https://academic.oup.com/eurheartj/article/39/21/1883/4939241
by
guest
on
22
January
2026
--- Страница 49 ---
ESCGuidelines 1931
Table10 Differentiatingsyncopefromepilepticseizures9,50,410,411
Clinicalfeature Syncope Epilepticseizures
Usefulfeatures
Presenceoftrigger Veryoften Rare
Natureoftrigger Differsbetweentypes:pain,standing,emo- Flashinglightsisbestknown;alsorangeofrare
tionsforVVS;specifictriggerforsituational triggers
syncope;standingforOH
Prodromes Oftenpresyncope(autonomicactivationin Epilepticaura:repetitive,specificforeachpatient.
reflexsyncope,light-headednessinOH,palpi- Includesde´j(cid:3)avu.Risingsensationintheabdomen
tationsincardiacsyncope) (epigastricaura)and/oranunusualunpleasant
smell
Detailedcharacteristicsof • <10,irregularinamplitude,asynchronous, • 20–100,synchronous,symmetrical,hemilateral
myoclonus asymmetrical • TheonsetmostlycoincideswithLOC
• StartsaftertheonsetofLOC • Clearlong-lastingautomatismsaschewingorlip
smackingatthemouth
Tonguebite Rare,tipoftongue Sideoftongue(rarelybilateral)
Durationofrestorationof 10–30seconds Maybemanyminutes
consciousness
Confusionafterattack Nounderstandingofsituationfor<10seconds Memorydeficit,i.e.repeatedquestionswithout
inmostsyncope,fullalertnessandawareness imprintingformanyminutes
afterwards
Featuresoflimitedutility
Incontinence Notuncommon Common
Presenceofmyoclonus(seebelow Veryoften (cid:5)60%,dependentonaccuracyofobservation
fornatureofmyoclonus)
EyesopenduringLOC Frequent Nearlyalways
Fatigueandsleepafterwards Common,particularlyinchildren Verycommon
Blueface Rare Fairlyoften
LOC=lossofconsciousness;OH=orthostatichypotension;VVS=vasovagalsyncope.
.
.
stenosisorocclusionofthesubclavianartery.ATIAmayoccurwhen . ATIAofthevertebrobasilarsystemcancauseLOC,butthereare .
.
flowthrough the vertebral artery cannot supply both the arm and . alwaysfocalsigns,usuallylimbweakness,gaitandlimbataxia,vertigo,
.
.
part of the brain during forceful use of the arm. Steal most often . diplopia, nystagmus, dysarthria, and oropharyngeal dysfunction.
.
.
affectstheleftside.Whendetectedwithultrasound,stealisasympto- . Fewer than 1% of patients with vertebrobasilar ischaemia present
.
.
maticin64%ofcases.422ATIAislikelyduetostealonlywhenitis .. withasinglepresentingsymptom.425
.
vertebrobasilar(seebelow)andassociatedwithexerciseofonearm. ..
.
TherearenoreliablereportsofisolatedLOCwithoutfocalneuro- ..
.
logicalsymptomsandsignsinsubclaviansteal. .. 8.1.4Migraine
.
ATIArelatedtoacarotidarterydoesnotusuallycauseTLOC.An .. Syncope,presumableVVS,and orthostaticintoleranceoccurmore
.
exception concerns orthostatic TIAs, concerning a combination of .. ofteninpatientswithmigraine,whohaveahigherlifetimeprevalence
.
multiplestenosesofcerebralarteriesandOH.Thismayrarelyresult .. of syncope and oftenfrequent syncope.426 In migraineurs,syncope
.
inrepetitive,orthostatic,short-lasting,andstereotypedTIAs.423,424 . andmigraineattacksrarelyoccursimultaneously.
Downloaded
from
https://academic.oup.com/eurheartj/article/39/21/1883/4939241
by
guest
on
22
January
2026
--- Страница 50 ---
1932 ESCGuidelines
.
.
8.1.5Cataplexy . 8.2.3Neurovascularstudies
.
.
Cataplexyconcernsparesisorparalysistriggeredbyemotions,usu- . NostudiessuggestthatcarotidDopplerultrasonographyisvaluable
.
allylaughter,butalsobyarangeofothertriggers.427Patientsarecon- .. inpatientswithtypicalsyncope.
.
.
scious even when considered unconscious by eyewitnesses, and .
.
.
thereisnoamnesia.Cataplexyisakeyfeatureofnarcolepsy;other .
.
. 8.2.4Bloodtests
cardinal symptoms are excessive daytime sleepiness, sleep-onset .
.
. An acuteorsubacuteonset ofmultidomain autonomic failuresug-
paralysis,andhypnagogichallucinations.Cataplexymaybemistaken .
.
. gests a paraneoplastic orautoimmunecause.Screening for specific
forsyncope,butalsoforPPS:apartialawarenessofeventsmaybe .
.
. paraneoplasticantibodiesisrecommended:themostcommonpara-
presentinPPS,andthefallsofcataplexyarepartlycontrolledbecause .
.
. neoplasticantibodiesareanti-Hu,whileothersareanti-Purkinjecell
paralysisneednotbeimmediatelycomplete. .
.
.. cytoplasmicautoantibodytype2andanti-collapsinresponsemedia-
.
.. torprotein5.431Seropositivityforanyoftheabove-mentionedanti-
8.1.6Dropattacks .
.. bodies may therefore prompt further investigation for occult
The term drop attacks is confusing as it is variably used for .
.. malignancy (e.g. whole-body fluorodeoxyglucose-positron emission
Menie`re’s disease, atonic epileptic seizures, and unexplained .
falls.387 A specific condition also labelled drop attacks concerns
... tomography).432
.. Seropositivity for antiganglionic acetylcholine receptor
middle-aged women (rarely men) who suddenly find themselves .
falling.428 They usually remember hitting the floor and can stand
... antibodies is the serological hallmark of autoimmune autonomic
. ganglionopathy.433,434
upimmediatelyafterwards.
Neurologicalevaluation
Neurologicaltests
Recommendations Classa Levelb
Recommendations Classa Levelb
Neurologicalevaluationisindicated
BrainMRIisrecommendedifneurological
whensyncopeisduetoautonomicfail- I C
examinationindicatesParkinsonism,ataxia, I C
uretoevaluatetheunderlyingdisease.
orcognitiveimpairment.
Neurologicalevaluationisindicatedin
Screeningforparaneoplasticantibodiesand
patientsinwhomTLOCissuspectedto I C
antiganglionicacetylcholinereceptoranti-
beepilepsy.
bodiesisrecommendedincasesofacuteor I B
subacuteonsetofmultidomainautonomic
TLOC=transientlossofconsciousness. failure.432,433
aClassofrecommendation.
bLevelofevidence.
EEG,ultrasoundofneckarteries,andcom-
putedtomographyormagneticresonance
III B
imagingofthebrainarenotindicatedin
8.2 Neurological tests patientswithsyncope.178,435–440
A schematic comprehensive figure of neurological tests used for
Additionaladviceandclinicalperspectives
autonomicfailureisshowninFigure17.
Seropositivityforanyparaneoplasticantibodyorforantigan-
glionicacetylcholinereceptorantibodiesshouldpromptfurther
8.2.1Electroencephalography investigationsforoccultmalignancy.
TheresultsofinterictalEEGsarenormalinsyncope.410,430Aninteric-
tal normal EEG cannot rule out epilepsy and the EEG in epilepsy EEG=electroencephalogram;MRI=magneticresonanceimaging.
mustalwaysbeinterpretedinaclinicalcontext.AnEEGisnotrec-
aClassofrecommendation.
bLevelofevidence.
ommendedwhensyncopeisthemostlikelycauseofTLOC,butitis
whenepilepsyisthelikelycauseorwhenclinicaldataareequivocal.
TheEEGisalsousefultoestablishPPS,ifrecordedduringaprovoked
attack. 9. Organizational aspects
9.1 Syncope (transient loss of
8.2.2Braincomputedtomographyandmagnetic
consciousness) management unit
resonanceimaging
Computed tomography and MRI in uncomplicated syncope should Since the publication of the 2009 ECS Guidelines, the EHRA Task
be avoided. If neurological examination points out Parkinsonism, Forcehaspublishedafurtherpositionstatementontherationaleand
ataxia, or cognitive impairment, MRI is recommended. In cases of requirementfor syncopeunits.63 The positionpaper offersa prag-
contraindicationforMRI,computedtomographyisrecommendedto maticapproachtotherationaleandrequirementforasyncopeunit.
excludebrainlesions. It is addressed to physicians and others in administration who are
Downloaded
from
https://academic.oup.com/eurheartj/article/39/21/1883/4939241
by
guest
on
22
January
2026
--- Страница 51 ---
ESCGuidelines 1933
Figure17 Diagnosticwork-upofcardiovascularautonomicfailure(adaptedfromFanciullietal.429).CNS=centralnervoussystem;CRMP-5=
collapsinresponsemediatorprotein5;DAT=dopamineactivetransporter;HbA1c=haemoglobinA1c;HIV=humanimmunodeficiencyvirus;123I-
MIBG=123I-metaiodobenzylguanidine;MRI=magneticresonanceimaging;PCA-2=Purkinjecellcytoplasmicautoantibodytype2;SPECT=single-
photonemissioncomputedtomography;SS-A=Sjogren’ssyndrome-associatedantigenA;SS-B=Sjogren’ssyndrome-associatedantigenB.
Table11 Keycomponentsofasyncopeunit
• Thesyncopeunitshouldtaketheleadinservicedeliveryforsyncope,andineducationandtrainingofhealthcareprofessionalswhoencountersyncope.
• ThesyncopeunitshouldbeledbyaclinicianwithspecificknowledgeofTLOCandadditionalnecessaryteammembers(i.e.clinicalnursespecial-
ist)dependingonthelocalmodelofservicedelivery.
• ThesyncopeunitshouldprovideminimumcoretreatmentsforreflexsyncopeandOH,andtreatmentsorpreferentialaccessforcardiacsyn-
cope,falls,psychogenicpseudosyncope,andepilepsy.
• Referralsshouldbedirectlyfromfamilypractitioners,EDs,in-hospitalandout-hospitalservices,orself-referraldependingontheriskstratifica-
tionofreferrals.Fast-trackaccess,withaseparatewaitinglistandscheduledfollow-upvisits,shouldberecommended.
• Syncopeunitsshouldemployqualityindicators,processindicators,anddesirableoutcometargets.
ED=emergencydepartment;OH=orthostatichypotension;TLOC=transientlossofconsciousness.
.
interestedinestablishingasyncopeunitintheirhospitalsothatthey .. 9.1.1Definitionofasyncopeunit
.
can meet the standards proposed by the ESC, the EHRA, and the .. Asyncopeunitisafacilityfeaturingastandardizedapproachtothe
.
HeartRhythmSociety.Thefollowingisthecontextandevidencefor .. diagnosis and management of TLOC and related symptoms, with
.
.
recommendationsregardingsyncopeunits(Table11). . dedicatedstaffandaccesstoappropriatediagnosticsandtherapies.
Downloaded
from
https://academic.oup.com/eurheartj/article/39/21/1883/4939241
by
guest
on
22
January
2026
--- Страница 52 ---
1934 ESCGuidelines
.
.
9.1.2Definitionofsyncopespecialist . scientific or economic scrutiny, the consensus is that a dedicated
.
.
Thesyncope specialistis defined asone who has responsibilityfor . service(asyncopeunit)affordsbettermanagementofTLOC,from
.
.
thecomprehensivemanagementofthepatientfromriskstratification . riskstratificationtodiagnosis,therapy,andfollow-up,andbetteredu-
.
.
todiagnosis,therapy,andfollow-up,throughastandardizedprotocol. . cationandtrainingofstakeholders.Furtherresearchislikelytohave
.
.
A syncope specialistisa physicianwho hassufficientknowledgeof . animportantimpactonourconfidenceintheestimateofeffect.
.
.
historicalcluesandphysicalfindingstorecognizeallmajorformsof .
.
.
TLOC, including mimics, as well as syndromes of orthostatic .
.
.
intolerance. .. 9.1.4Modelofasyncopeunit
.
.. The syncope unit should provide minimum core treatments for
.
.. reflex syncope and OH, and treatments or preferential access for
.
9.1.3Goalofasyncopeunit .. cardiacsyncope,falls,psychogenicsyncope,andepilepsy(Table12).
.
Althoughthebenefitofasyncopeunitorasyncopespecialistinthe .. Thetestsandassessmentsavailableinthesyncopeunitaredetailed
. different healthcare systems has not been exposed to rigorous . inTable13.
Table12 Structureofthesyncopeunit
Staffingofasyncopeunitiscomposedof:
(1) Oneormorephysiciansofanyspecialtywhoaresyncopespecialists.OwingtothemultidisciplinarynatureofTLOCmanagement,eachsyn-
copeunitshouldidentifyspecificspecialistsforthesyncopeunitandforconsultancies.
(2) Astaffcomprisingprofessionalswhowilladvancethecareofpatientswithsyncope.Thesemaybephysicians,specializednurses,orotherswho
bringmultidisciplinaryskillstothefacility,coupledwithadministrativesupport.Therolesplayedbymembersoftheteammayvaryaccordingto
localcircumstancesandindividualskill.Nursesmaybeexpectedtotakeveryimportantrolesincludinginitialassessment,follow-upclinicevalua-
tion,selectionofinvestigations(includingtilttesting),andimplantation/insertionofECGlooprecordersaccordingtopredefinedprotocolsand
localregulations(seeTable14).
(3) Giventhatthesyncopeunitisintegratedwithinahospitalorganization,syncopespecialistsandstaffarenotnecessarilyemployedfull-time,but
frequentlyhaveotherdutiesdependingonthevolumeofactivityintheunit.
Facility,protocol,andequipment
(1) AsyncopeunitwilldelivermostofitscaretooutpatientsinadditiontoEDandinpatients.
(2) Thesyncopeunitshouldfollowaninternalprotocol,whichappliestodiagnosisandmanagementandisagreedbystakeholders.
(3) Anequippedfacilitymustbeavailable.
(4) Essentialequipment/tests:
-12-leadECGand3-leadECGmonitoring
-Non-invasivebeat-to-beatBPmonitorwithrecordingfacilitiesforsubsequentanalysis
-Tilt-table
-Holtermonitors/externallooprecorders
-ILRs
-Follow-upofILRsa
-24-hourBPmonitoring
-Basicautonomicfunctiontests.
(5) Establishedproceduresfor:
-Echocardiography
-EPS
-Stresstest
-Neuroimagingtests.
(6) Specialists’consultancies(cardiology,neurology,internalmedicine,geriatric,psychology),whenneeded.
Therapy
Patientswithsyncopewillreceivetheirtherapyunderthecareofthesyncopeunitunlessexpertiseoutsidethatoftheunitisrequired.
Databasemanagement
Thesyncopeunitisrequiredtokeepmedicalrecordsthatshouldalsoincludefollow-upwhenappropriate.Thedatabasewillalsoofferthepossibil-
ityofcollaborativeresearchwithothersyncopeunits.
BP=bloodpressure;ECG=electrocardiogram;ED=emergencydepartment;EPS=electrophysiologicalstudy;ILR=implantablelooprecorder;
TLOC=transientlossofconsciousness.
aImplantationoflooprecordersmaybeperformedeitherbysyncopeunitphysiciansorbyexternalcardiologistsattherequestofthesyncopeunitphysicians.
Downloaded
from
https://academic.oup.com/eurheartj/article/39/21/1883/4939241
by
guest
on
22
January
2026
--- Страница 53 ---
ESCGuidelines 1935
Table13 Testandassessmentsavailableinasyncopeunit
Initialassessment
Historyandphysicalevaluationincluding3-minorthostaticBPmeasurementa
12-leadstandardECG
Subsequenttestsandassessments(onlywhenindicated)
Bloodtests Electrolytes,haemoglobin,troponin,B-typenatriureticpeptide,glucose,D-dimer,haemogasanal-
ysis/oxygensaturation
Provocativetests CSM,tilttesting
Monitoring Externallooprecording,implantablelooprecording,ambulatory1–7daysECGmonitoring,
24–48-hourBPmonitoring
Autonomicfunctiontests Standingtest,Valsalvamanoeuvre,deep-breathingtest,coldpressortest,and/orestablishedpro-
ceduresforaccesstootherautonomicfunctiontests
Cardiacevaluation Establishedproceduresforaccesstoechocardiogram,stresstest,electrophysiologicalstudy,cor-
onaryangiography
Neurologicalevaluation Establishedproceduresforaccesstoneurologicaltests(computedtomography,magneticreso-
nanceimaging,EEG,video-EEG)
Geriatricevaluation Establishedproceduresforaccesstofallriskassessment(cognitive,gaitandbalance,visual,envi-
ronmental)andforgaitandbalanceretraining
Psychologicalorpsychiatricevaluation Establishedproceduresforaccesstopsychologicalorpsychiatricconsultancy(mentalhealth
problemorpsychogenicsyncope)
BP=bloodpressure;CSM=carotidsinusmassage;ECG=electrocardiogram;EEG=electroencephalogram.
aPosturalorthostatictachycardiamayrequirelongerperiodofstanding.
.
.
9.1.5Accessandreferralstoasyncopeunit . 9.2 The clinical nurse specialist in the
.
.
Referralcanbedirectfromfamilypractitioners,EDs,in-hospitaland .. syncope unit
.
out-hospital services, or self-referral from the patient. Fast-track .
.. 9.2.1Definition
access witha separate waitinglist and scheduled follow-upvisits is .
.. Thesyncopeunitclinicalnursespecialistisdefinedasanexperienced
recommended.Inparticular,patientsatlow/intermediateriskadmit- .
.. practitioner who has sufficient knowledge of history features and
tedtotheEDshouldbenefitfromsuchfast-trackfacilities(so-called . .. physicalfindingstorecognizeallmajorformsofTLOC,aswellassyn-
protected discharge or advanced access with an appointment for ...
dromesoforthostaticintolerance.Theclinicalnursespecialistshould
earlyassessment)toreduce hospitalizationrates, directly fromthe ...
work in close collaboration with the syncope specialist. The core
EDorafterashortstayintheshortobservationunitoftheED(see ...
competenciesoftheclinicalnursespecialistincludeaspecializedclini-
section4.1.2). ...
calfocus,patientadvocacy,educationandtraining,auditing,research,
.
.. andinter-andintradisciplinaryconsultations.
.
.
.
9.1.6Outcomesandqualityindicators ..
. 9.2.2Roleandskillsoftheclinicalnursespecialist
The EHRA Task Force63 has developed the following preliminary ..
. Theclinicalnursespecialistshouldbeskilledintheperformanceand
quality indicators, based on consensus, as a rough guide for ..
. interpretationofstructuredhistorytaking,12-leadECGandroutine
practitioners: ..
.. bloodtestresults,tilttesting,activestandtests,autonomicfunction
.
(1) AbsoluterateofundiagnosedTLOCshouldbereducedby20%; .. tests, ECG monitoring (Holter and/or external loop recorder),
.
(2) Lessthan20%oflow-/intermediate-riskTLOCpatientsshouldbe .. ABPM,ILRmonitoring,andsubsequenttriagingofpatientsandmoni-
.
admittedfromtheED; .. toringresponsestotherapy.Otherskillswilldependontheservice
.
(3) Thesyncopeunitshouldhavea20%reductionincostsrelative .. model,e.g.pacemakerinterrogation.Theclinicalnursespecialistmay
.
tousualpracticeandimprovedoutcomes(i.e.<5%readmissions .. haveresponsibilityforfollow-upclinicsforcardiovascularriskfactor
.
for syncope and <20% of paced patients with recurrence at .. management, autonomic function testing and monitoring, manage-
.
1year). . ment(includingeducationin PCM) of VVSand OH,and follow-up
Downloaded
from
https://academic.oup.com/eurheartj/article/39/21/1883/4939241
by
guest
on
22
January
2026
--- Страница 54 ---
1936 ESCGuidelines
Table14 Theroleofphysiciansandstaffinperformingproceduresandtests
Procedureortest Syncopeunit Syncope Non-syncope
physician unitstaff unitpersonnel
Historytaking X
Structuredhistorytaking(e.g.applicationofsoftwaretechnologiesandalgorithms) X
12-leadECG X
Bloodtests X
Echocardiogramandimaging X
CSM X
Activestandingtest X
Tilttesting (X)a X
Basicautonomicfunctiontest X
ECGmonitoring(Holter,externallooprecorder):administrationandinterpretation X X
ILR X (X)b
Remotemonitoring X
Othercardiactests(stresstest,EPS,angiograms) X
Neurologicaltests(computedtomography,magneticresonanceimaging,EEG,video-EEG) X
PacemakerandICDimplantation,catheterablation X
Patienteducation,biofeedbacktraining,candinstructionsheetonPCM X X
Finalreportandclinicnote X
Communicationwithpatients,referringphysicians,andstakeholders. X X
Follow-up X X
BP=bloodpressure;CSM=carotidsinusmassage;ECG=electrocardiogram;EEG=electroencephalogram;EPS=electrophysiologicalstudy;ICD=implantablecardioverter
defibrillator;ILR=implantablelooprecorder;PCM=physicalcounter-pressuremanoeuvres.
aPhysicianneednotbeintheroom,butaphysicianadequatelytrainedinresuscitationneedstobeinthevicinityofthetest.
bCurrentpracticelimitedtoafewcountries.
cBiofeedbackmeansthatthePCMtrainingsessionconsistsofbiofeedbacktrainingusingacontinuousBPmonitor.Eachmanoeuvreisdemonstratedandexplained.Themanoeu-
vresarepractisedundersupervision,withimmediatefeedbackoftherecordingstogainoptimalperformance.
.
of external and internal loop and Holter monitors and ABPM63 .. 10. Key messages
.
.
(Table14). .
.
Theclinicalnursespecialistshouldbekeyindevelopinganddeliv- .. TheESCTaskForcehasselected19simplerulestoguidethediagno-
.
eringcommunicationstrategiesandprocessesforthesyncopeunit .. sisandmanagementofsyncopepatientswithTLOCaccordingtothe
.
for all stakeholders—patients and practitioners—andplaya pivotal .. 2018ESCGuidelinesonsyncope:
.
.
role ineducationand trainingtogether withthe syncope specialist. .. Diagnosis:initialevaluation
.
Theclinicalnursespecialistshouldbeinvolvedinregularauditingand .
.
. (1) Attheinitialevaluationanswerthefollowingfourkeyquestions:
collectionofdatatoinformqualityindicators.SeethevideoinWeb .
.
. (cid:3)WastheeventTLOC?
PracticalInstructionssection11. .
.
. (cid:3)IncasesofTLOC,aretheyofsyncopalornon-syncopalorigin?
.
.
. (cid:3)Incasesofsuspectedsyncope,isthereaclearaetiologicaldiagnosis?
Althoughtheskillmixofaclinicalnursespecialisthasnotbeen .
.
. (cid:3)Isthereevidencetosuggestahighriskofcardiovasculareventsor
exposedtorigorousscientificoreconomicscrutiny,theconsen- .
.
. death?
susisthattheclinicalnursespecialistshouldhavetheneces- ..
. (2) AttheevaluationofTLOCintheED,answerthefollowingthree
saryskillstodeliverassessmentandtreatmentforsyncopeand ..
. keyquestions:
TLOC.Furtherresearchisrequiredtoestablishthebenefits. ..
. (cid:3)Isthereaseriousunderlyingcausethatcanbeidentified?
Downloaded
from
https://academic.oup.com/eurheartj/article/39/21/1883/4939241
by
guest
on
22
January
2026
--- Страница 55 ---
ESCGuidelines 1937
.
.
(cid:3)Ifthecauseisuncertain,whatistheriskofaseriousoutcome? . 16.InpatientswithOH,selectoneormoreofthefollowingadditional
.
.
(cid:3)Shouldthepatientbeadmittedtohospital? . specifictreatmentsaccordingtoclinicalseverity:
.
.
(3) Inallpatients,performacompletehistorytaking,physicalexamina- . (cid:3)Educationregardinglifestylemanoeuvres.
.
.
tion(includingstandingBPmeasurement),andstandardECG. . (cid:3)Adequatehydrationandsaltintake.
.
.
(4) PerformimmediateECGmonitoring(inbedortelemetry)inhigh- . (cid:3)Discontinuation/reductionofhypotensivetherapy.
.
.
riskpatientswhenthereisasuspicionofarrhythmicsyncope. . (cid:3)Counter-pressuremanoeuvres.
.
.
(5) Performanechocardiogramwhenthereispreviousknownheart .. (cid:3)Abdominalbindersand/orsupportstockings.
.
disease,ordatasuggestiveofstructural heartdisease orsyncope .. (cid:3)Head-uptiltsleeping.
.
secondarytocardiovascularcause. .. (cid:3)Midodrineorfludrocortisone.
.
(6) PerformCSMinpatients>40yearsofagewithsyncopeofunknown .. 17.Ensurethatallpatientswithcardiacsyncopereceivethespecificther-
.
origincompatiblewithareflexmechanism. .. apyoftheculpritarrhythmiaand/oroftheunderlyingdisease.
.
(7) Performtilttestingincaseswherethereissuspicionofsyncopedue .. 18.BalancethebenefitsandharmofICDimplantationinpatientswith
. toreflexoranorthostaticcause. .. unexplainedsyncopeathighriskofSCD(e.g.thoseaffectedbyleft
.
(8) Performbloodtestswhenclinicallyindicated,e.g.haematocritand .. ventricle systolic dysfunction, HCM, ARVC, or inheritable arrhyth-
.
cellbloodcountwhenhaemorrhageissuspected,oxygensaturation .. mogenicdisorders).Inthissituation,unexplainedsyncopeisdefinedas
.
andbloodgasanalysiswhenhypoxicsyndromesaresuspected,tro- .. syncopethatdoesnotmeetanyclassIdiagnosticcriteriondefinedin
. poninwhencardiacischaemia-relatedsyncopeissuspected,andD- .. thetablesofrecommendationsofthe2018ESCGuidelinesonsyn-
.
dimerwhenpulmonaryembolismissuspected,etc. .. copeandisconsideredasuspectedarrhythmicsyncope.
.
.. 19.Re-evaluatethediagnosticprocessandconsideralternativetherapies
Diagnosis:subsequentinvestigations ..
. iftheaboverulesfailorarenotapplicabletoanindividualpatient.
.
.
9. Perform prolonged ECG monitoring (external or implantable) in .. BearinmindthatGuidelinesareonlyadvisory.Eventhoughtheyare
.
patientswithrecurrentsevereunexplainedsyncopewhohaveallof .. basedonthebestavailablescientificevidence,treatmentshouldbe
.
thefollowingthreefeatures: .. tailoredtoanindividualpatient’sneed.
.
(cid:3)ClinicalorECGfeaturessuggestingarrhythmicsyncope. ..
.
(cid:3)Ahighprobabilityofrecurrenceofsyncopeinareasonabletime. .. 11. Gaps in evidence and areas for
.
(cid:3) Whomaybenefitfromaspecifictherapyifacauseforsyncopeis ..
. future research
found. ..
.
10. Perform EPS in patients with unexplained syncope and bifascicular ..
BBB(impendinghigh-degreeAVblock)orsuspectedtachycardia.
... Clinicians responsible for managing patients with TLOC must fre-
11.Performanexercisestresstestinpatientswhoexperiencesyncope
... quently make treatment decisions without adequate evidence or a
.. consensusofexpertopinion.Thefollowingisashortlistofselected,
duringorshortlyafterexertion. .
.. common issues that deserve to be addressed in future clinical
12. Consider basic autonomic function tests (Valsalva manoeuvre and .
.. research.
deep-breathing test) and ABPM for the assessment of autonomic .
.
.
functioninpatientswithsuspectedneurogenicOH. .
.
13. Consider video recording (at home or in hospital) of TLOC sus- .. Diagnosis: the gap between the best
.
.
pectedtobeofnon-syncopalnature. . available scientific evidence and the need
.
. .. for the dissemination of these concepts
Treatment .
.
. into clinical practice
.
.
14. To all patients with reflex syncope and OH, explainthe diagnosis, . . Thereiswidevariationinthepracticeofsyncopeevaluation,and
.
reassure,explaintheriskofrecurrence,andgiveadviceonhowto . . wide variation in the adoption of recommendations from pub-
.
avoidtriggersandsituations.Thesemeasuresarethecornerstoneof . . lishedguidelines.TheabsenceofasystematicapproachtoTLOC
.
treatment and have a high impact in reducing the recurrence of .
. incurshigherhealthandsocialcarecosts,unnecessaryhospitaliza-
.
syncope. .
.. tions and diagnostic procedures, prolongation of hospital stays,
15.Inpatientswithsevereformsofreflexsyncope,selectoneormoreof .
.. lowerdiagnosticrates,andhigherratesofmisdiagnosesandsymp-
thefollowingadditionalspecifictreatmentsaccordingtotheclinical .
.. tomrecurrence.
features: ...
Therefore,thereisaneedfor:
(cid:3)MidodrineorfludrocortisoneinyoungpatientswithlowBP ..
.
phenotype. .. 1)Largeclinicalstudiesthatassessthediagnosticyieldandcomplianceofa
.
(cid:3)Counter-pressuremanoeuvres(includingtilttrainingifneeded)in .. guideline-basedstandardizedsystematicapproach
.
youngpatientswithprodromes. ..
.
(cid:3)ILR-guidedmanagementstrategyinselectedpatientswithout .. Despite the recommendation from the ESC Guidelines on syncope,
.
orwithshortprodromes. .. syncopeunitsarenotwidelyestablishedinclinicalpractice.Barriersto
.
(cid:3)Discontinuation/reductionofhypotensivetherapytargetinga .. establishing a syncope unit include lack of resources, lack of trained
.
systolicBPof140mmHginoldhypertensivepatients. .. dedicatedstaff,andcomplexpresentationstomultiplesettings,necessi-
.
(cid:3)Pacemakerimplantationinoldpatientswithdominant .. tatinginvolvementfrommultipledisciplines.Theevidencefortheuse-
.
cardioinhibitoryforms. . fulnessofsyncopeunitsiscontroversial.
Downloaded
from
https://academic.oup.com/eurheartj/article/39/21/1883/4939241
by
guest
on
22
January
2026
--- Страница 56 ---
1938 ESCGuidelines
.
Therefore,thereisaneedfor: .. Therefore,thereisstrongurgentneedforRCTsontheefficacyof:
.
.
.
2)Largeclinicalstudiesthattestthesuperiorityofmanagementinadedicated .. 4)Pharmacologicaltherapiestargetedtospecificsubgroupsofreflexsyncope.
.
syncopefacilityvs.conventionalmanagement .. 5)Pacemakertherapytargetedtospecificsubgroupsofcardioinhibitoryreflex
.
.. syncope.
.
Diagnosis: the need for new diagnostic .. 6)PharmacologicaltherapiesofOH-mediatedsyncope.
.
tests and devices ... 7)ICDtherapytargetedtospecificsubgroupsofpatientswithunexplainedsyn-
.. copeatriskofSCD.
BP recording is crucial for the majority of clinical TLOC situations ..
.
and will yield important information for the treatment of syncope. ..
.
Unfortunately, current long-term BP (or surrogate) recording sys- ..
.
tems are not optimal for diagnostic use in the syncope evaluation .. Treatment: the need for new therapies
.
setting. ...
Thereisaneedtomovetowardspersonalizedmedicine.Improving
Therefore,thereisaneedfor: ...
our knowledge of the biochemical mechanisms underlying specific
.
3)Developmentandvalidationofnewdiagnosticmultiparametricdevicesthat ... formsofreflexsyncopewillallowthedevelopmentofnewtherapies
canrecordheartrhythmandBP(andpossiblyotherphysiologicalparameters ... in such specific settings. For example, a low adenosine phenotype
.
suchascerebralsaturationorEEG)atthetimeofasyncopalevent. .. andalownorepinephrinephenotypehavebeenrecentlyidentified.
.
. Therefore,thereisaneedfor:
. .
.
Treatment: lackof evidence of efficacyof .
. 8)Randomizedclinicaltrialsontheefficacyoftheophylline(andotherxantine
.
most available therapies .. antagonists)forlowadenosinesyncopeandnorepinephrinetransportinhibi-
.
.
OnlyafewsmallRCTshavebeenconductedontreatmentofsyncope. .. torsforlowepinephrinesyncope.
.
Inaddition,syncopalrecurrencesareunpredictableandoftendecrease ...
Syncopeisatransientphenomenon.Theidealtherapyshouldbe
spontaneouslyaftermedicalassessment,evenintheabsenceofaspecific ...
onethatisadministeredonlywhenneeded.
therapy.Theconsequenceofthespontaneousdecreaseisthatanyther- ...
Therefore,thereisaneedfor:
apyforsyncopepreventionappearstobemoreeffectivethanitactually ..
.
is,makingtheresultsofobservationaldataontherapyquestionablein .. 9)Randomizedclinicaltrialsofon-demandadministrationofspecifictherapy
.
the absence of a control group. No therapy can be effective for all .. basedonspecificsensorssimilartoadrenalininjectorsinasthmaornasal
.
patients.Anytherapyshouldbeassessedinhomogeneoussubgroups. . sprayforparoxysmalSVT.
12. ‘What to do’ and ‘what not to do’ messages from the Guidelines
Recommendations Class Level
Diagnosticcriteriawithinitialevaluation
VVSishighlyprobableifsyncopeisprecipitatedbypain,fear,orstanding,andisassociatedwithtypicalprogressivepro-
I C drome(pallor,sweating,and/ornausea).8,13–17
SituationalreflexsyncopeishighlyprobableifsyncopeoccursduringorimmediatelyafterspecifictriggerslistedinTable3.8,13–17 I C
SyncopeduetoOHisconfirmedwhensyncopeoccurswhilestandingandthereisconcomitantOH.18–24 I C
ArrhythmicsyncopeishighlyprobablewhentheECGshows25–39:
• Persistentsinusbradycardia<40b.p.m.orsinuspauses>3sintheawakestateandintheabsenceofphysicaltraining.
• MobitzIIsecond-andthird-degreeAVblock.
• AlternatingleftandrightBBB. I C
• VTorrapidparoxysmalSVT.
• Non-sustainedepisodesofpolymorphicVTandlongorshortQTinterval.
• PacemakerorICDmalfunctionwithcardiacpauses.
Continued
Downloaded
from
https://academic.oup.com/eurheartj/article/39/21/1883/4939241
by
guest
on
22
January
2026
--- Страница 57 ---
ESCGuidelines 1939
ManagementofsyncopeintheED
Itisrecommendedthatpatientswithlow-riskfeatures,likelytohavereflexorsituationalsyncopeorsyncopeduetoOH,
I B
aredischargedfromtheED.27,35,36,49–54,58,62,69
Itisrecommendedthatpatientswithhigh-riskfeaturesreceiveanearlyintensivepromptevaluationinasyncopeunitorin
I B
anEDobservationunit(ifavailable),orarehospitalized.26,27,35,36,44–46,50,55–57,59,60,70–76
Itisrecommendedthatpatientswhohaveneitherhigh-norlow-riskfeaturesareobservedintheEDorinasyncopeunit
I B
insteadofbeinghospitalized.40,63–65,77
CSM
CSMisindicatedinpatients>40yearsofagewithsyncopeofunknownorigincompatiblewithareflexmechanism.92–94 I B
CSSisconfirmedifCSMcausesbradycardia(asystole)and/orhypotensionthatreproducesspontaneoussymptoms,and
I B
patientshaveclinicalfeaturescompatiblewithareflexmechanismofsyncope.89,90,92,93,98–102
Activestanding
IntermittentdeterminationbysphygmomanometerofBPandHRwhilesupineandduringactivestandingfor3minareindi-
I C
catedatinitialsyncopeevaluation.20,103,104
SyncopeduetoOHisconfirmedwhenthereisafallinsystolicBPfromabaselinevalue>_20mmHg,diastolicBP>_10
I C
mmHg,oradecreaseinsystolicBPto<90mmHgthatreproducesspontaneoussymptoms.6,20,103,104
ECGmonitoring
Immediatein-hospitalmonitoring(inbedorbytelemetry)isindicatedinhigh-riskpatients(definedinTable6). I C
ILRisindicatedinanearlyphaseofevaluationinpatientswithrecurrentsyncopeofuncertainorigin,absenceofhigh-risk
criteria(listedinTable6),andahighlikelihoodofrecurrencewithinthebatterylifeofthedevice.175,176,181–184,202, I A
SupplementaryDataTable5
ILRisindicatedinhigh-risk(criterialistedinTable6)patientsinwhomacomprehensiveevaluationdidnotdemonstratea
causeofsyncopeorleadtoaspecifictreatment,andwhodonothaveconventionalindicationsforprimarypreventionICD I A
orpacemakerindication.174,180,187,188,195,SupplementaryDataTables5and6
Arrhythmicsyncopeisconfirmedwhenacorrelationbetweensyncopeandanarrhythmia(bradyarrhythmiaortachyar-
I B
rhythmia)isdetected.172,184–186,188,200
EPS
Inpatientswithsyncopeandpreviousmyocardialinfarctionorotherscar-relatedconditions,EPSisindicatedwhensyncope
I B
remainsunexplainedafternon-invasiveevaluation.218
InpatientswithunexplainedsyncopeandbifascicularBBB,apacemakerisindicatedinthepresenceofeitherabaselineH-V
intervalof>_70ms,second-orthird-degreeHis-Purkinjeblockduringincrementalatrialpacing,orwithpharmacological I B
challenge.188,214–217,221
Inpatientswithunexplainedsyncopeandpreviousmyocardialinfarctionorotherscar-relatedconditions,itisrecom-
I B
mendedthatinductionofsustainedmonomorphicVTismanagedaccordingtothecurrentESCGuidelinesforVA.46
Inpatientswithoutstructuralheartdiseasewithsyncopeprecededbysuddenandbriefpalpitations,itisrecommendedthat
theinductionofrapidSVTorVT,whichreproduceshypotensiveorspontaneoussymptoms,ismanagedwithappropriate I C
therapyaccordingtothecurrentESCGuidelines.46,222
Echocardiography
Echocardiographyisindicatedfordiagnosisandriskstratificationinpatientswithsuspectedstructuralheartdisease.235,236 I B
Exercisetesting
Exercisetestingisindicatedinpatientswhoexperiencesyncopeduringorshortlyafterexertion. I C
Syncopeduetosecond-orthird-degreeAVblockisconfirmedwhentheAVblockdevelopsduringexercise,evenwithout
I C
syncope.253–257
Reflexsyncopeisconfirmedwhensyncopeisreproducedimmediatelyafterexerciseinthepresenceofseverehypotension.250–252 I C
Continued
Downloaded
from
https://academic.oup.com/eurheartj/article/39/21/1883/4939241
by
guest
on
22
January
2026
--- Страница 58 ---
1940 ESCGuidelines
Treatmentofreflexsyncope
Explanationofthediagnosis,provisionofreassurance,andexplanationoftheriskofrecurrenceandtheavoidanceoftrig-
I B
gersandsituationsareindicatedinallpatients.SupplementaryDataTable10
Beta-adrenergicblockingdrugsarenotindicated.279,280 III A
Cardiacpacingisnotindicatedintheabsenceofadocumentedcardioinhibitoryreflex.299,300 III B
TreatmentofOH
Explanationofthediagnosis,provisionofreassurance,andexplanationoftheriskofrecurrenceandtheavoidanceoftrig-
I C
gersandsituationsareindicatedinallpatients.
Adequatehydrationandsaltintakeareindicated.310,311 I C
Treatmentofsyncopeduetocardiacarrhythmias
Cardiacpacingisindicatedwhenthereisanestablishedrelationshipbetweensyncopeandsymptomatic
I B
bradycardia.200,210–212,255,334–338,341
Cardiacpacingisindicatedinpatientswithintermittent/paroxysmalintrinsicthird-orsecond-degreeAVblock(including
I C
AFwithslowventricularconduction),althoughthereisnodocumentationofacorrelationbetweensymptomsandECG.
Cardiacpacingisnotindicatedinpatientswhentherearereversiblecausesforbradycardia. III C
Cardiacpacingisindicatedinpatientswithsyncope,BBB,andapositiveEPSorILR-documentedAVblock.188,217 I B
CatheterablationisindicatedinpatientswithsyncopeduetoSVTorVTinordertopreventsyncoperecurrence. I C
AnICDisindicatedinpatientswithsyncopeduetoVTandejectionfraction<_35%.46 I A
AnICDisindicatedinpatientswithsyncopeandpreviousmyocardialinfarctionwhohaveVTinducedduringEPS.218 I C
ICDindicationsinpatientswithunexplainedsyncopeandleftventricularsystolicdysfunction
ICDtherapyisrecommendedtoreduceSCDinpatientswithsymptomaticheartfailure(NYHAclassII–III)andLVEF
<_35%after>_3monthsofoptimalmedicaltherapy,whoareexpectedtosurvivefor>_1yearwithgoodfunctionalstatus.46 I A
systolicdysfunction
Syncopeinpatientswithcomorbidityandfrailty
Amultifactorialevaluationandinterventionisrecommendedinolderpatientsbecausemorethanonepossiblecausefor
I B
syncopeandunexplainedfallmaybepresent.33,372–374,376–380
Neurologicalevaluation
Neurologicalevaluationisindicatedwhensyncopeissuspectedtobeepilepsyorduetoautonomicfailuretoevaluatethe
I C
underlyingdisease.
AF=atrialfibrillation;AV=atrioventricular;BBB=bundlebranchblock;BP=bloodpressure;b.p.m.=beatsperminute;CSM=carotidsinusmassage;CSS=carotidsinussyn-
drome;ECG=electrocardiogram;ED=emergencydepartment;EPS=electrophysiologicalstudy;ESC=EuropeanSocietyofCardiology;HR=heartrate;ICD=implantable
cardioverterdefibrillator;ILR=implantablelooprecorder;LVEF=leftventricularejectionfraction;NYHA=NewYorkHeartAssociation;OH=orthostatichypotension;
SCD=suddencardiacdeath;SVT=supraventriculartachycardia;VA=ventriculararrhythmia;VT=ventriculartachycardia;VVS=vasovagalsyncope.
.
.
13. Supplementary Data and Web . 14. Appendix
.
.
.
Practical Instructions .
.
. ESC Committee for Practice Guidelines (CPG): Stephan
.
.
. Windecker (Chairperson) (Switzerland), Victor Aboyans (France),
SupplementaryDatawithadditionalWebTablescomplementingthe ..
full text, and an additional Web Practical Instructions document—
... Stefan Agewall (Norway), Emanuele Barbato (Italy), He´ctor Bueno
withaglossarycontainingdefinitionsofsyncopeandrelatedconcepts
... (Spain), Antonio Coca (Spain), Jean-Philippe Collet (France), Ioan
withtracings,videos,flowcharts,andchecklists—areavailableonthe
... MirceaComan(Romania),VeronicaDean(France),VictoriaDelgado
European Heart Journal website and via the ESC Website at www.
... (The Netherlands), Donna Fitzsimons (UK), Oliver Gaemperli
escardio.org/guidelines.
... (Switzerland), Gerhard Hindricks (Germany), Bernard Iung
. (France), Peter Ju¨ni (Canada), Hugo Albert Katus (Germany), Juhani
Downloaded
from
https://academic.oup.com/eurheartj/article/39/21/1883/4939241
by
guest
on
22
January
2026
--- Страница 59 ---
ESCGuidelines 1941
.
.
Knuuti (Finland), Patrizio Lancellotti (Belgium), Christophe . 3. AlboniP,AlboniM.Vasovagalsyncope.Heidelberg:Springer;2015.p3–17.
.
Leclercq (France), Theresa McDonagh (UK), Massimo Francesco .. 4. DeharoJC, Guieu R,MechulanA, Peyrouse E, Kipson N,Ruf J, Gerolami V,
.. DevotoG,MarreV,BrignoleM.Syncopewithoutprodromesinpatientswith
Piepoli(Italy),PiotrPonikowski(Poland),DimitriosJ.Richter(Greece), .. normalheartandnormalelectrocardiogram:adistinctentity.JAmCollCardiol
.
Marco Roffi (Switzerland), Evgeny Shlyakhto (Russia), Miguel Sousa- . 2013;62:1075–1080.
.
Uva(Portugal),IainA.Simpson(UK),JoseLuisZamorano(Spain). .. 5. BrignoleM,DeharoJC,DeRoyL,MenozziC,BlommaertD,DabiriL,RufJ,
.. Guieu R. Syncope due to idiopathic paroxysmal atrioventricular block: long-
.
ESCNationalCardiacSocietiesactivelyinvolvedinthereview .. term follow-up of a distinct form of atrioventricular block. J Am Coll Cardiol
. 2011;58:167–173.
process of the 2018 ESC Guidelines for the diagnosis and ... 6. Freeman R, Wieling W, Axelrod FB, Benditt DG, Benarroch E, Biaggioni I,
managementofsyncope: .. CheshireWP,ChelimskyT,CortelliP,GibbonsCH,GoldsteinDS,Hainsworth
.
. R, Hilz MJ, Jacob G, Kaufmann H, Jordan J, Lipsitz LA, Levine BD, Low PA,
.
Austria: Austrian Society of Cardiology, Franz Xaver Roithinger; .. MathiasC,RajSR,RobertsonD,SandroniP,SchatzI,SchondorffR,StewartJM,
Belarus: Belorussian Scientific Society of Cardiologists, Alexandr
... vanDijkJG.Consensusstatementonthedefinitionoforthostatichypotension,
. neurallymediatedsyncopeandtheposturaltachycardiasyndrome.ClinAuton
Chasnoits; Belgium: Belgian Society of Cardiology, Yves .. Res2011;21:69–72.
. Vandekerckhove;Bulgaria:BulgarianSocietyofCardiology,VasilB. .. 7. Fedorowski A, Melander O. Syndromes of orthostatic intolerance: a hidden
Traykov; Croatia: Croatian Cardiac Society, Davor Puljevic;
... danger.JInternMed2013;273:322–335.
. 8. Wieling W, Thijs RD, van Dijk N, Wilde AA, Benditt DG, van Dijk JG.
Cyprus: Cyprus Society of Cardiology, Elias Papasavvas; Czech .. Symptomsandsignsofsyncope:areviewofthelinkbetweenphysiologyand
.
Republic:CzechSocietyofCardiology,JosefKautzner;Denmark: .. clinicalclues.Brain2009;132:2630–2642.
Danish Society of Cardiology, Henning Mølgaard; Egypt: Egyptian
... 9. vanDijkJG,ThijsRD,vanZwetE,TannemaatMR,vanNiekerkJ,BendittDG,
. WielingW.Thesemiologyoftilt-inducedreflexsyncopeinrelationtoelectro-
Society of Cardiology, Mostafa Nawar; Finland: Finnish Cardiac ... encephalographicchanges.Brain2014;137:576–585.
Society, Hannu Parikka; The Former Yugoslav Republic of .. 10. BreningstallGN.Breath-holdingspells.PediatrNeurol1996;14:91–97.
.
Macedonia:MacedonianFYRSocietyofCardiology,MarijaVavlukis; .. 11. StephensonJBP.Fitsandfaints.London:MacKeithPress;1990,202pages.
. 12.vanDijkN,BoerKR,ColmanN,BakkerA,StamJ,vanGriekenJJ,WildeAA,
.
France: French Society of Cardiology, Olivier Piot; Georgia: .. LinzerM,ReitsmaJB,WielingW.Highdiagnosticyieldandaccuracyofhistory,
Georgian Society of Cardiology, Kakhaber Etsadashvili; Germany: .. physicalexamination,andECGinpatientswithtransientlossofconsciousnessin
.
. FAST:theFaintingAssessmentstudy.JCardiovascElectrophysiol2008;19:48–55.
GermanCardiacSociety,ThomasKlingenheben;Greece: Hellenic .
. 13. StephensonJ.Chapter7-Anoxicseizuresorsyncope.Fitsandfaints.Oxford:
.
Society of Cardiology, Spyridon Deftereos; Hungary: Hungarian .. BlackwellScientificPublications;1990.p41–57.
.
Society of Cardiology, L(cid:2)aszlo(cid:2) S(cid:2)aghy; Iceland: Icelandic Society of . 14. vanDijkJG,SheldonR.Isthereanypointtovasovagalsyncope?ClinAutonRes
.
. 2008;18:167–169.
Cardiology,KristjanGudmundsson;Israel:IsraelHeartSociety,Roy .
.. 15. AlboniP,AlboniM,BertorelleG.Theoriginofvasovagalsyncope:toprotect
Beinart; Italy: Italian Federation of Cardiology, Antonio Raviele; .. theheartortoescapepredation?ClinAutonRes2008;18:170–178.
.
Kazakhstan: Association of Cardiologists of Kazakhstan, Ayan . 16. GanzeboomKS,ColmanN,ReitsmaJB,ShenWK,WielingW.Prevalenceand
.
. triggersofsyncopeinmedicalstudents.AmJCardiol2003;91:1006–1008,A8.
Abdrakhmanov; Kyrgyzstan: Kyrgyz Society of Cardiology, Erkin .
.. 17. SerletisA,RoseS,SheldonAG,SheldonRS.Vasovagalsyncopeinmedicalstu-
Mirrakhimov, Latvia: Latvian Society of Cardiology, Oskars Kalejs; .. dentsandtheirfirst-degreerelatives.EurHeartJ2006;27:1965–1970.
.
Libya: Libyan Cardiac Society, Hisham A. Benlamin; Lithuania: .. 18. ShibaoC,LipsitzLA,BiaggioniI.ASHpositionpaper:evaluationandtreatment
LithuanianSocietyofCardiology,ArasPuodziukynas;Luxembourg:
....
19.
Mof ao thrt iah sos Cta J,ti Mch aly lip po et de dn isi Ro ,n. BJ leC ali sn daH leyp -Be art re rns K( .G Sr ye men pw ti och m) s20 a1 ss3 o;1 c5 ia: t1 e4 d7– w1 i5 th3.
ortho-
LuxembourgSocietyofCardiology,CarloDimmer;Malta:Maltese .. static hypotension in pure autonomic failure and multiple system atrophy.
.
CardiacSociety, MarkA. Sammut; Moldova: MoldavianSociety of .. JNeurol1999;246:893–898.
Cardiology, Aurica Raducan; Montenegro: Montenegro Society
.... 20. PN oa ss tgc rh ai dtz MJE e, dR Jo 2s 0n 0e 7r ;8I 3. :O 56r 8th –o 5s 7t 4a .tic hypotension: framework of the syndrome.
ofCardiology,MihailoVukmirovi(cid:2)c;Morocco:MoroccanSocietyof .. 21. Consensusstatementonthedefinitionoforthostatichypotension,pureauto-
.
Cardiology, Salima Abdelali; The Netherlands: Netherlands .. nomicfailure,andmultiplesystematrophy.JNeurolSci1996;144:218–219.
Society of Cardiology, Martin E.W. Hemels; Norway: Norwegian .... 22. sW tai te icling hW ypo, tK er ne sd ioie nt :C rT e, vv iea wnD oijk
f
N a,L fi on rz ge or ttM e, nTs cc oh nak do itv iosk ny
.
M CE li. nIni Sti ca ilo (Lrt oh no d-
)
Society of Cardiology, Kristina H. Haugaa; Poland: Polish Cardiac .. 2007;112:157–165.
. Society, Rafał Baranowski; Portugal: Portuguese Society of .. 23. Podoleanu C, Maggi R, Brignole M, Croci F, Incze A, Solano A, Puggioni E,
Cardiology, Pedro Silva Cunha; Romania: Romanian Society of
... CarascaE.Lowerlimbandabdominalcompressionbandagespreventprogres-
. siveorthostatichypotensioninelderlypersons:arandomizedsingle-blindcon- Cardiology, Gheorghe-Andrei Dan; Russian Federation: Russian .. trolledstudy.JAmCollCardiol2006;48:1425–1432.
.
Society of Cardiology, Tatyana Tyurina; San Marino: San Marino .. 24. GibbonsCH,FreemanR.Delayedorthostatichypotension:afrequentcauseof
.. orthostaticintolerance.Neurology2006;67:28–32.
Society of Cardiology, Luca Bertelli; Slovakia: Slovak Society of .
. 25. SarasinFP, HanusaBH,PernegerT,Louis-SimonetM,RajeswaranA,Kapoor
.
Cardiology, Peter Mitro; Spain: Spanish Society of Cardiology, . WN.Ariskscoretopredictarrhythmiasinpatientswithunexplainedsyncope.
.
IgnacioFern(cid:2)andezLozano;Sweden:SwedishSocietyofCardiology, .. AcadEmergMed2003;10:1312–1317.
.
. 26. QuinnJ,McDermottD,StiellI,KohnM,WellsG.Prospectivevalidationofthe
LennartBergfeldt;Switzerland:SwissSocietyofCardiology,Stefan .
. San Francisco Syncope Rule to predict patients with serious outcomes. Ann
.
Osswald; Tunisia: Tunisian Society of Cardiology and Cardio- .. EmergMed2006;47:448–454.
Vascular Surgery, Ben Halima Afef; Turkey: Turkish Society of .. 27. Middlekauff HR, Stevenson WG, Stevenson LW, Saxon LA. Syncope in
.
Cardiology, H. Murat O€zdem(cid:2)ır; United Kingdom: British .. advancedheartfailure:highriskofsuddendeathregardlessoforiginofsyncope.
. JAmCollCardiol1993;21:110–116.
.
CardiovascularSociety,P.BoonLim. .. 28. Brembilla-Perrot B, Suty-Selton C, Beurrier D, Houriez P, Nippert M, de la
.. ChaiseAT,LouisP,ClaudonO,AndronacheM,AbdelaalA,SadoulN,Juilliere
.
15. References .. Y.Differencesinmechanismsandoutcomesofsyncopeinpatientswithcoro-
.. narydiseaseoridiopathicleftventriculardysfunctionasassessedbyelectrophy-
1. Mosqueda-GarciaR,FurlanR,TankJ,Fernandez-ViolanteR.Theelusivepatho- .. siologictesting.JAmCollCardiol2004;44:594–601.
physiologyofneurallymediatedsyncope.Circulation2000;102:2898–2906. .. 29. Steinberg JS, Beckman K, Greene HL, Marinchak R, Klein RC, Greer SG,
.
2. Morillo CA, Eckberg DL, Ellenbogen KA, Beightol LA, Hoag JB, Tahvanainen . EhlertF,FosterP,MenchavezE,RaittM,WathenMS,MorrisM,HallstromA.
.
KU,KuuselaTA,DiedrichAM.Vagalandsympatheticmechanismsinpatients .. Follow-up of patients with unexplained syncope and inducible ventricular
withorthostaticvasovagalsyncope.Circulation1997;96:2509–2513. . tachyarrhythmias: analysis of the AVID registry and an AVID substudy.
Downloaded
from
https://academic.oup.com/eurheartj/article/39/21/1883/4939241
by
guest
on
22
January
2026
--- Страница 60 ---
1942 ESCGuidelines
.
Antiarrhythmics Versus Implantable Defibrillators. J Cardiovasc Electrophysiol .. orthostatic hypotension: a meta-analysis of prospective observational studies.
.
2001;12:996–1001. . EurHeartJ2015;36:1609–1617.
.
30. Pezawas T, Stix G, Kastner J, Wolzt M, Mayer C, Moertl D, Schmidinger H. . 49. Calkins H, Shyr Y, Frumin H, Schork A, Morady F. The value of the
.
Unexplained syncope in patients with structural heart disease and no docu- .. clinical history in the differentiation of syncope due to ventricular
mentedventriculararrhythmias:valueofelectrophysiologicallyguidedimplant- .. tachycardia,atrioventricularblock,andneurocardiogenicsyncope.AmJMed
.
ablecardioverterdefibrillatortherapy.Europace2003;5:305–312. . 1995;98:365–373.
.
31. OlshanskyB,PooleJE,JohnsonG,AndersonJ,HellkampAS,PackerD,Mark .. 50. Sheldon R, Rose S, Connolly S, Ritchie D, Koshman ML, Frenneaux M.
DB, Lee KL, Bardy GH, SCD-HeFT Investigators. Syncope predicts the out- .. Diagnosticcriteriaforvasovagalsyncopebasedonaquantitativehistory.Eur
.
comeofcardiomyopathypatients:analysisoftheSCD-HeFTstudy.JAmColl . HeartJ2006;27:344–350.
.
Cardiol2008;51:1277–1282. . 51. LipsitzLA.Syncopeintheelderlypatient.HospPract(OffEd)1986;21:33–44.
.
32. GoldbergerJJ,CainME,HohnloserSH,KadishAH,KnightBP,LauerMS,Maron .. 52. DermksianG,LambLE.Syncopeinapopulationofhealthyyoungadults;inci-
BJ,PageRL,PassmanRS,SiscovickD,SiscovickD,StevensonWG,ZipesDP, .. dence,mechanisms,andsignificance.JAmMedAssoc1958;168:1200–1207.
.
American Heart Association, American College of Cardiology Foundation, . 53. BrignoleM,OddoneD,CogornoS,MenozziC,GianfranchiL,BertullaA.Long-
.
Heart Rhythm Society. American Heart Association/American College of .. term outcome in symptomatic carotid sinus hypersensitivity. Am Heart J
CardiologyFoundation/HeartRhythmSocietyscientificstatementonnoninva- .. 1992;123:687–692.
.
siveriskstratificationtechniquesforidentifyingpatientsatriskforsuddencar- . 54. Jamjoom AA, Nikkar-Esfahani A, Fitzgerald JE. Operating theatre related
. diacdeath:ascientificstatementfromtheAmericanHeartAssociationCouncil . syncopeinmedicalstudents:acrosssectionalstudy.BMCMedEduc2009;9:14.
.
on Clinical Cardiology Committee on Electrocardiography and Arrhythmias .. 55. Quinn JV, Stiell IG, McDermott DA, Sellers KL, Kohn MA, Wells GA.
andCouncilonEpidemiologyandPrevention.Circulation2008;118:1497–1518. .. DerivationoftheSanFranciscoSyncopeRuletopredictpatientswithshort-
.
33. DelRossoA,AlboniP,BrignoleM,MenozziC,RavieleA.Relationofclinical . termseriousoutcomes.AnnEmergMed2004;43:224–232.
.
presentation of syncope to the age of patients. Am J Cardiol . 56. CostantinoG,PeregoF,DipaolaF,BorellaM,GalliA,CantoniG,Dell’OrtoS,
.
2005;96:1431–1435. .. DassiS,FilardoN,DucaPG,MontanoN,FurlanR,STePSInvestigators.Short-
34. MartinTP,HanusaBH,KapoorWN.Riskstratificationofpatientswithsyncope. .. andlong-termprognosisofsyncope,riskfactors,androleofhospitaladmission:
. AnnEmergMed1997;29:459–466. . results from the STePS (Short-Term Prognosis of Syncope) study. J Am Coll
.
35. Colivicchi F, Ammirati F, Melina D, Guido V, Imperoli G, Santini M, OESIL .. Cardiol2008;51:276–283.
(Osservatorio Epidemiologico sulla Sincope nel Lazio) Study Investigators. .. 57. Colman N,BakkerA,LinzerM,Reitsma JB,WielingW,WildeAA.Valueof
.
Development and prospective validation of a risk stratification system for . history-taking in syncope patients: in whom to suspect long QT syndrome?
.
patientswithsyncopeintheemergencydepartment:theOESILriskscore.Eur . Europace2009;11:937–943.
.
HeartJ2003;24:811–819. .. 58. KapoorWN,PetersonJ,WieandHS,KarpfM.Diagnosticandprognosticimpli-
36. DelRossoA,UngarA,MaggiR,GiadaF,PetixNR,DeSantoT,MenozziC, .. cationsofrecurrencesinpatientswithsyncope.AmJMed1987;83:700–708.
.
BrignoleM.Clinicalpredictorsofcardiacsyncopeatinitialevaluationinpatients . 59. Oh JH, Hanusa BH, Kapoor WN. Do symptoms predict cardiac arrhythmias
.
referred urgently to a general hospital: the EGSYS score. Heart . andmortalityinpatientswithsyncope?ArchInternMed1999;159:375–380.
.
2008;94:1620–1626. .. 60. Grossman SA, Fischer C, Lipsitz LA, Mottley L, Sands K, Thompson S,
.
37. MittalS,HaoSC,IwaiS,SteinKM,MarkowitzSM,SlotwinerDJ,LermanBB. . Zimetbaum P, Shapiro NI. Predicting adverse outcomes in syncope. J Emerg
.
Significanceofinducibleventricularfibrillationinpatientswithcoronaryartery . Med2007;33:233–239.
.
diseaseandunexplainedsyncope.JAmCollCardiol2001;38:371–376. .. 61. SurawiczB,ChildersR,DealBJ,GettesLS,BaileyJJ,GorgelsA,HancockEW,
38. AlboniP,BrignoleM,MenozziC,RavieleA,DelRossoA,DinelliM,SolanoA, .. JosephsonM,KligfieldP,KorsJA,MacfarlaneP,MasonJW,MirvisDM,OkinP,
.
BottoniN.Diagnosticvalueofhistoryinpatientswithsyncopewithorwithout . Pahlm O, Rautaharju PM, van Herpen G, Wagner GS, Wellens H, American
.
heartdisease.JAmCollCardiol2001;37:1921–1928. . Heart Association Electrocardiography and Arrhythmias Committee, Council
.
39. Berecki-GisolfJ,SheldonA,WielingW,vanDijkN,Costantino G,FurlanR, .. on Clinical Cardiology, American College of Cardiology Foundation, Heart
Shen WK, Sheldon R. Identifying cardiac syncope based on clinical history: a .. Rhythm Society. AHA/ACCF/HRS recommendations for the standardization
.
literature-based model tested in four independent datasets. PLoS One . andinterpretationoftheelectrocardiogram:partIII:intraventricularconduction
.
2013;8:e75255. .. disturbances: a scientific statement from the American Heart Association
40. Casagranda I, Brignole M, Cencetti S, Cervellin G, Costantino G, Furlan R, .. Electrocardiography and Arrhythmias Committee, Council on Clinical
.
MossiniG,NumerosoF,PesentiCampagnoniM,PinnaParpagliaP,RafanelliM, . Cardiology; the American College of Cardiology Foundation; and the Heart
.
UngarA.Managementoftransientlossofconsciousnessofsuspectedsyncopal .. Rhythm Society. Endorsed by the International Society for Computerized
cause,aftertheinitialevaluationintheEmergencyDepartment.EmergencyCare .. Electrocardiology.JAmCollCardiol2009;53:976–981.
J2016;12:25–27. .. 62. CostantinoG,SunBC,BarbicF,BossiI,CasazzaG,DipaolaF,McDermottD,
.
41. CraneSD.Riskstratificationofpatientswithsyncopeinanaccidentandemer- .. Quinn J, Reed MJ, Sheldon RS, Solbiati M, Thiruganasambandamoorthy V,
gencydepartment.EmergMedJ2002;19:23–27. .. Beach D, Bodemer N, Brignole M, Casagranda I, Del Rosso A, Duca P,
42. SheldonR,RoseS,RitchieD,ConnollySJ,KoshmanML,LeeMA,FrenneauxM, .. Falavigna G, Grossman SA, Ippoliti R, Krahn AD, Montano N, Morillo CA,
FisherM,MurphyW.Historicalcriteriathatdistinguishsyncopefromseizures. ... OlshanskyB,RajSR,RuwaldMH,SarasinFP,ShenWK,StiellI,UngarA,Gert
JAmCollCardiol2002;40:142–148. .. vanDijkJ,vanDijkN,WielingW,FurlanR.Syncopeclinicalmanagementin
43. NumerosoF,MossiniG,GiovanelliM,LippiG,CervellinG.Short-termprogno- .. the emergency department: a consensus from the first international work-
sisandcurrentmanagementofsyncopalpatientsatintermediaterisk:results .. shoponsyncoperiskstratificationintheemergencydepartment.EurHeartJ
.
from the IRiS (Intermediate-Risk Syncope) study. Acad Emerg Med .. 2016;37:1493–1498.
2016;23:941–948. .. 63. KennyRA,BrignoleM,DanGA,DeharoJC,vanDijkJG,DohertyC,Hamdan
44. ReedMJ,NewbyDE,CoullAJ,PrescottRJ,JacquesKG,GrayAJ.TheROSE
.. M,MoyaA,ParrySW,SuttonR,UngarA,WielingW.SyncopeUnit:rationale
(RiskStratificationOfSyncopeintheEmergencydepartment)study.JAmColl ... andrequirement–theEuropeanHeartRhythmAssociationpositionstatement
Cardiol2010;55:713–721. .. endorsedbytheHeartRhythmSociety.Europace2015;17:1325–1340.
45. MartinGJ,AdamsSL,MartinHG,MathewsJ,ZullD,ScanlonPJ.Prospective .. 64. SunBC,McCreathH,LiangLJ,BohanS,BaughC,RagsdaleL,HendersonSO,
evaluationofsyncope.AnnEmergMed1984;13:499–504. ... ClarkC,BastaniA,KeelerE,AnR,MangioneCM.Randomizedclinicaltrialof
46. PrioriSG,Blomstrom-LundqvistC,MazzantiA,BlomN,BorggrefeM,CammJ, .. anemergencydepartmentobservationsyncopeprotocolversusroutineinpa-
. tientadmission.AnnEmergMed2014;64:167–175.
ElliottPM,FitzsimonsD,HatalaR,HindricksG,KirchhofP,KjeldsenK,Kuck .
KH, Hernandez-Madrid A, Nikolaou N, Norekval TM, Spaulding C, Van
.. 65. ShenWK,DeckerWW,SmarsPA,GoyalDG,WalkerAE,HodgeDO,Trusty
VeldhuisenDJ.2015ESCGuidelinesforthemanagementofpatientswithven-
... JM,BrekkeKM,JahangirA,BradyPA,MungerTM,GershBJ,HammillSC,Frye
. RL.SyncopeEvaluationintheEmergencyDepartmentStudy(SEEDS):amulti-
tricular arrhythmias and the prevention of sudden cardiac death: The Task .
. disciplinaryapproachtosyncopemanagement.Circulation2004;110:3636–3645.
Force for the Management of Patients with Ventricular Arrhythmias and the .
P (Er Se Cve )n .ti Eo nn doo rf seS dudd be yn
:
C Aa ssr od cia ic atiD oneat fh orof Euth re opE eu ar nop Pe aa en diS ao trc iciety ano df C Ca or nd gio enlo itg ay
l
..... 66. MTh ,ir Tu ag lja an aa rs dam Mb .a Ond ua tm coo mo ert sh iy nV p, rS et si ye nll cI oG p, eW pae tl il es nG tsA :, aV pa rid oy sa pn ea ct th iva en cA o, hM oru tka str ura dm
y.
. AnnEmergMed2015;65:268–276.e6.
Cardiology(AEPC).EurHeartJ2015;36:2793–2867. .
47. SoteriadesES,EvansJC,LarsonMG,ChenMH,ChenL,BenjaminEJ,LevyD.
.. 67. GreveY,GeierF,PoppS,BertschT,SinglerK,MeierF,SmolarskyA,MangH,
Incidenceandprognosisofsyncope.NEnglJMed2002;347:878–885.
... MullerC,ChristM.Theprevalenceandprognosticsignificanceofnearsyncope
48. Ricci F, Fedorowski A, Radico F, Romanello M, Tatasciore A, Di Nicola M, .. and syncope: a prospective study of 395 cases in an emergency department
. (theSPEEDstudy).DtschArzteblInt2014;111:197–204.
ZimarinoM,DeCaterinaR.Cardiovascularmorbidityandmortalityrelatedto
Downloaded
from
https://academic.oup.com/eurheartj/article/39/21/1883/4939241
by
guest
on
22
January
2026
--- Страница 61 ---
ESCGuidelines 1943
.
68. KrahnAD,KleinGJ,YeeR,SkanesAC,REVEALInvestigators.Predictivevalue .. Canadian Syncope Risk Score to predict serious adverse events after emer-
.
of presyncope in patients monitored for assessment of syncope. Am Heart J . gencydepartmentassessmentofsyncope.CMAJ2016;188:E289–E298.
.
2001;141:817–821. . 89. KerrSR,PearceMS,BrayneC,DavisRJ,KennyRA.Carotidsinushypersensitiv-
.
69. HuffJS,DeckerWW,QuinnJV,PerronAD,NapoliAM,PeetersS,JagodaAS, .. ity in asymptomatic older persons: implications for diagnosis of syncope and
AmericanCollegeofEmergencyPhysicians.Clinicalpolicy:criticalissuesinthe .. falls.ArchInternMed2006;166:515–520.
.
evaluation and management of adult patients presenting to the emergency . 90. PuggioniE,GuiducciV,BrignoleM,MenozziC,OddoneD,DonateoP,CrociF,
.
departmentwithsyncope.AnnEmergMed2007;49:431–444. . SolanoA,LolliG,TomasiC,BottoniN.Resultsandcomplicationsofthecaro-
.
70. ThiruganasambandamoorthyV,HessEP,AlreesiA,PerryJJ,WellsGA,StiellIG. .. tid sinus massage performed according to the “method of symptoms”. Am J
ExternalvalidationoftheSanFranciscoSyncopeRuleintheCanadiansetting. .. Cardiol2002;89:599–601.
.
AnnEmergMed2010;55:464–472. . 91. WielingW,KredietCT,SolariD,deLangeFJ,vanDijkN,ThijsRD,vanDijk
.
71. BrignoleM,MenozziC,BartolettiA,GiadaF,LagiA,UngarA,PonassiI,Mussi .. JG,BrignoleM,JardineDL.Attheheartofthearterialbaroreflex:aphysiologi-
C,MaggiR,ReG,FurlanR,RovelliG,PonziP,ScivalesA.Anewmanagement .. calbasisforanewclassificationofcarotidsinushypersensitivity.JInternMed
.
of syncope: prospective systematic guideline-based evaluation of patients . 2013;273:345–358.
.
referredurgentlytogeneralhospitals.EurHeartJ2006;27:76–82. . 92. Solari D, Maggi R, Oddone D, Solano A, Croci F, Donateo P, Brignole M.
.
72. Del Greco M, Cozzio S, Scillieri M, Caprari F, Scivales A, Disertori M. .. Clinicalcontextandoutcomeofcarotidsinussyndromediagnosedbymeansof
Diagnosticpathwayofsyncopeandanalysisoftheimpactofguidelinesinadis- .. the‘methodofsymptoms’.Europace2014;16:928–934.
.
trictgeneralhospital.TheECSITstudy(epidemiologyandcostsofsyncopein . 93. Solari D, Maggi R, Oddone D, Solano A, Croci F, Donateo P, Wieling W,
.
Trento).ItalHeartJ2003;4:99–106. . BrignoleM.Assessmentofthevasodepressorreflexincarotidsinussyndrome.
.
73. McCarthyF,McMahonCG,GearyU,PlunkettPK,KennyRA,CunninghamCJ, .. CircArrhythmElectrophysiol2014;7:505–510.
.
European Society of Cardiology. Management of syncope in the Emergency . 94. BrignoleM,UngarA,CasagrandaI,GuliziaM,LunatiM,AmmiratiF,DelRosso
.
Department:asinglehospitalobservationalcaseseriesbasedontheapplicationof . A,SasdelliM,SantiniM,MaggiR,VitaleE,MorrioneA,FranceseGM,Vecchi
.
EuropeanSocietyofCardiologyGuidelines.Europace2009;11:216–224. .. MR,GiadaF,SyncopeUnitProject(SUP)investigators.Prospectivemulticentre
74. Numeroso F,MossiniG,SpaggiariE,CervellinG.Syncope intheemergency .. systematic guideline-based management of patients referred to the Syncope
. departmentofalargenorthernItalianhospital:incidence,efficacyofashort- . Unitsofgeneralhospitals.Europace2010;12:109–118.
.
stay observation ward and validation of the OESIL risk score. Emerg Med J . 95. MunroNC,McIntoshS,LawsonJ,MorleyCA,SuttonR,KennyRA.Incidence
.
2010;27:653–658. .. of complications after carotid sinus massage in older patients with syncope.
75. LinM,WolfeRE,ShapiroNI,NovackV,LiorY,GrossmanSA.Observationvs .. JAmGeriatrSoc1994;42:1248–1251.
.
admissioninsyncope:canwepredictshortlengthofstays?AmJEmergMed . 96. UngarA,RivasiG,RafanelliM,ToffanelloG,MussiC,CeccofiglioA,McDonagh
.
2015;33:1684–1686. .. R,DrummB,MarchionniN,AlboniP,KennyRA.SafetyandtolerabilityofTilt
76. Grossman AM, Volz KA, Shapiro NI, Salem R, Sanchez LD, Smulowitz P, .. Testing and Carotid Sinus Massage in the octogenarians. Age Ageing
.
Grossman SA. Comparison of 1-day emergency department observation and . 2016;45:242–248.
.
inpatient ward for 1-day admissions in syncope patients. J Emerg Med . 97. DaviesAJ,KennyRA.Frequencyofneurologiccomplicationsfollowingcarotid
.
2016;50:217–222. .. sinusmassage.AmJCardiol1998;81:1256–1257.
77. UngarA,TesiF,ChisciottiVM,PepeG,VanniS,GrifoniS,BalziD,RafanelliM, .. 98. BrignoleM,MenozziC,LolliG,BottoniN,GaggioliG.Long-termoutcomeof
.
MarchionniN,BrignoleM.Assessmentofastructuredmanagementpathway . pacedandnonpacedpatientswithseverecarotidsinussyndrome.AmJCardiol
.
forpatientsreferredtotheEmergencyDepartmentforsyncope:resultsina . 1992;69:1039–1043.
.
tertiaryhospital.Europace2016;18:457–462. .. 99. Claesson JE, Kristensson BE, Edvardsson N, Wahrborg P. Less syncope and
78. SerranoLA,HessEP,BellolioMF,MuradMH,MontoriVM,ErwinPJ,Decker .. mildersymptomsinpatients treated withpacingforinducedcardioinhibitory
.
WW.Accuracyandqualityofclinicaldecisionrulesforsyncopeintheemer- . carotidsinussyndrome:arandomizedstudy.Europace2007;9:932–936.
.
gency department: a systematic review and meta-analysis. Ann Emerg Med .. 100.MenozziC,BrignoleM,LolliG,BottoniN,OddoneD,GianfranchiL,Gaggioli
2010;56:362–373.e1. .. G. Follow-up of asystolic episodes in patients with cardioinhibitory, neurally
.
79. Dipaola F, Costantino G, Perego F, Borella M, Galli A, Cantoni G, Barbic F, . mediatedsyncopeandVVIpacemaker.AmJCardiol1993;72:1152–1155.
.
CasellaF,DucaPG,FurlanR,STePSinvestigators.SanFranciscoSyncopeRule, . 101.MaggiR,MenozziC,BrignoleM,PodoleanuC,IoriM,SuttonR,MoyaA,Giada
.
Osservatorio Epidemiologico sulla Sincope nel Lazio risk score, and clinical .. F,OraziS,GrovaleN.Cardioinhibitorycarotidsinushypersensitivitypredicts
judgment in the assessment of short-term outcome of syncope. Am J Emerg .. an asystolic mechanism of spontaneous neurally mediated syncope. Europace
.
Med2010;28:432–439. . 2007;9:563–567.
.
80. SheldonRS,MorilloCA,KrahnAD,O’NeillB,ThiruganasambandamoorthyV, .. 102.Thomas JE.Hyperactivecarotidsinus reflexandcarotidsinus syncope. Mayo
Parkash R, Talajic M, Tu JV, Seifer C, Johnstone D, Leather R. Standardized .. ClinProc1969;44:127–139.
.
approaches to the investigation of syncope: Canadian Cardiovascular Society . 103.SmitAA,HalliwillJR,LowPA,WielingW.Pathophysiologicalbasisofortho-
.
positionpaper.CanJCardiol2011;27:246–253. . statichypotensioninautonomicfailure.JPhysiol1999;519:1–10. .
81. PeregoF, Costantino G,Dipaola F, Scannella E,BorellaM,GalliA,BarbicF, .. 104.RicciF,DeCaterinaR,FedorowskiA.Orthostatichypotension:epidemiology,
CasellaF,SolbiatiM,AngaroniL,DucaP,FurlanR.Predictorsofhospitaladmis- .. prognosis,andtreatment.JAmCollCardiol2015;66:848–860.
. sion after syncope: relationships with clinical risk scores. Int J Cardiol . 105.KennyRA,IngramA,BaylissJ,SuttonR.Head-uptilt:ausefultestforinvestigat-
.
2012;161:182–183. . ingunexplainedsyncope.Lancet1986;1:1352–1355.
.
82. SchladenhaufenR,FeilingerS,PollackM,BenensonR,KusmieszAL.Application .. 106.BartolettiA,AlboniP,AmmiratiF,BrignoleM,DelRossoA,FogliaManzilloG,
of San Francisco Syncope Rule in elderly ED patients. Am J Emerg Med .. MenozziC,RavieleA,SuttonR.‘TheItalianProtocol‘:asimplifiedhead-uptilt
.
2008;26:773–778. . testingpotentiatedwithoralnitroglycerintoassesspatientswithunexplained
.
83. Sun BC, Mangione CM, Merchant G, Weiss T, Shlamovitz GZ, Zargaraff G, .. syncope.Europace2000;2:339–342.
Shiraga S, Hoffman JR, Mower WR. External validation of the San Francisco .. 107.KennyRA,O’SheaD,ParrySW.TheNewcastleprotocolsforhead-uptilttable
.
SyncopeRule.AnnEmergMed2007;49:420–427,427.e1–4. . testinginthediagnosisofvasovagalsyncope,carotidsinushypersensitivity,and
.
84. ReedMJ,HendersonSS,NewbyDE,GrayAJ.One-yearprognosisaftersyn- . relateddisorders.Heart2000;83:564–569.
.
cope and the failure of the ROSE decision instrument to predict one-year .. 108.BendittDG,FergusonDW,GrubbBP,KapoorWN,KuglerJ,LermanBB,Maloney
adverseevents.AnnEmergMed2011;58:250–256. .. JD,RavieleA,RossB,SuttonR,WolkMJ,WoodDL.Tilttabletestingforassessing
.
85. BirnbaumA,EssesD,BijurP,WollowitzA,GallagherEJ.Failuretovalidatethe . syncope.AmericanCollegeofCardiology.JAmCollCardiol1996;28:263–275.
.
SanFranciscoSyncopeRuleinanindependentemergencydepartmentpopula- . 109.MorilloCA,KleinGJ,ZandriS,YeeR.Diagnosticaccuracyofalow-doseiso-
.
tion.AnnEmergMed2008;52:151–159. .. proterenolhead-uptiltprotocol.AmHeartJ1995;129:901–906.
.
86. Costantino G, Casazza G, Reed M, Bossi I, Sun B, Del Rosso A, Ungar A, . 110.ForleoC,GuidaP,IacovielloM,RestaM,MonitilloF,SorrentinoS,FavaleS.
.
Grossman S, D’Ascenzo F, Quinn J, McDermott D, Sheldon R, Furlan R. . Head-up tilt testing for diagnosing vasovagal syncope: a meta-analysis. Int J
.
Syncoperiskstratificationtoolsvsclinicaljudgment:anindividualpatientdata .. Cardiol2013;168:27–35.
meta-analysis.AmJMed2014;127:1126.e13–25. .. 111.ParrySW,GrayJC,NewtonJL,ReeveP,O’SheaD,KennyRA.‘Front-loaded‘
.
87. CanzonieroJV,AfsharE,HedianH,KochC,MorganDJ.Unnecessaryhospital- . head-uptilttabletesting:validationofarapidfirstlinenitrate-provokedtiltpro-
.
izationandrelatedharmforpatientswithlow-risksyncope.JAMAInternMed . tocolforthediagnosisofvasovagalsyncope.AgeAgeing2008;37:411–415.
.
2015;175:1065–1067. .. 112.Verheyden B, Gisolf J, Beckers F, Karemaker JM, Wesseling KH, Aubert AE,
88. ThiruganasambandamoorthyV,KwongK,WellsGA,SivilottiML,MukarramM, .. WielingW.Impactofageonthevasovagalresponseprovokedbysublingual
.
RoweBH,LangE,PerryJJ,SheldonR,StiellIG,TaljaardM.Developmentofthe nitroglycerineinroutinetilttesting.ClinSci(Lond)2007;113:329–337.
Downloaded
from
https://academic.oup.com/eurheartj/article/39/21/1883/4939241
by
guest
on
22
January
2026
--- Страница 62 ---
1944 ESCGuidelines
.
.
113. NilssonD,SuttonR,TasW,BurriP,MelanderO,FedorowskiA.Orthostatic . 135.BrignoleM,MenozziC,GianfranchiL,OddoneD,LolliG,BertullaA.Neurally
.
changes in hemodynamics and cardiovascular biomarkers in dysautonomic . mediatedsyncopedetected bycarotidsinusmassageandhead-up tilttestin
.
patients.PLoSOne2015;10:e0128962. .. sicksinussyndrome.AmJCardiol1991;68:1032–1036.
114. Low PA, Sandroni P, Joyner M, Shen WK. Postural tachycardia syndrome .. 136.AlboniP,MenozziC,BrignoleM,PaparellaN,LolliG,OddoneD,DinelliM.An
.
(POTS).JCardiovascElectrophysiol2009;20:352–358. . abnormalneuralreflexplaysaroleincausingsyncopeinsinusbradycardia.JAm
.
115. PetersenME,WilliamsTR,SuttonR.Psychogenicsyncopediagnosedbypro- .. CollCardiol1993;22:1130–1134.
longedhead-uptilttesting.QJM1995;88:209–213. .. 137.ZaidiA,CloughP,CooperP,ScheepersB,FitzpatrickAP.Misdiagnosisofepi-
.
116. TannemaatMR,vanNiekerkJ,ReijntjesRH,ThijsRD,SuttonR,vanDijkJG. . lepsy:manyseizure-like attackshaveacardiovascularcause.JAmCollCardiol
.
The semiology of tilt-induced psychogenic pseudosyncope. Neurology . 2000;36:181–184.
.
2013;81:752–758. .. 138.GoldsteinDS,PechnikS,HolmesC,EldadahB,SharabiY.Associationbetween
117. BladH,LambertsRJ,vanDijkGJ,ThijsRD.Tilt-inducedvasovagalsyncopeand .. supine hypertension and orthostatic hypotension in autonomic failure.
.
psychogenic pseudosyncope: Overlapping clinical entities. Neurology . Hypertension2003;42:136–142.
.
2015;85:2006–2010. . 139.Novak P. Assessment of sympathetic index from the Valsalva maneuver.
.
118. Moya A, Permanyer-Miralda G, Sagrista-Sauleda J, Carne X, Rius T, Mont L, .. Neurology2011;76:2010–2016.
.
Soler-SolerJ.Limitationsofhead-uptilttestforevaluatingtheefficacyofthera- . 140.FanciulliA,StranoS,NdayisabaJP,GoebelG,GioffreL,RizzoM,ColosimoC,
.
peuticinterventionsinpatientswithvasovagalsyncope:resultsofacontrolled . CaltagironeC,PoeweW,WenningGK,PontieriFE.Detectingnocturnalhyper-
. studyofetilefrineversusplacebo.JAmCollCardiol1995;25:65–69. .. tension in Parkinson’s disease and multiple system atrophy: proposal of a
119. BrignoleM,CrociF,MenozziC,SolanoA,DonateoP,OddoneD,PuggioniE, .. decision-supportalgorithm.JNeurol2014;261:1291–1299.
.
LolliG.Isometricarmcounter-pressuremaneuverstoabortimpendingvasova- . 141.Jones PK, Gibbons CH. The role of autonomic testing in syncope. Auton
.
galsyncope.JAmCollCardiol2002;40:2053–2059. . Neurosci2014;184:40–45.
.
120. KredietCT,vanDijkN,LinzerM,vanLieshoutJJ,WielingW.Managementof .. 142.BaschieriF,Calandra-BuonauraG,DoriaA,MastrolilliF,PalaretiA,BarlettaG,
vasovagal syncope: controlling or aborting faints by leg crossing and muscle .. SolieriL,GuaraldiP,MartinelliP,CortelliP.Cardiovascularautonomictestingper-
.
tensing.Circulation2002;106:1684–1689. . formedwithanewintegratedinstrumentalapproachisusefulindifferentiating
.
121. vanDijkN,QuartieriF,BlancJJ,Garcia-CiveraR,BrignoleM,MoyaA,Wieling .. MSA-PfromPDatanearlystage.ParkinsonismRelatDisord2015;21:477–482.
W,PCTrialInvestigators.Effectivenessofphysicalcounterpressuremaneuvers .. 143.Rocchi C, Pierantozzi M, Galati S, Chiaravalloti A, Pisani V, Prosperetti C,
.
in preventing vasovagal syncope: the Physical Counterpressure Manoeuvres . Lauretti B, Stampanoni Bassi M, Olivola E, Schillaci O, Stefani A. Autonomic
.
Trial(PC-Trial).JAmCollCardiol2006;48:1652–1657. . functiontestsandMIBGinParkinson’sdisease:correlationtodiseaseduration
.
122. DeharoJC,JegoC,LanteaumeA,DjianeP.Animplantablelooprecorderstudy .. andmotorsymptoms.CNSNeurosciTher2015;21:727–732.
ofhighlysymptomaticvasovagalpatients:theheartrhythmobservedduringa .. 144.Kim AJ, Frishman WH. Laughter-induced syncope. Cardiol Rev
.
spontaneoussyncopeisidenticaltotherecurrentsyncopebutnotcorrelated . 2012;20:194–196.
.
with the head-up tilt test or adenosine triphosphate test. J Am Coll Cardiol . 145.NdayisabaJP,FanciulliA,GranataR,DuerrS,HintringerF,GoebelG,Krismer
.
2006;47:587–593. .. F,WenningGK.Sexandageeffectsoncardiovascularautonomicfunctionin
.
123. Brignole M, Sutton R, Menozzi C, Garcia-Civera R, Moya A, Wieling W, . healthyadults.ClinAutonRes2015;25:317–326.
.
AndresenD,BendittDG,GrovaleN,DeSantoT,VardasP,InternationalStudy . 146.BonuccelliU,LucettiC,DelDottoP,CeravoloR,GambacciniG,BernardiniS,
.
on Syncope of Uncertain Etiology 2 (ISSUE 2) Group. Lack of correlation .. RossiG,PiaggesiA.OrthostatichypotensionindenovoParkinsondisease.Arch
betweentheresponsestotilttestingandadenosinetriphosphatetestandthe .. Neurol2003;60:1400–1404.
.
mechanism of spontaneous neurally mediated syncope. Eur Heart J . 147.StruhalW,JavorA,BrunnerC,BeneschT,SchmidtV,VoskoMR,RansmayrG.
.
2006;27:2232–2239. . Thephoenixfromtheashes:cardiovascularautonomicdysfunctioninbehavio-
.
124. FlevariP,LeftheriotisD,KomborozosC,FountoulakiK,DagresN,Theodorakis .. ralvariantoffrontotemporaldementia.JAlzheimersDis2014;42:1041–1046.
G,KremastinosD.Recurrentvasovagalsyncope:comparisonbetweenclomipr- .. 148.ParatiG,StergiouG,O’BrienE,AsmarR,BeilinL,BiloG,ClementD,dela
.
amineandnitroglycerinasdrugchallengesduringhead-uptilttesting.EurHeart . SierraA,deLeeuwP,DolanE,FagardR,GravesJ,HeadGA,ImaiY,KarioK,
.
J2009;30:2249–2253. .. LurbeE,MallionJM,ManciaG,MengdenT,MyersM,OgedegbeG,OhkuboT,
125. PetersenME,WilliamsTR,GordonC,Chamberlain-WebberR,SuttonR.The .. Omboni S, Palatini P, Redon J, Ruilope LM, Shennan A, Staessen JA,
.
normal response to prolonged passive head up tilt testing. Heart . vanMontfrans G, Verdecchia P, Waeber B, Wang J, Zanchetti A, Zhang Y,
.
2000;84:509–514. . European Society of Hypertension Working Group on Blood Pressure
.
126. FurukawaT,MaggiR,SolanoA,CrociF,BrignoleM.Effectofclinicaltriggers .. Monitoring and Cardiovascular Variability. European Society of Hypertension
onpositiveresponsestotilt-tabletestingpotentiatedwithnitroglycerinorclo- .. practice guidelines for ambulatory blood pressure monitoring. J Hypertens
.
mipramine.AmJCardiol2011;107:1693–1697. . 2014;32:1359–1366.
.
127. PetixNR,DelRossoA,FurlanR,GuarnacciaV,ZipoliA.Nitrate-potentiated . 149.Schmidt C, Berg D, Herting, Prieur S, Junghanns S, Schweitzer K, Globas C, .
head-uptilttesting(HUT)hasalowdiagnosticyieldinpatientswithlikelyvaso- .. ScholsL,ReichmannH,ZiemssenT.Lossofnocturnalbloodpressurefallin
vagalsyncope.PacingClinElectrophysiol2014;37:164–172. .. variousextrapyramidalsyndromes.MovDisord2009;24:2136–2142.
.
128. Raviele A, Menozzi C, Brignole M, Gasparini G, Alboni P, Musso G, Lolli G, . 150.VoichanskiS,GrossmanC,LeibowitzA,PelegE,Koren-MoragN,SharabiY,
. OddoneD,DinelliM,MuredduR.Valueofhead-uptilttestingpotentiatedwith .. ShamissA,GrossmanE.Orthostatichypotensionisassociatedwithnocturnal
sublingualnitroglycerintoassesstheoriginofunexplainedsyncope.AmJCardiol .. changeinsystolicbloodpressure.AmJHypertens2012;25:159–164.
.
1995;76:267–272. . 151.FanciulliA,StranoS,ColosimoC,CaltagironeC,SpallettaG,PontieriFE.The .
129. UngarA,SgobinoP,RussoV,VitaleE,SuttonR,MelissanoD,BeirasX,Bottoni . potentialprognosticroleofcardiovascularautonomicfailureinalpha-synuclei-
.
N,EbertHH,GuliziaM,JorfidaM,MoyaA,AndresenD,GrovaleN,Brignole .. nopathies.EurJNeurol2013;20:231–235.
M, International Study on Syncope of Uncertain Etiology 3 (ISSUE-3) .. 152.Stuebner E, Vichayanrat E, Low DA, Mathias CJ, Isenmann S, Haensch CA.
.
Investigators.Diagnosisofneurallymediatedsyncopeatinitialevaluationand . Twenty-fourhournon-invasiveambulatorybloodpressureandheartratemon-
.
withtilttabletestingcomparedwiththatrevealedbyprolongedECGmonitor- . itoringinParkinson’sdisease.FrontNeurol2013;4:49.
.
ing. An analysis from the Third International Study on Syncopeof Uncertain .. 153.Norcliffe-KaufmannL,KaufmannH.Isambulatorybloodpressuremonitoring
.
Etiology(ISSUE-3).Heart2013;99:1825–1831. . useful in patients with chronic autonomic failure? Clin Auton Res
.
130. BrignoleM,GianfranchiL,MenozziC,RavieleA,OddoneD,LolliG,BottoniN. . 2014;24:189–192.
.
Roleofautonomicreflexesinsyncopeassociatedwithparoxysmalatrialfibrilla- .. 154.TannemaatMR,ThijsRD,vanDijkJG.Managingpsychogenicpseudosyncope:
tion.JAmCollCardiol1993;22:1123–1129. .. factsandexperiences.CardiolJ2014;21:658–664.
.
131. Leitch JW, Klein GJ, Yee R, Leather RA, Kim YH. Syncope associated with . 155.Braune S, Auer A, Schulte-Monting J, Schwerbrock S, Lucking CH.
.
supraventriculartachycardia.Anexpressionoftachycardiarateorvasomotor . Cardiovascular parameters: sensitivity to detect autonomic dysfunction and
.
response?Circulation1992;85:1064–1071. .. influenceofageandsexinnormalsubjects.ClinAutonRes1996;6:3–15.
132. SuttonR,BrignoleM.Twenty-eightyearsofresearchpermitreinterpretationof .. 156.LowPA,DenqJC,Opfer-GehrkingTL,DyckPJ,O’BrienPC,SlezakJM.Effect
.
tilt-testing: hypotensive susceptibility rather than diagnosis. Eur Heart J . ofageandgenderonsudomotorandcardiovagalfunctionandbloodpressure
.
2014;35:2211–2212. .. responsetotiltinnormalsubjects.MuscleNerve1997;20:1561–1568.
133. TanejaI,MarneyA,RobertsonD.Aorticstenosisandautonomicdysfunction: .. 157.Barnett SR, Morin RJ, Kiely DK, Gagnon M, Azhar G, Knight EL, Nelson JC,
.
co-conspiratorsinsyncope.AmJMedSci2004;327:281–283. . LipsitzLA.Effectsofageandgenderonautonomiccontrolofbloodpressure
.
134. ThomsonHL,Morris-ThurgoodJ,AthertonJ,FrenneauxM.Reducedcardiopul- . dynamics.Hypertension1999;33:1195–1200.
.
monary baroreflex sensitivity in patients with hypertrophic cardiomyopathy. .. 158.ChiuDT,ShapiroNI,SunBC,MottleyJL,GrossmanSA.Areechocardiography,
JAmCollCardiol1998;31:1377–1382. . telemetry,ambulatoryelectrocardiographymonitoring,andcardiacenzymesin
Downloaded
from
https://academic.oup.com/eurheartj/article/39/21/1883/4939241
by
guest
on
22
January
2026
--- Страница 63 ---
ESCGuidelines 1945
.
.
emergency department patients presenting with syncope usefultests? Apre- . DocumentsCommittee.Indicationsfortheuseofdiagnosticimplantableand
.
liminaryinvestigation.JEmergMed2014;47:113–118. . externalECGlooprecorders.Europace2009;11:671–687.
.
159. Benezet-MazuecosJ,IbanezB,RubioJM,NavarroF,MartinE,RomeroJ,FarreJ. .. 180.Menozzi C, Brignole M, Garcia-Civera R, Moya A, Botto G, Tercedor L,
Utilityofin-hospitalcardiacremotetelemetryinpatientswithunexplainedsyn- .. MiglioriniR,NavarroX,InternationalStudyonSyncopeofUncertainEtiology
.
cope.Europace2007;9:1196–1201. . (ISSUE)Investigators.Mechanismofsyncopeinpatientswithheartdiseaseand
.
160. CrociF,BrignoleM,AlboniP,MenozziC,RavieleA,DelRossoA,DinelliM, .. negativeelectrophysiologictest.Circulation2002;105:2741–2745.
SolanoA,BottoniN,DonateoP.Theapplicationofastandardizedstrategyof .. 181.LinkerNJ,VoulgarakiD,GaruttiC,RiegerG,EdvardssonN,PICTUREStudy
.
evaluationinpatientswithsyncopereferredtothreesyncopeunits.Europace . Investigators.Earlyversusdelayedimplantationofalooprecorderinpatients
.
2002;4:351–355. . with unexplained syncope–effectson care pathway and diagnostic yield. Int J
.
161. BassEB,CurtissEI,ArenaVC,HanusaBH,CecchettiA,KarpfM,KapoorWN. .. Cardiol2013;170:146–151.
The duration of Holter monitoring in patients with syncope. Is 24 hours .. 182.Edvardsson N, Frykman V, van Mechelen R, Mitro P, Mohii-Oskarsson A,
.
enough?ArchInternMed1990;150:1073–1078. . Pasquie JL, Ramanna H,Schwertfeger F, Ventura R, VoulgarakiD, Garutti C,
.
162. RockxMA,HochJS,KleinGJ,YeeR,SkanesAC,GulaLJ,KrahnAD.Isambula- . Stolt P, Linker NJ, PICTURE Study Investigators. Use of an implantable loop
.
torymonitoringfor“community-acquired”syncopeeconomicallyattractive?A .. recordertoincreasethediagnosticyieldinunexplainedsyncope:resultsfrom
.
cost-effectivenessanalysisofarandomizedtrialofexternallooprecordersver- . thePICTUREregistry.Europace2011;13:262–269.
.
susHoltermonitoring.AmHeartJ2005;150:1065. . 183.Lacunza-Ruiz FJ, Moya-Mitjans A, Martinez-Alday J, Baron-Esquivias G, Ruiz-
. 163. KinlayS,LeitchJW,NeilA,ChapmanBL,HardyDB,FletcherPJ.Cardiacevent .. Granell R, Rivas-Gandara N, Gonzalez-Enriquez S, Leal-del-Ojo J, Arcocha-
recorders yield more diagnoses and are more cost-effective than 48-hour .. Torres MF, Perez-Villacastin J, Garcia-Heil N, Garcia-Alberola A. Implantable
.
Holtermonitoringinpatientswithpalpitations.Acontrolledclinicaltrial.Ann . looprecorderallowsanetiologicdiagnosisinone-thirdofpatients.Resultsof
.
InternMed1996;124:16–20. . theSpanishrevealregistry.CircJ2013;77:2535–2541.
.
164. BruiningN,CaianiE,ChronakiC,GuzikP,vanderVeldeE,TaskForceofthe .. 184.Brignole M, Sutton R, Menozzi C, Garcia-Civera R, Moya A, Wieling W,
e-Cardiology Working. Acquisition and analysis of cardiovascular signals on .. Andresen D, Benditt DG, Vardas P, International Study on Syncope of
.
smartphones:potential,pitfallsandperspectives:bytheTaskForceofthee- . UncertainEtiology2(ISSUE2)Group.Earlyapplicationofanimplantableloop
.
Cardiology Working Group of European Society of Cardiology. Eur J Prev .. recorderallowseffectivespecifictherapyinpatientswithrecurrentsuspected
Cardiol2014;21:4–13. .. neurallymediatedsyncope.EurHeartJ2006;27:1085–1092.
.
165. WaksJW,FeinAS,DasS.Widecomplextachycardiarecordedwithasmart- . 185.BrignoleM,MenozziC,MoyaA,AndresenD,BlancJJ,KrahnAD,WielingW,
.
phonecardiacrhythmmonitor.JAMAInternMed2015;175:437–439. . BeirasX,DeharoJC,RussoV,TomainoM,SuttonR,InternationalStudyon
.
166. Locati ET, Moya A, Oliveira M, Tanner H, Willems R, Lunati M, Brignole M. .. SyncopeofUncertainEtiology3(ISSUE-3)Investigators.Pacemakertherapyin
Externalprolongedelectrocardiogrammonitoringinunexplainedsyncopeand .. patients with neurally mediated syncope and documented asystole: Third
.
palpitations:resultsoftheSYNARR-Flashstudy.Europace2016;18:1265–1272. . InternationalStudyonSyncopeofUncertainEtiology(ISSUE-3):arandomized
.
167. LinzerM,PritchettEL,PontinenM,McCarthyE,DivineGW.Incrementaldiag- . trial.Circulation2012;125:2566–2571.
.
nosticyieldofloopelectrocardiographicrecordersinunexplainedsyncope.Am .. 186.BrignoleM,AmmiratiF,ArabiaF,QuartieriF,TomainoM,UngarA,LunatiM,
.
JCardiol1990;66:214–219. . Russo V, Del Rosso A, Gaggioli G, Syncope Unit Project (SUP) Two
.
168. Schuchert A, Maas R, Kretzschmar C, Behrens G, Kratzmann I, Meinertz T. . Investigators.Assessmentofastandardizedalgorithmforcardiacpacinginolder
.
Diagnostic yield of external electrocardiographic loop recorders in patients .. patients affected by severe unpredictable reflex syncopes. Eur Heart J
with recurrent syncope and negative tilt table test. Pacing Clin Electrophysiol .. 2015;36:1529–1535.
.
2003;26:1837–1840. . 187.BrignoleM,MenozziC,MoyaA,Garcia-CiveraR,MontL,AlvarezM,Errazquin
.
169. Drak-Hern(cid:2)andezY,Toquero-RamosJ,Fern(cid:2)andezJM,Pe´rez-PereiraE,Castro- . F,BeirasJ,BottoniN,DonateoP,InternationalStudyonSyncopeofUncertain
.
UrdaV,Fern(cid:2)andez-LozanoI.Effectivenessandsafetyofremotemonitoringof .. Etiology(ISSUE)Investigators.Mechanismofsyncopeinpatientswithbundle
patients with an implantable loop recorder. Rev Esp Cardiol (Engl Ed) .. branch block and negative electrophysiological test. Circulation
.
2013;66:943–948. . 2001;104:2045–2050.
.
170. Furukawa T, Maggi R, Bertolone C, Ammirati F, Santini M, Ricci R, Giada F, .. 188.Moya A, Garcia-Civera R, Croci F, Menozzi C, Brugada J, Ammirati F, Del
BrignoleM.Effectivenessofremotemonitoringinthemanagementofsyncope .. RossoA,Bellver-NavarroA,Garcia-SacristanJ,BortnikM,MontL,Ruiz-Granell
.
andpalpitations.Europace2011;13:431–437. . R, Navarro X, Bradycardia detection in Bundle Branch Block (B4) study.
.
171. RothmanSA, Laughlin JC, Seltzer J,Walia JS, Baman RI, Siouffi SY, Sangrigoli . Diagnosis, management, and outcomes of patients with syncope and bundle
.
RM, Kowey PR. The diagnosis of cardiac arrhythmias: a prospective multi- .. branchblock.EurHeartJ2011;32:1535–1541.
centerrandomizedstudycomparingmobilecardiacoutpatienttelemetryversus .. 189.HoRT,WicksT,WyethD,NeiM.Generalizedtonic-clonicseizuresdetected
.
standardloopeventmonitoring.JCardiovascElectrophysiol2007;18:241–247. . by implantable loop recorder devices: diagnosing more than cardiac arrhyth-
.
172. Farwell DJ, Freemantle N, Sulke N. The clinical impact of implantable loop . mias.HeartRhythm2006;3:857–861. .
recordersinpatientswithsyncope.EurHeartJ2006;27:351–356. .. 190.PetkarS,HamidT,IddonP,CliffordA,RiceN,ClaireR,McKeeD,CurtisN,
173. Krahn AD, Klein GJ, Yee R, Skanes AC. Randomized assessment of syncope .. CooperPN,FitzpatrickAP.Prolongedimplantableelectrocardiographicmoni-
.
trial: conventional diagnostic testing versus a prolonged monitoring strategy. . toringindicatesahighrateofmisdiagnosisofepilepsy–REVISEstudy.Europace
. Circulation2001;104:46–51. .. 2012;14:1653–1660.
174. DaCostaA,DefayeP,Romeyer-BouchardC,RocheF,DauphinotV,Deharo .. 191.MaggiR,RafanelliM,CeccofiglioA,SolariD,BrignoleM,UngarA.Additional
.
JC,JaconP,LamaisonD,BathelemyJC,IsaazK,LaurentG.Clinicalimpactof . diagnosticvalueofimplantablelooprecorderinpatientswithinitialdiagnosisof .
theimplantablelooprecorderinpatientswithisolatedsyncope,bundlebranch . realorapparenttransientlossofconsciousnessofuncertainorigin.Europace
.
blockandnegativeworkup:arandomizedmulticentreprospectivestudy.Arch .. 2014;16:1226–1230.
CardiovascDis2013;106:146–154. .. 192.Armstrong VL, Lawson J, Kamper AM, Newton J, Kenny RA. The use of an
.
175. PodoleanuC,DaCostaA,DefayeP,TaiebJ,GalleyD,BruP,MauryP,MaboP, . implantablelooprecorderintheinvestigationofunexplainedsyncopeinolder
.
BovedaS,CellarierG,AnselmeF,KouakamC,DelarcheN,DeharoJC,FRESH . people.AgeAgeing2003;32:185–188.
.
investigators.Earlyuseofanimplantablelooprecorderinsyncopeevaluation:a .. 193.RyanDJ,NickS,ColetteSM,RoseanneK.Carotidsinussyndrome,shouldwe
.
randomized study in the context of the French healthcare system (FRESH . pace? A multicentre, randomised control trial (Safepace 2). Heart
.
study).ArchCardiovascDis2014;107:546–552. . 2010;96:347–351.
.
176. SulkeN,SugiharaC,HongP,PatelN,FreemantleN.Thebenefitofaremotely .. 194.BhanguJ,McMahonCG,HallP,BennettK,RiceC,CreanP,SuttonR,Kenny
monitoredimplantablelooprecorderasafirstlineinvestigationinunexplained .. RA. Long-term cardiac monitoring in older adults with unexplained falls and
.
syncope:theEaSyASIItrial.Europace2016;18:912–918. . syncope.Heart2016;102:681–686.
.
177. Edvardsson N, GaruttiC, Rieger G, Linker NJ, PICTURE Study Investigators. . 195.Krahn AD, Klein GJ, Norris C, Yee R. The etiology of syncope in patients
.
Unexplainedsyncope:implicationsofageandgenderonpatientcharacteristics .. with negative tilt table and electrophysiological testing. Circulation
andevaluation, thediagnostic yieldofanimplantablelooprecorder, andthe .. 1995;92:1819–1824.
.
subsequenttreatment.ClinCardiol2014;37:618–625. . 196.KrahnAD,KleinGJ,YeeR,Takle-NewhouseT,NorrisC.Useofanextended
.
178. EdvardssonN,WolffC,TsintzosS,RiegerG,LinkerNJ.Costsofunstructured .. monitoringstrategyinpatientswithproblematicsyncope.RevealInvestigators.
investigationofunexplainedsyncope:insightsfromamicro-costinganalysisof .. Circulation1999;99:406–410.
.
theobservationalPICTUREregistry.Europace2015;17:1141–1148. . 197.KrahnAD,KleinGJ,YeeR,SkanesAC.Detectionofasymptomaticarrhythmias
.
179. BrignoleM,VardasP,HoffmanE,HuikuriH,MoyaA,RicciR,SulkeN,Wieling . inunexplainedsyncope.AmHeartJ2004;148:326–332.
.
W, Auricchio A, Lip GY, Almendral J, Kirchhof P, Aliot E, Gasparini M, .. 198.Ermis C, Zhu AX, Pham S, Li JM, Guerrero M, Vrudney A, Hiltner L, Lu F,
Braunschweig F, Lip GY, Almendral J, Kirchhof P, Botto GL, EHRA Scientific . Sakaguchi S, Lurie KG, Benditt DG. Comparison of automatic and patient-
Downloaded
from
https://academic.oup.com/eurheartj/article/39/21/1883/4939241
by
guest
on
22
January
2026
--- Страница 64 ---
1946 ESCGuidelines
.
.
activatedarrhythmiarecordingsbyimplantablelooprecordersintheevaluation . AntzelevitchC,AlloccaG,PrioriSG,LubitzSA.Programmedventricularstimu-
.
ofsyncope.AmJCardiol2003;92:815–819. . lation for risk stratification in the Brugada syndrome: a pooled analysis.
.
199. Moya A, Brignole M, Sutton R, Menozzi C, Garcia-Civera R, Wieling W, .. Circulation2016;133:622–630.
AndresenD,BendittDG,Garcia-SacristanJF,BeirasX,GrovaleN,VardasP, .. 221.ScheinmanMM,PetersRW,SuaveMJ,DesaiJ,Abbott JA,CoganJ,WohlB,
.
International Study on Syncope of Uncertain Etiology 2 (ISSUE 2) . WilliamsK.ValueoftheH-Qintervalinpatientswithbundlebranchblockand
.
Group. Reproducibility of electrocardiographic findings in patients with .. theroleofprophylacticpermanentpacing.AmJCardiol1982;50:1316–1322.
suspected reflex neurally-mediated syncope. Am J Cardiol .. 222.Blomstro¨m-LundqvistC,ScheinmanMM,AliotEM,AlpertJS,CalkinsH,Camm
.
2008;102:1518–1523. . AJ,CampbellWB,HainesDE,KuckKH,LermanBB,MillerDD,ShaefferCWJr,
.
200. SudS,KleinGJ,SkanesAC,GulaLJ,YeeR,KrahnAD.Implicationsofmecha- . StevensonWG,TomaselliGF,AntmanEM,SmithSCJr,AlpertJS,FaxonDP,
.
nism of bradycardia onresponseto pacing inpatients with unexplained syn- .. FusterV,GibbonsRJ,GregoratosG,HiratzkaLF,HuntSA,JacobsAK,Russell
cope.Europace2007;9:312–318. .. ROJr,PrioriSG,BlancJJ,BudajA,BurgosEF,CowieM,DeckersJW,Garcia
.
201. OlmosC,FrancoE,Suarez-BarrientosA,FortunyE,Martin-GarciaA,VilianiD, . MA,KleinWW,LekakisJ,LindahlB,MazzottaG,MoraisJC,OtoA,SmisethO,
.
MacayaC, PerezdeIslaL.Wearable wirelessremote monitoringsystem:an . TrappeHJ,AmericanCollegeofCardiology,AmericanHeartAssociationTask
.
alternative for prolonged electrocardiographic monitoring. Int J Cardiol .. ForceonPracticeGuidelines,EuropeanSocietyofCardiologyCommitteefor
.
2014;172:e43–44. . PracticeGuidelines,WritingCommitteetoDevelopGuidelinesforthemanage-
.
202. MoyaA,BrignoleM,MenozziC,Garcia-CiveraR,TognariniS,MontL,Botto . mentofPatientsWithSupraventricularArrhythmias.ACC/AHA/ESCguidelines
. G, Giada F, Cornacchia D, International Study on Syncope of .. for the management of patients with supraventricular arrhythmias–executive
Uncertain Etiology (ISSUE) Investigators. Mechanism of syncope in patients .. summary: a report of the American College of Cardiology/American Heart
.
with isolated syncope and in patients with tilt-positive syncope. Circulation . Association Task Force on Practice Guidelines and the European Society of
.
2001;104:1261–1267. . Cardiology Committee for Practice Guidelines (Writing Committee to
.
203. FurukawaT,MaggiR,BertoloneC,FontanaD,BrignoleM.Additionaldiagnostic .. Develop Guidelines for the Management of Patients With Supraventricular
valueofveryprolongedobservationbyimplantablelooprecorderinpatients .. Arrhythmias).Circulation2003;108:1871–1909.
.
withunexplainedsyncope.JCardiovascElectrophysiol2012;23:67–71. . 223.PfisterR,HagemeisterJ,EsserS,HellmichM,ErdmannE,SchneiderCA.NT-
.
204. LaFrance WC Jr, Baker GA, Duncan R, Goldstein LH, Reuber M. Minimum .. pro-BNP for diagnostic and prognostic evaluation inpatients hospitalized for
requirementsforthediagnosisofpsychogenicnonepilepticseizures:astaged .. syncope.IntJCardiol2012;155:268–272.
.
approach:areportfromtheInternationalLeagueAgainstEpilepsyNonepileptic . 224.Costantino G, Solbiati M, Casazza G, Bonzi M, Vago T, Montano N,
.
SeizuresTaskForce.Epilepsia2013;54:2005–2018. . McDermottD,QuinnJ,FurlanR.UsefulnessofN-terminalpro-B-typenatriu-
.
205. SaalDP,ThijsRD,vanZwetEW,BootsmaM,BrignoleM,BendittDG,vanDijk .. reticPeptideincreaseasamarkerforcardiacarrhythmiainpatientswithsyn-
JG.Temporalrelationshipofasystoletoonsetoftransientlossofconsciousness .. cope.AmJCardiol2014;113:98–102.
.
intilt-inducedreflexsyncope.JACC:ClinicalElectrophysiology2017;3:1592–1598. . 225.ThiruganasambandamoorthyV,RamaekersR,RahmanMO,StiellIG,SikoraL,
.
206. WhittakerRG.Videotelemetry:currentconceptsandrecentadvances.Pract . KellySL,ChristM,ClaretPG,ReedMJ.Prognosticvalueofcardiacbiomarkers
.
Neurol2015;15:445–450. .. in the risk stratification of syncope: a systematic review. Intern Emerg Med
.
207. Goodwin E, Kandler RH, Alix JJ. The value of home video with ambulatory . 2015;10:1003–1014.
.
EEG:aprospectiveservicereview.Seizure2014;23:480–482. . 226.Guieu R, Deharo JC, Ruf J, Mottola G, Kipson N, Bruzzese L, Gerolami V,
.
208. Stephenson J, Breningstall G, Steer C, Kirkpatrick M, Horrocks I, Nechay A, .. Franceschi F, Ungar A, Tomaino M, Iori M, Brignole M. Adenosine and
ZuberiS.Anoxic-epilepticseizures:homevideorecordingsofepilepticseizures .. clinical forms of neurally-mediated syncope. J Am Coll Cardiol
.
inducedbysyncopes.EpilepticDisord2004;6:15–19. . 2015;66:204–205.
.
209. Linzer M, Yang EH, Estes NA III, Wang P, Vorperian VR, Kapoor WN. . 227.FlammangD,ChurchTR,DeRoyL,BlancJJ,LeroyJ,MairesseGH,OtmaniA,
.
Diagnosingsyncope.Part2:Unexplainedsyncope.ClinicalEfficacyAssessment .. Graux PJ, Frank R, Purnode P, ATP Multicenter Study. Treatment of unex-
ProjectoftheAmericanCollegeofPhysicians.AnnInternMed1997;127:76–86. .. plained syncope: a multicenter, randomized trial of cardiac pacing guided by
.
210. Dhingra RC. Sinus node dysfunction. Pacing Clin Electrophysiol . adenosine5’-triphosphatetesting.Circulation2012;125:31–36.
.
1983;6:1062–1069. .. 228.BrignoleM,GaggioliG,MenozziC,GianfranchiL,BartolettiA,BottoniN,Lolli
211. GannD,TolentinoA,SametP.Electrophysiologicevaluationofelderlypatients .. G,OddoneD,DelRossoA,PellinghelliG.Adenosine-inducedatrioventricular
.
with sinus bradycardia: a long-term follow-up study. Ann Intern Med . blockinpatientswithunexplainedsyncope:thediagnosticvalueofATPtesting.
.
1979;90:24–29. . Circulation1997;96:3921–3927.
.
212. MenozziC,BrignoleM,AlboniP,BoniL,PaparellaN,GaggioliG,LolliG.The .. 229.DonateoP,BrignoleM,MenozziC,BottoniN,AlboniP,DinelliM,DelRosso
naturalcourseofuntreatedsicksinussyndromeandidentificationofthevaria- .. A,CrociF,OddoneD,SolanoA,PuggioniE.Mechanismofsyncopeinpatients
.
blespredictiveofunfavorableoutcome.AmJCardiol1998;82:1205–1209. . withpositiveadenosinetriphosphatetests.JAmCollCardiol2003;41:93–98.
.
213. McAnultyJH,RahimtoolaSH,MurphyE,DeMotsH,RitzmannL,KanarekPE, . 230.KrishnanB,Patarroyo-AponteM,DuprezD,PritzkerM,MissovE,BendittDG. .
KauffmanS.Naturalhistoryof“high-risk”bundle-branchblock:finalreportofa .. Orthostatichypotensionofunknowncause:unanticipatedassociationwithele-
prospectivestudy.NEnglJMed1982;307:137–143. .. vated circulating N-terminal brain natriuretic peptide (NT-proBNP). Heart
.
214. GrondaM,MagnaniA,OcchettaE,SauroG,D’AulerioM,CarforaA,RossiP. . Rhythm2015;12:1287–1294.
. Electrophysiologicalstudyofatrio-ventricularblockandventricularconduction .. 231.FedorowskiA,BurriP,StruckJ,Juul-MollerS,MelanderO.Novelcardiovascu-
defects. Prognostic and therapeutical implications. G Ital Cardiol .. larbiomarkersinunexplainedsyncopalattacks:theSYSTEMAcohort.JIntern
.
1984;14:768–773. . Med2013;273:359–367. .
215. BergfeldtL,EdvardssonN,RosenqvistM,VallinH,EdhagO.Atrioventricular . 232.LiH,KemDC,ReimS,KhanM,Vanderlinde-WoodM,ZillnerC,CollierD,
.
blockprogressioninpatientswithbifascicularblockassessedbyrepeatedelec- .. LilesC,HillMA,CunninghamMW,AstonCE,YuX.Agonisticautoantibodies
trocardiography and a bradycardia-detecting pacemaker. Am J Cardiol .. as vasodilators in orthostatic hypotension: a new mechanism. Hypertension
.
1994;74:1129–1132. . 2012;59:402–408.
.
216. Kaul U, Dev V, Narula J, Malhotra AK, Talwar KK, Bhatia ML. Evaluation of . 233.Li H, Yu X, Liles C, Khan M, Vanderlinde-Wood M, Galloway A, Zillner C,
.
patientswithbundlebranchblockand“unexplained”syncope:astudybased .. Benbrook A, Reim S, Collier D, Hill MA, Raj SR, Okamoto LE, Cunningham
.
on comprehensive electrophysiologic testing and ajmaline stress. Pacing Clin . MW, Aston CE, Kem DC. Autoimmune basis for postural tachycardia syn-
.
Electrophysiol1988;11:289–297. . drome.JAmHeartAssoc2014;3:e000755.
.
217. KalscheurMM,DonateoP,WenzkeKE,AsteM,OddoneD,SolanoA,MaggiR, .. 234.FedorowskiA,LiH,YuX,KoelschKA,HarrisVM,LilesC,MurphyTA,Quadri
Croci F, Page RL, Brignole M, Hamdan MH. Long-term outcome of patients .. SMS,ScofieldRH,SuttonR,MelanderO,KemDC.Antiadrenergicautoimmun-
.
withbifascicularblockandunexplainedsyncopefollowingcardiacpacing.Pacing . ityinposturaltachycardiasyndrome.Europace2017;19:1211–1219.
.
ClinElectrophysiol2016;39:1126–1131. . 235.RecchiaD,BarzilaiB.Echocardiographyintheevaluationofpatientswithsyn-
.
218. OlshanskyB,HahnEA,HartzVL,PraterSP,MasonJW.Clinicalsignificanceof .. cope.JGenInternMed1995;10:649–655.
syncopeintheelectrophysiologicstudyversuselectrocardiographicmonitoring .. 236.SarasinFP,JunodAF,CarballoD,SlamaS,UngerPF,Louis-SimonetM.Roleof
.
(ESVEM)trial.TheESVEMInvestigators.AmHeartJ1999;137:878–886. . echocardiography in the evaluation of syncope: a prospective study. Heart
.
219. LinkMS,KimKM,HomoudMK,EstesNAIII,WangPJ.Long-termoutcomeof .. 2002;88:363–367.
patientswithsyncopeassociatedwithcoronaryarterydiseaseandanondiag- .. 237.HoegholmA,ClementsenP,MortensenSA.Syncopeduetorightatrialthrom-
.
nosticelectrophysiologicevaluation.AmJCardiol1999;83:1334–1337. . boembolism:diagnosticimportanceoftwo-dimensionalechocardiography.Acta
.
220. Sroubek J, Probst V, Mazzanti A, Delise P, Hevia JC, Ohkubo K, Zorzi A, . Cardiol1987;42:469–473.
.
ChampagneJ,KostopoulouA,YinX,NapolitanoC,MilanDJ,WildeA,Sacher .. 238.OmranH,FehskeW,RabahiehR,HagendorffA,PizzulliL,ZirbesM,Luderitz
F,BorggrefeM,Ellinor PT,TheodorakisG,NaultI,Corrado D,WatanabeI, . B.Valvularaorticstenosis:riskofsyncope.JHeartValveDis1996;5:31–34.
Downloaded
from
https://academic.oup.com/eurheartj/article/39/21/1883/4939241
by
guest
on
22
January
2026
--- Страница 65 ---
ESCGuidelines 1947
.
.
239. BogaertAM,DeScheerderI,ColardynF.Successfultreatmentofaorticrupture . 263.KimKH,ChoJG,LeeKO,SeoTJ,ShonCY,LimSY,YunKH,SohnIS,HongYJ,
.
presentingasasyncope:theroleofechocardiographyindiagnosis.IntJCardiol .. ParkHW,KimJH,KimW,AhnYK,JeongMH,ParkJC,KangJC.Usefulnessof
1987;16:212–214. .. physical maneuvers for prevention of vasovagal syncope. Circ J
.
240. Acikel M, Yekeler I, Ates A, Erkut B. A giant left atrial myxoma: an unusual . 2005;69:1084–1088.
.
causeofsyncopeandcerebralemboli.IntJCardiol2004;94:325–326. .. 264.TomainoM,RomeoC,VitaleE,KusT,MoyaA,vanDijkN,GiuliS,D’Ippolito
241. NogueiraDC,BontempoD,MenardiAC,VicenteWV,RibeiroPJ,EvoraPR. .. G,GentiliA,SuttonR,InternationalStudyonSyncopeofUncertainEtiology3
.
Leftatrialmyxomaasthecauseofsyncopeinanadolescent.ArqBrasCardiol . (ISSUE 3) Investigators. Physical counter-pressure manoeuvres in preventing
.
2003;81:206–209,202–205. . syncopal recurrence in patients older than 40 years with recurrent neurally
.
242. SinhaAK,SinghBP.LAmyxomapresentingasrecurrentsyncope.IndianHeartJ .. mediated syncope: a controlled study from the Third International Study on
2013;65:643. .. SyncopeofUncertainEtiology(ISSUE-3)†.Europace2014;16:1515–1520.
.
243. RahmanMS,MichaelH.Ararepresentationofchestpainandsyncope:massive . 265.Reybrouck T, Heidbuchel H, Van De Werf F, Ector H. Long-term follow-up
.
rightatrialmyxoma.PostgradMedJ2012;88:671–672. . resultsoftilttrainingtherapyinpatientswithrecurrentneurocardiogenicsyn-
.
244. HanH,LiY,GuoS,YuX.Rightatrialmyxoma-inducedsyncope.PostgradMedJ .. cope.PacingClinElectrophysiol2002;25:1441–1446.
.
2011;87:438–439. . 266.ZengH,GeK,ZhangW,WangG,GuoL.Theeffectoforthostatictrainingin
.
245. Elliott PM, Anastasakis A, Borger MA, Borggrefe M, Cecchi F, Charron P, . the prevention of vasovagal syncope and its influencing factors. Int Heart J
.
HagegeAA,LafontA,LimongelliG,MahrholdtH,McKennaWJ,MogensenJ, .. 2008;49:707–712.
Nihoyannopoulos P, Nistri S, Pieper PG, Pieske B, Rapezzi C, Rutten FH, .. 267.JangWJ,YimHR,LeeSH,ParkSJ,KimJS,OnYK.Prognosisaftertilttrainingin
.
TillmannsC,WatkinsH.2014ESCGuidelinesondiagnosisandmanagementof . patientswithrecurrentvasovagalsyncope.IntJCardiol2013;168:4264–4265.
.
hypertrophic cardiomyopathy: the Task Force for the Diagnosis and . 268.Foglia-Manzillo G, Giada F, Gaggioli G, Bartoletti A, Lolli G, Dinelli M, Del
.
Management of Hypertrophic Cardiomyopathy of the European Society of .. Rosso A, Santarone M, Raviele A, Brignole M. Efficacy of tilt training in the
Cardiology(ESC).EurHeartJ2014;35:2733–2779. .. treatment of neurally mediated syncope. A randomized study. Europace
. 246. Maron MS, Olivotto I, Zenovich AG, Link MS, Pandian NG, Kuvin JT, Nistri S, . 2004;6:199–204.
.
CecchiF,UdelsonJE,MaronBJ.Hypertrophiccardiomyopathyispredominantlya .. 269.KinayO,YaziciM,NazliC,AcarG,GedikliO,AltinbasA,KahramanH,Dogan
diseaseofleftventricularoutflowtractobstruction.Circulation2006;114:2232–2239. .. A,OzaydinM,TuzunN,ErgeneO.Tilttrainingforrecurrentneurocardiogenic
.
247. ShahJS,EstebanMT,ThamanR,SharmaR,MistB,PantazisA,WardD,Kohli . syncope: effectiveness, patient compliance, and scheduling the frequency of
.
SK, Page SP, Demetrescu C, Sevdalis E, Keren A, Pellerin D, McKenna WJ, . trainingsessions.JpnHeartJ2004;45:833–843.
.
Elliott PM. Prevalence of exercise-induced left ventricular outflow tract .. 270.OnYK,ParkJ,HuhJ,KimJS.Ishomeorthostaticself-trainingeffectiveinpre-
obstructioninsymptomaticpatientswithnon-obstructivehypertrophiccardio- .. ventingneurallymediatedsyncope?PacingClinElectrophysiol2007;30:638–643.
.
myopathy.Heart2008;94:1288–1294. . 271.DuyguH,ZoghiM,TurkU,AkyuzS,OzerkanF,AkilliA,ErturkU,OnderR,
.
248. DimitrowPP,BoberM,MichalowskaJ,SoryszD.Leftventricularoutflowtract . Akin M. The role of tilt training in preventing recurrent syncope in patients
.
gradient provoked by upright position or exercise in treated patients with .. with vasovagal syncope: a prospective and randomized study. Pacing Clin
hypertrophic cardiomyopathy without obstruction at rest. Echocardiography .. Electrophysiol2008;31:592–596.
.
2009;26:513–520. . 272.TanMP,NewtonJL,ChadwickTJ,GrayJC,NathS,ParrySW.Homeortho-
.
249. Marwick TH, Nakatani S, Haluska B, Thomas JD, Lever HM. Provocation of .. static training in vasovagal syncope modifies autonomic tone: results of a
latentleftventricularoutflowtractgradientswithamylnitriteandexercisein .. randomized,placebo-controlledpilotstudy.Europace2010;12:240–246.
.
hypertrophiccardiomyopathy.AmJCardiol1995;75:805–809. . 273.Verheyden B, Liu J, van Dijk N, Westerhof BE, Reybrouck T, Aubert AE,
.
250. Sneddon JF, Scalia G, Ward DE, McKenna WJ, Camm AJ, Frenneaux MP. . WielingW.Steepfallincardiacoutputismaindeterminantofhypotensiondur-
.
Exerciseinducedvasodepressorsyncope.BrHeartJ1994;71:554–557. .. ing drug-free and nitroglycerine-induced orthostatic vasovagal syncope. Heart
251. SakaguchiS,ShultzJJ,RemoleSC,AdlerSW,LurieKG,BendittDG.Syncope .. Rhythm2008;5:1695–1701.
.
associated with exercise, a manifestation of neurally mediated syncope. Am J . 274.Burklow TR, Moak JP, Bailey JJ, Makhlouf FT.Neurally mediated cardiacsyn-
.
Cardiol1995;75:476–481. . cope: autonomic modulation after normal saline infusion. J Am Coll Cardiol
.
252. Colivicchi F, Ammirati F, Biffi A, Verdile L, Pelliccia A, Santini M. Exercise- .. 1999;33:2059–2066.
.
relatedsyncopeinyoungcompetitiveathleteswithoutevidenceofstructural . 275.SheldonR,RajSR,RoseMS,MorilloCA,KrahnAD,MedinaE,TalajicM,KusT,
.
heart disease. Clinical presentation and long-term outcome. Eur Heart J . SeiferCM,LelonekM,KlingenhebenT,ParkashR,RitchieD,McRaeM,POST2
.
2002;23:1125–1130. .. Investigators. Fludrocortisone for the prevention of vasovagal syncope: a
253. WoelfelAK,SimpsonRJJr,GettesLS,FosterJR.Exercise-induceddistalatrio- .. randomized,placebo-controlledtrial.JAmCollCardiol2016;68:1–9.
.
ventricularblock.JAmCollCardiol1983;2:578–581. . 276.SalimMA,DiSessaTG.Effectivenessoffludrocortisoneandsaltinpreventing
.
254. ByrneJM,MaraisHJ,CheekGA.Exercise-induced completeheartblockina . syncoperecurrenceinchildren:adouble-blind,placebo-controlled,randomized
.
patientwithchronicbifascicularblock.JElectrocardiol1994;27:339–342. .. trial.JAmCollCardiol2005;45:484–488.
255. AsteM,OddoneD,DonateoP,SolanoA,MaggiR,CrociF,SolariD,Brignole .. 277.RavieleA,BrignoleM,SuttonR,AlboniP,GianiP,MenozziC,MoyaA.Effect .
M. Syncope in patients paced for atrioventricular block. Europace . ofetilefrineinpreventingsyncopalrecurrenceinpatientswithvasovagalsyn-
.
2016;18:1735–1739. .. cope: a double-blind, randomized, placebo-controlled trial. The Vasovagal
256. SumiyoshiM,NakataY,YasudaM,TokanoT,OguraS,NakazatoY,Yamaguchi .. SyncopeInternationalStudy.Circulation1999;99:1452–1457.
. H.Clinicalandelectrophysiologicfeaturesofexercise-inducedatrioventricular . 278.IzcovichA,GonzalezMallaC,ManzottiM,CatalanoHN,GuyattG.Midodrine
.
block.AmHeartJ1996;132:1277–1281. . fororthostatichypotensionandrecurrentreflexsyncope:asystematicreview. .
257. WissocqL,EnnezatPV,MouquetF.Exercise-inducedhigh-degreeatrioventricu- .. Neurology2014;83:1170–1177.
larblock.ArchCardiovascDis2009;102:733–735. .. 279.MadridAH,OrtegaJ,RebolloJG,ManzanoJG,SegoviaJG,SanchezA,Pena
.
258. Anderson LL, Dai D, Miller AL, Roe MT, Messenger JC, Wang TY. . G,MoroC.Lackofefficacyofatenololforthepreventionofneurallymedi-
. Percutaneouscoronaryinterventionforolderadultswhopresentwithsyncope . ated syncope in a highly symptomatic population: a prospective, double-
.
and coronary artery disease? Insights from the National Cardiovascular Data .. blind, randomized and placebo-controlled study. J Am Coll Cardiol
.
Registry.AmHeartJ2016;176:1–9. . 2001;37:554–559.
.
259. El-Sayed H, Hainsworth R. Salt supplement increases plasma volume and . 280.SheldonR,ConnollyS,RoseS,KlingenhebenT,KrahnA,MorilloC,TalajicM,
.
orthostatic tolerance in patients with unexplained syncope. Heart .. KuT,Fouad-TaraziF,RitchieD,KoshmanML,POSTInvestigators.Prevention
1996;75:134–140. .. ofSyncopeTrial(POST):arandomized,placebo-controlledstudyofmetopro-
.
260. SolariD,TesiF,UnterhuberM,GaggioliG,UngarA,TomainoM,BrignoleM. . lolinthepreventionofvasovagalsyncope.Circulation2006;113:1164–1170.
.
Stop vasodepressor drugs in reflex syncope: a randomised controlled trial. . 281.DiGirolamoE,DiIorioC,SabatiniP,LeonzioL,BarboneC,BarsottiA.Effects
.
Heart2017;103:449–455. .. ofparoxetinehydrochloride,aselectiveserotoninreuptakeinhibitor,onrefrac-
261. SPRINTResearchGroup,WrightJTJr,WilliamsonJD,WheltonPK,SnyderJK, .. toryvasovagalsyncope:arandomized,double-blind,placebo-controlledstudy.
.
SinkKM,RoccoMV,ReboussinDM,RahmanM,OparilS,LewisCE,Kimmel . JAmCollCardiol1999;33:1227–1230.
.
PL, Johnson KC, Goff DC Jr, Fine LJ, Cutler JA, Cushman WC, Cheung AK, .. 282.TheodorakisGN,MarkianosM,ZarvalisE,LivanisEG,FlevariP,Kremastinos
Ambrosius WT. A Randomized Trial of Intensive versus Standard Blood- .. DT.Provocationofneurocardiogenicsyncopebyclomipramineadministration
.
PressureControl.NEnglJMed2015;373:2103–2116. . during the head-up tilt test in vasovagal syndrome. J Am Coll Cardiol
.
262. Brignole M, Menozzi C, Gaggioli G, Musso G, Foglia-Manzillo G, Mascioli G, . 2000;36:174–178.
.
FradellaG,BottoniN,MuredduR.Effectsoflong-termvasodilatortherapyin .. 283.MarquezMF,Urias-MedinaK,Gomez-FloresJ,SobrinoA,Sotomayor-Gonzalez
patientswithcarotidsinushypersensitivity.AmHeartJ1998;136:264–268. . A, Gonzalez-Hermosillo A, Cardenas M. [Comparison of metoprolol vs
Downloaded
from
https://academic.oup.com/eurheartj/article/39/21/1883/4939241
by
guest
on
22
January
2026
--- Страница 66 ---
1948 ESCGuidelines
.
clonazepamasafirsttreatmentchoiceamongpatientswithneurocardiogenic .. 303.Baron-EsquiviasG,MorilloCA,Moya-MitjansA,Martinez-AldayJ,Ruiz-Granell
syncope].GacMedMex2008;144:503–507. .. R,Lacunza-RuizJ,Garcia-CiveraR,Gutierrez-CarreteroE,Romero-GarridoR.
.
284. KanjwalK,SaeedB,KarabinB,KanjwalY,GrubbBP.Useofoctreotideinthe . Dual-chamberpacingwithclosedloopstimulationinrecurrentreflexvasovagal
.
treatmentofrefractoryorthostaticintolerance.AmJTher2012;19:7–10. .. syncope:theSPAINStudy.JAmCollCardiol2017;70:1720–1728.
285. BrignoleM,SolariD,IoriM,BottoniN,GuieuR,DeharoJC.Efficacyoftheo- .. 304.MadiganNP,FlakerGC,CurtisJJ,ReidJ,MuellerKJ,MurphyTJ.Carotidsinus
.
phylline in patients affected by low adenosine syncope. Heart Rhythm . hypersensitivity: beneficial effects of dual-chamber pacing. Am J Cardiol
.
2016;13:1151–1154. . 1984;53:1034–1040.
.
286. BrignoleM,GuieuR,TomainoM,IoriM,UngarA,BertoloneC,UnterhuberM, .. 305.BrignoleM,SartoreB,BarraM,MenozziC,LolliG.IsDDDsuperiortoVVI
BottoniN,TesiF,ClaudeDeharoJ.Mechanismofsyncopewithoutprodromes .. pacing in mixed carotid sinus syndrome? An acute and medium-term study.
.
with normal heart and normal electrocardiogram. Heart Rhythm . PacingClinElectrophysiol1988;11:1902–1910.
.
2017;14:234–239. .. 306.SuttonR.Pacinginpatientswithcarotidsinusandvasovagalsyndromes.Pacing
287. Vaddadi G, Guo L, Esler M, Socratous F, Schlaich M, Chopra R, Eikelis N, .. ClinElectrophysiol1989;12:1260–1263.
.
LambertG,TrauerT,LambertE.Recurrentposturalvasovagalsyncope:sympa- . 307.PalmisanoP,Dell’EraG,RussoV,ZaccariaM,MangiaR,BortnikM,DeVecchi
.
theticnervoussystemphenotypes.CircArrhythmElectrophysiol2011;4:711–718. . F,GiubertoniA,PattiF,MagnaniA,NigroG,RagoA,OcchettaE,AccogliM.
.
288. SchroederC,BirkenfeldAL,MayerAF,TankJ,DiedrichA,LuftFC,JordanJ. .. Effectsofclosed-loopstimulationvs.DDDpacingonhaemodynamicvariations
Norepinephrinetransporterinhibitionpreventstilt-inducedpre-syncope.JAm .. andoccurrenceofsyncopeinducedbyhead-uptilttestinolderpatientswith
.
CollCardiol2006;48:516–522. . refrac\torycardioinhibitoryvasovagalsyncope:theTilttest-InducedREsponse
.
289. SheldonRS,RitchieD,McRaeM,RajS.Norepinephrinetransportinhibitionfor . in Closed-loop Stimulation multicentre, prospective, single blind, randomized
.
treatmentofvasovagalsyncope.JCardiovascElectrophysiol2013;24:799–803. .. study.Europace;doi:10.1093/europace/eux015.Publishedonlineaheadofprint
290. PachonJC,PachonEI,CunhaPachonMZ,LoboTJ,PachonJC,SantillanaTG. .. 12April2017.
.
Catheterablationofsevereneurallymeditatedreflex(neurocardiogenicorvas- . 308.Russo V, Rago A, Papa AA, Golino P, Calabro R, Russo MG, Nigro G.
.
ovagal) syncope: cardioneuroablation long-term results. Europace .. Theeffect of dual-chamber closed-loop stimulation on syncoperecurrence
2011;13:1231–1242. .. in healthy patients with tilt-induced vasovagal cardioinhibitory syncope: a
291. Aksu T, Gu¨ler TE, Bozyel S, O€zcan KS, Yalin K, Mutluer FO. .. prospective, randomised, single-blind, crossover study. Heart 2013;99:
.
Cardioneuroablation in the treatment of neurally mediated reflex syncope: a . 1609–1613.
.
reviewofthecurrentliterature.TurkKardiyolDernArs2017;45:33–41. .. 309.BrignoleM,DeharoJC,MenozziC,MoyaA,SuttonR,TomainoM,UngarA.
292. Brignole M, Arabia F, Ammirati F, Tomaino M, Quartieri F, Rafanelli M, Del .. Thebenefitofpacemakertherapyinpatientswithneurally-mediatedsyncope
.
RossoA,RitaVecchiM,RussoV,GaggioliG,SyncopeUnitProject2(SUP2) . anddocumentedasystole:ameta-analysisofimplantablelooprecorderstudies.
.
investigators. Standardized algorithm for cardiac pacing in older patients . Europace; doi:10.1093/europace/eux321. Published online ahead of print 15
.
affected by severe unpredictable reflex syncope: 3-year insights from the .. December2017.
SyncopeUnitProject2(SUP2)study.Europace2016;18:1427–1433. .. 310.ClaydonVE,HainsworthR.Saltsupplementationimprovesorthostaticcerebral
.
293. BrignoleM,MenozziC.Thenaturalhistoryofcarotidsinussyncopeandthe . and peripheral vascular control in patients with syncope. Hypertension
.
effectofcardiacpacing.Europace2011;13:462–464. .. 2004;43:809–813.
294. BrignoleM,AuricchioA,Baron-EsquiviasG,BordacharP,BorianiG,Breithardt .. 311.Schroeder C,Bush VE,NorcliffeLJ, Luft FC, TankJ,Jordan J,HainsworthR.
.
OA, Cleland J, Deharo JC, Delgado V, Elliott PM, Gorenek B, Israel CW, . Water drinking acutely improves orthostatic tolerance in healthy subjects.
.
Leclercq C, Linde C, Mont L, Padeletti L, Sutton R, Vardas PE. 2013 ESC . Circulation2002;106:2806–2811.
.
Guidelinesoncardiacpacingandcardiacresynchronizationtherapy:theTask .. 312.ZiaA,KamaruzzamanSB,TanMP.Bloodpressureloweringtherapyinolder
ForceoncardiacpacingandresynchronizationtherapyoftheEuropeanSociety .. people: does it really cause postural hypotension or falls? Postgrad Med
.
of Cardiology (ESC). Developed in collaboration with the European Heart . 2015;127:186–193.
.
RhythmAssociation(EHRA).EurHeartJ2013;34:2281–2329. .. 313.VerwoertGC,Mattace-RasoFU,HofmanA,HeeringaJ,StrickerBH,Breteler
295. Gaggioli G, Brignole M, Menozzi C, Devoto G, Oddone D, Gianfranchi L, .. MM,WittemanJC.Orthostatichypotensionandriskofcardiovasculardisease
.
GostoliE,BottoniN,LolliG.Apositiveresponsetohead-uptilttestingpre- . inelderlypeople:theRotterdamstudy.JAmGeriatrSoc2008;56:1816–1820.
.
dictssyncopalrecurrenceincarotidsinussyndromepatientswithpermanent . 314.Kamaruzzaman S, Watt H, Carson C, Ebrahim S. The association between
.
pacemakers.AmJCardiol1995;76:720–722. .. orthostatichypotensionandmedicationuseintheBritishWomen’sHeartand
296. ConnollySJ,SheldonR,RobertsRS,GentM.TheNorthAmericanVasovagal .. HealthStudy.AgeAgeing2010;39:51–56.
.
PacemakerStudy(VPS).Arandomizedtrialofpermanentcardiacpacingforthe . 315.ValbusaF,LabatC,SalviP,VivianME,HanonO,BenetosA,PARTAGEinvesti-
.
preventionofvasovagalsyncope.JAmCollCardiol1999;33:16–20. . gators.Orthostatichypotensioninveryoldindividualslivinginnursinghomes:
.
297. SuttonR,BrignoleM,MenozziC,RavieleA,AlboniP,GianiP,MoyaA.Dual- .. thePARTAGEstudy.JHypertens2012;30:53–60.
chamberpacinginthetreatmentofneurallymediatedtilt-positivecardioinhibi- .. 316.Romero-OrtunoR,O’ConnellMD,FinucaneC,SoraghanC,FanCW,Kenny
.
torysyncope:pacemakerversusnotherapy:amulticenterrandomizedstudy. . RA. Insights into the clinical management of the syndrome of supine .
The Vasovagal Syncope International Study (VASIS) Investigators. Circulation .. hypertension–orthostatic hypotension (SH-OH): the Irish Longitudinal Study
2000;102:294–299. .. onAgeing(TILDA).BMCGeriatr2013;13:73.
. 298. Ammirati F, Colivicchi F, Santini M, Syncope Diagnosis and Treatment Study . 317.CanneyM,O’ConnellMD,MurphyCM,O’LearyN,LittleMA,O’SeaghdhaCM,
.
Investigators.Permanentcardiacpacingversusmedicaltreatmentforthepre- . KennyRA.Singleagentantihypertensivetherapyandorthostaticbloodpressure
.
ventionofrecurrentvasovagalsyncope:amulticenter,randomized,controlled .. behaviour in older adults using beat-to-beat measurements: the Irish
trial.Circulation2001;104:52–57. .. LongitudinalStudyonAgeing.PLoSOne2016;11:e0146156.
.
299. Connolly SJ,Sheldon R, Thorpe KE, Roberts RS, Ellenbogen KA, Wilkoff BL, . 318.FogariR,ZoppiA,MugelliniA,CorradiL,LazzariP,PretiP,DerosaG.Efficacy
.
MorilloC,GentM,VPSIIInvestigators.Pacemakertherapyforpreventionof . and safety of two treatment combinations of hypertension in very elderly
. syncopeinpatientswithrecurrentseverevasovagalsyncope:SecondVasovagal .. patients.ArchGerontolGeriatr2009;48:401–405.
.
PacemakerStudy(VPSII):arandomizedtrial.JAMA2003;289:2224–2229. . 319.vanLieshoutJJ,tenHarkelAD,WielingW.Physicalmanoeuvresforcombating
.
300. Raviele A, Giada F, Menozzi C, Speca G, Orazi S, Gasparini G, Sutton R, . orthostaticdizzinessinautonomicfailure.Lancet1992;339:897–898.
.
Brignole M, Vasovagal Syncope and Pacing Trial Investigators. A randomized, .. 320.Smit AA, Wieling W, Fujimura J, Denq JC, Opfer-Gehrking TL, Akarriou M,
double-blind, placebo-controlled study of permanent cardiac pacing for the .. Karemaker JM, Low PA. Use of lower abdominal compression to combat
.
treatmentofrecurrenttilt-inducedvasovagalsyncope.TheVasovagalSyncope . orthostatichypotensioninpatientswithautonomicdysfunction.ClinAutonRes
.
andPacingTrial(SYNPACE).EurHeartJ2004;25:1741–1748. . 2004;14:167–175.
.
301. SudS,MasselD,KleinGJ,Leong-SitP,YeeR,SkanesAC,GulaLJ,KrahnAD. .. 321.FanciulliA,GoebelG,MetzlerB,SprengerF,PoeweW,WenningGK,SeppiK.
Theexpectationeffectandcardiacpacingforrefractoryvasovagalsyncope.Am .. ElasticabdominalbindersattenuateorthostatichypotensioninParkinson’sdis-
.
JMed2007;120:54–62. . ease.MovDisClinPractice2015;3:156–160.
.
302. BrignoleM,DonateoP,TomainoM,MassaR,IoriM,BeirasX,MoyaA,KusT, .. 322.TenHarkelAD,VanLieshoutJJ,WielingW.Treatmentoforthostatichypoten-
Deharo JC, Giuli S, Gentili A, Sutton R, International Study on Syncope of .. sionwithsleepinginthehead-uptiltposition,aloneandincombinationwith
.
UncertainEtiology3(ISSUE-3)Investigators.Benefitofpacemakertherapyin . fludrocortisone.JInternMed1992;232:139–145.
.
patientswithpresumedneurallymediatedsyncopeanddocumentedasystoleis . 323.OmboniS,SmitAA,vanLieshoutJJ,SettelsJJ,LangewoutersGJ,WielingW.
.
greaterwhentilttestisnegative:ananalysisfromthethirdInternationalStudy .. Mechanismsunderlyingtheimpairmentinorthostatictoleranceafternocturnal
on Syncope of Uncertain Etiology (ISSUE-3). Circ Arrhythm Electrophysiol .. recumbency in patients with autonomic failure. Clin Sci (Lond) 2001;101:
.
2014;7:10–16. 609–618.
Downloaded
from
https://academic.oup.com/eurheartj/article/39/21/1883/4939241
by
guest
on
22
January
2026
--- Страница 67 ---
ESCGuidelines 1948a
.
.
324. JankovicJ,GildenJL,HinerBC,KaufmannH,BrownDC,CoghlanCH,RubinM, . 346.MoradyF,HigginsJ,PetersRW,SchwartzAB,ShenEN,BhandariA,Scheinman
.
Fouad-TaraziFM.Neurogenicorthostatichypotension:adouble-blind,placebo- . MM, Sauve MJ. Electrophysiologic testing in bundle branch block and unex-
.
controlledstudywithmidodrine.AmJMed1993;95:38–48. .. plainedsyncope.AmJCardiol1984;54:587–591.
325. Low PA, Gilden JL, Freeman R, Sheng KN, McElligott MA. Efficacy of .. 347.TabriziF,RosenqvistM,BergfeldtL,EnglundA.Long-termprognosisinpatients
.
midodrine vs placebo in neurogenic orthostatic hypotension. A randomized, . withbifascicularblock–thepredictivevalueofnoninvasiveandinvasiveassess-
.
double-blind multicenter study. Midodrine Study Group. JAMA 1997;277: .. ment.JInternMed2006;260:31–38.
1046–1051. .. 348.RuwaldMH,OkumuraK,KimuraT,AonumaK,ShodaM,KutyifaV,Ruwald
.
326. WrightRA,KaufmannHC,PereraR,Opfer-GehrkingTL,McElligottMA,Sheng . AC, McNitt S, Zareba W, Moss AJ. Syncope in high-risk cardiomyopathy
.
KN,LowPA.Adouble-blind,dose-responsestudyofmidodrineinneurogenic . patientswithimplantabledefibrillators:frequency,riskfactors,mechanisms,and
.
orthostatichypotension.Neurology1998;51:120–124. .. associationwithmortality:resultsfromthemulticenterautomaticdefibrillator
327. vanLieshoutJJ,tenHarkelAD,WielingW.Fludrocortisoneandsleepinginthe .. implantationtrial-reduceinappropriatetherapy(MADIT-RIT)study.Circulation
.
head-uppositionlimittheposturaldecreaseincardiacoutputinautonomicfail- . 2014;129:545–552.
.
ure.ClinAutonRes2000;10:35–42. . 349.SacherF,ProbstV,MauryP,BabutyD,MansouratiJ,KomatsuY,MarquieC,
.
328. FinkeJ,SagemullerI.[Fludrocortisoneinthetreatmentoforthostatichypoten- .. Rosa A, Diallo A, Cassagneau R, Loizeau C, Martins R, Field ME, Derval N,
.
sion: ophthalmodynamography during standing(author’s transl)]. Dtsch Med . Miyazaki S, Denis A, Nogami A, Ritter P, Gourraud JB, Ploux S, Rollin A,
.
Wochenschr1975;100:1790–1792. . ZemmouraA,LamaisonD,BordacharP,PierreB,JaisP,PasquieJL,HociniM,
. 329. KaufmannH,FreemanR,BiaggioniI,LowP,PedderS,HewittLA,MauneyJ, .. LegalF,DefayeP,BovedaS,IesakaY,MaboP,HaissaguerreM.Outcomeafter
FeirtagM,MathiasCJ,NOH301Investigators.Droxidopaforneurogenicortho- .. implantationofacardioverter-defibrillatorinpatientswithBrugadasyndrome:a
.
statichypotension: arandomized, placebo-controlled, phase 3trial.Neurology . multicenterstudy-part2.Circulation2013;128:1739–1747.
.
2014;83:328–335. . 350.O’MahonyC,JichiF,PavlouM,MonserratL,AnastasakisA,RapezziC,BiaginiE,
.
330. HauserRA,IsaacsonS,LiskJP,HewittLA,RowseG.Droxidopafortheshort- .. Gimeno JR, Limongelli G, McKenna WJ, Omar RZ, Elliott PM, Hypertrophic
term treatment of symptomatic neurogenic orthostatic hypotension in .. CardiomyopathyOutcomesInvestigators.Anovelclinicalriskpredictionmodel
.
Parkinson’sdisease(nOH306B).MovDisord2015;30:646–654. . forsuddencardiacdeathinhypertrophiccardiomyopathy(HCMrisk-SCD).Eur
.
331. BiaggioniI,FreemanR,MathiasCJ,LowP,HewittLA,KaufmannH,Droxidopa .. HeartJ2014;35:2010–2020.
302Investigators.Randomizedwithdrawalstudyofpatientswithsymptomatic .. 351.CorradoD,CalkinsH,LinkMS,LeoniL,FavaleS,BevilacquaM,BassoC,Ward
.
neurogenic orthostatic hypotension responsive to droxidopa. Hypertension . D,BorianiG,RicciR,PicciniJP,DalalD,SantiniM,BujaG,IlicetoS,EstesNA
.
2015;65:101–107. . III, Wichter T, McKenna WJ, Thiene G, Marcus FI. Prophylactic implantable
.
332. Hauser RA, Hewitt LA, Isaacson S. Droxidopa in patients with neurogenic .. defibrillatorinpatientswitharrhythmogenicrightventricularcardiomyopathy/
orthostatic hypotension associated with Parkinson’s disease (NOH306A). .. dysplasiaandnopriorventricularfibrillationorsustainedventriculartachycar-
.
JParkinsonsDis2014;4:57–65. . dia.Circulation2010;122:1144–1152.
.
333. ElgebalyA,AbdelazeimB,MattarO,GadelkarimM,SalahR,NegidaA.Meta- . 352.LiuJF,JonsC,MossAJ,McNittS,PetersonDR,QiM,ZarebaW,RobinsonJL,
.
analysisofthesafetyandefficacyofdroxidopaforneurogenicorthostatichypo- .. BarsheshetA,AckermanMJ,BenhorinJ,KaufmanES,LocatiEH,NapolitanoC,
.
tension.ClinAutonRes2016;26:171–180. . Priori SG, Schwartz PJ, Towbin J, Vincent M, Zhang L, Goldenberg I,
.
334. AlboniP,MenozziC,BrignoleM,PaparellaN,GaggioliG,LolliG,CappatoR. . InternationalLongQTSyndromeRegistry.Riskfactorsforrecurrentsyncope
.
Effectsofpermanentpacemakerandoraltheophyllineinsicksinussyndrome .. andsubsequentfatalornear-fataleventsinchildrenandadolescentswithlong
the THEOPACE study: a randomized controlled trial. Circulation .. QTsyndrome.JAmCollCardiol2011;57:941–950.
.
1997;96:260–266. . 353.Probst V, Veltmann C, Eckardt L, Meregalli PG, Gaita F, Tan HL, Babuty D,
.
335. Breivik K, Ohm OJ, Segadal L. Sick sinus syndrome treated with permanent . SacherF,GiustettoC,Schulze-BahrE,BorggrefeM,HaissaguerreM,MaboP,
.
pacemaker in 109 patients. A follow-up study. Acta Med Scand .. LeMarecH,WolpertC,WildeAA.Long-termprognosisofpatientsdiagnosed
1979;206:153–159. .. withBrugadasyndrome:ResultsfromtheFINGERBrugadaSyndromeRegistry.
.
336. HartelG,TalvensaariT.Treatmentofsinoatrialsyndromewithpermanentcar- . Circulation2010;121:635–643.
.
diacpacingin90patients.ActaMedScand1975;198:341–347. .. 354.Spirito P, Autore C, Rapezzi C, Bernabo P, Badagliacca R, Maron MS,
337. RasmussenK. Chronicsinus nodedisease: natural course andindications for .. BongioanniS,CoccoloF,EstesNA,BarillaCS,BiaginiE,QuartaG,ConteMR,
.
pacing.EurHeartJ1981;2:455–459. . BruzziP,MaronBJ.Syncopeandriskofsuddendeathinhypertrophiccardio-
.
338. SasakiY,ShimotoriM,AkahaneK,YonekuraH,HiranoK,EndohR,KoikeS, . myopathy.Circulation2009;119:1703–1710.
.
KawaS,FurutaS,HommaT.Long-termfollow-upofpatientswithsicksinus .. 355.ConteG,SieiraJ,CiconteG,deAsmundisC,ChierchiaGB,BaltogiannisG,Di
syndrome:acomparisonofclinicalaspectsamongunpaced,ventricularinhibited .. GiovanniG,LaMeirM,WellensF,CzaplaJ,WautersK,LevinsteinM,SaitohY,
.
paced, and physiologically paced groups. Pacing Clin Electrophysiol . Irfan G, Julia J, Pappaert G, Brugada P. Implantable cardioverter-defibrillator
.
1988;11:1575–1583. . therapy in Brugada syndrome: a 20-year single-center experience. J Am Coll .
339. SgarbossaEB,PinskiSL,JaegerFJ,TrohmanRG,MaloneyJD.Incidenceandpre- .. Cardiol2015;65:879–888.
dictors of syncope in paced patients with sick sinus syndrome. Pacing Clin .. 356.OldeNordkampLR,VinkAS,WildeAA,deLangeFJ,deJongJS,WielingW,
.
Electrophysiol1992;15:2055–2060. . vanDijkN,TanHL.SyncopeinBrugadasyndrome:prevalence,clinicalsignifi-
. 340. NgKamChuenMJ,KirkfeldtRE,AndersenHR,NielsenJC.Syncopeinpaced .. cance,andcluesfromhistorytakingtodistinguisharrhythmicfromnonarrhyth-
patientswithsicksinussyndromefromtheDANPACEtrial:incidence,predic- .. miccauses.HeartRhythm2015;12:367–375.
.
torsandprognosticimplication.Heart2014;100:842–847. . 357.OldeNordkampLR,WildeAA,TijssenJG,KnopsRE,vanDesselPF,deGroot .
341. LangenfeldH,GrimmW,MaischB,KochsiekK.Courseofsymptomsandspon- . JR.TheICDforprimarypreventioninpatientswithinheritedcardiacdiseases:
.
taneous ECG in pacemaker patients: a 5-year follow-up study. Pacing Clin .. indications, use, and outcome: a comparison with secondary prevention. Circ
Electrophysiol1988;11:2198–2206. .. ArrhythmElectrophysiol2013;6:91–100.
.
342. DonateoP,BrignoleM,AlboniP,MenozziC,RavieleA,DelRossoA,Dinelli . 358.SpezzacateneA,SinagraG,MerloM,BarbatiG,GrawSL,BrunF,SlavovD,Di
.
M,SolanoA,BottoniN,CrociF.Astandardizedconventionalevaluationofthe . LenardaA,SalcedoEE,TowbinJA,SaffitzJE,MarcusFI,ZarebaW,TaylorMR,
.
mechanism of syncope in patients with bundle branch block. Europace .. Mestroni L, Familial Cardiomyopathy Registry. Arrhythmogenic Phenotype in
.
2002;4:357–360. . Dilated Cardiomyopathy: Natural History and Predictors of Life-Threatening
.
343. Azocar D, Ruiz-Granell R, Ferrero A, Martinez-Brotons A, Izquierdo M, . Arrhythmias.JAmHeartAssoc2015;4:e002149.
.
DominguezE,PalauP,MorellS,Garcia-CiveraR.Syncopeandbundlebranch .. 359.Russo AM, Verdino R, Schorr C, Nicholas M, Dias D, Hsia H, Callans D,
block.Diagnosticyieldofasteppeduseofelectrophysiologystudyandimplant- .. MarchlinskiFE.Occurrenceofimplantabledefibrillatoreventsinpatientswith
.
ablelooprecorders.RevEspCardiol2011;64:213–219. . syncope and nonischemic dilated cardiomyopathy. Am J Cardiol
.
344. SantiniM,CastroA,GiadaF,RicciR,InamaG,Gaggioli G,CaloL,Orazi S, . 2001;88:1444–1446,A1449.
.
ViscusiM,ChiodiL,BartolettiA,Foglia-ManzilloG,AmmiratiF,LoricchioML, .. 360.PhangRS,KangD,TighiouartH,EstesNAIII,LinkMS.Highriskofventricular
PedrinazziC,TurreniF,GaspariniG,AccardiF,RacitiG,RavieleA.Prevention .. arrhythmias in patients with nonischemic dilated cardiomyopathy presenting
.
ofsyncopethroughpermanentcardiacpacinginpatientswithbifascicularblock . withsyncope.AmJCardiol2006;97:416–420.
.
andsyncopeofunexplainedorigin:thePRESSstudy.CircArrhythmElectrophysiol .. 361.Christiaans I, van Engelen K, van Langen IM, Birnie E, Bonsel GJ, Elliott PM,
2013;6:101–107. .. WildeAA.Riskstratificationforsuddencardiacdeathinhypertrophiccardio-
.
345. EnglundA,BergfeldtL,RehnqvistN,AstromH,RosenqvistM.Diagnosticvalue . myopathy: systematic review of clinical risk markers. Europace
.
ofprogrammedventricularstimulationinpatientswithbifascicularblock:apro- . 2010;12:313–321.
.
spective study of patients with and without syncope. J Am Coll Cardiol .. 362.CorradoD,WichterT,LinkMS,HauerR,MarchlinskiF,AnastasakisA,Bauce
1995;26:1508–1515. . B, Basso C, Brunckhorst C, Tsatsopoulou A, Tandri H, Paul M, Schmied C,
Downloaded
from
https://academic.oup.com/eurheartj/article/39/21/1883/4939241
by
guest
on
22
January
2026
--- Страница 68 ---
1948b ESCGuidelines
.
.
Pelliccia A, Duru F, Protonotarios N, Estes NA III, McKenna WJ, Thiene G, . predictors, and the impact of co-morbidity and polypharmacy on the risk of
.
MarcusFI,CalkinsH.Treatmentofarrhythmogenicrightventricularcardiomy- . recurrent syncope in patients <85 versus >/=85 years of age. Am J Cardiol
.
opathy/dysplasia:aninternational taskforceconsensusstatement. Eur HeartJ .. 2013;112:1610–1615.
2015;36:3227–3237. .. 383.MosselloE,PieraccioliM,NestiN,BulgaresiM,LorenziC,CaleriV,TononE,
.
363. Bhonsale A, James CA, Tichnell C, Murray B, Gagarin D, Philips B, Dalal D, . Cavallini MC, Baroncini C, Di Bari M, Baldasseroni S, Cantini C, Biagini CA,
.
TedfordR,RussellSD,AbrahamT,TandriH,JudgeDP,CalkinsH.Incidence .. MarchionniN,UngarA.Effectsoflowbloodpressureincognitivelyimpaired
andpredictorsofimplantablecardioverter-defibrillatortherapyinpatientswith .. elderly patients treated with antihypertensive drugs. JAMA Intern Med
.
arrhythmogenicrightventriculardysplasia/cardiomyopathyundergoingimplant- . 2015;175:578–585.
.
able cardioverter-defibrillator implantation for primary prevention. J Am Coll . 384.McLachlanCY,YiM,LingA,JardineDL.Adversedrugeventsareamajorcause
.
Cardiol2011;58:1485–1496. .. ofacutemedicaladmission.InternMedJ2014;44:633–638.
364. JonsC,MossAJ,GoldenbergI,LiuJ,McNittS,ZarebaW,QiM,RobinsonJL. .. 385.UngarA,MussiC,CeccofiglioA,BellelliG,NicosiaF,BoM,RiccioD,Martone
.
Risk of fatal arrhythmic events in long QT syndrome patients after syncope. . AM, Guadagno L, Noro G, Ghidoni G, Rafanelli M, Marchionni N, Abete P.
.
JAmCollCardiol2010;55:783–788. . Etiology of syncope and unexplained falls in elderly adults with Dementia:
.
365. Giustetto C, Cerrato N, Ruffino E, Gribaudo E, Scrocco C, Barbonaglia L, .. SyncopeandDementia(SYD)study.JAmGeriatrSoc2016;64:1567–1573.
.
Bianchi F, Bortnik M, Rossetti G, Carvalho P, Riccardi R, Castagno D, . 386.Ryan DJ, Harbison JA, Meaney JF, Rice CP, King-Kallimanis B, Kenny RA.
.
Anselmino M, Bergamasco L, Gaita F. Etiological diagnosis, prognostic signifi- . Syncopecausestransientfocalneurologicalsymptoms.QJM2015;108:711–718.
. canceandroleofelectrophysiologicalstudyinpatientswithBrugadaECGand .. 387.ParrySW,KennyRA.Dropattacksinolderadults:systematicassessmenthasa
syncope.IntJCardiol2017;241:188–193. .. highdiagnosticyield.JAmGeriatrSoc2005;53:74–78.
.
366. KubalaM,AissouL,TraulleS,GugenheimAL,HermidaJS.Useofimplantable . 388.ParrySW,SteenIN,BaptistM,KennyRA.Amnesiaforlossofconsciousnessin
.
looprecordersinpatientswithBrugadasyndromeandsuspectedriskofven- . carotidsinussyndrome:implicationsforpresentationwithfalls.JAmCollCardiol
.
triculararrhythmia.Europace2012;14:898–902. .. 2005;45:1840–1843.
367. Delise P, Allocca G, Marras E, Giustetto C, Gaita F, Sciarra L, Calo L, .. 389.O’DwyerC,BennettK,LanganY,FanCW,KennyRA.Amnesiaforlossofcon-
.
ProclemerA,MarzialiM,RebellatoL,BertonG,CoroL,SittaN.Riskstratifica- . sciousnessiscommoninvasovagalsyncope.Europace2011;13:1040–1045.
.
tioninindividualswiththeBrugadatype1ECGpatternwithoutpreviouscar- .. 390.Rafanelli M, Ruffolo E, Chisciotti VM, Brunetti MA, Ceccofiglio A, Tesi F,
diacarrest:usefulnessofacombinedclinicalandelectrophysiologicapproach. .. MorrioneA,MarchionniN,UngarA.Clinicalaspectsanddiagnosticrelevance
.
EurHeartJ2011;32:169–176. . ofneuroautonomicevaluationinpatientswithunexplainedfalls.AgingClinExp
.
368. Maury P, Rollin A, Sacher F, Gourraud JB, Raczka F, Pasquie JL, Duparc A, . Res2014;26:33–37.
.
Mondoly P, Cardin C, Delay M, Derval N, Chatel S, Bongard V, Sadron M, .. 391.ShawFE,BondJ,RichardsonDA,DawsonP,SteenIN,McKeithIG,KennyRA.
Denis A, Davy JM, Hocini M, Jais P, Jesel L, Haissaguerre M, Probst V. .. Multifactorialinterventionafterafallinolderpeoplewithcognitiveimpairment
.
Prevalenceandprognosticroleofvariousconductiondisturbancesinpatients . and dementia presenting to the accident and emergency department: rando-
.
withtheBrugadasyndrome.AmJCardiol2013;112:1384–1389. . misedcontrolledtrial.BMJ2003;326:73.
.
369. MauryP,SacherF,GourraudJB,PasquieJL,RaczkaF,BongardV,DuparcA, .. 392.FrewenJ,FinucaneC,SavvaGM,BoyleG,KennyRA.Orthostatichypotension
.
MondolyP,SadronM,ChatelS,DervalN,DenisA,CardinC,DavyJM,Hocini . is associated with lower cognitive performance in adults aged 50 plus with
.
M, Jais P, Jesel L, Carrie D, Galinier M, Haissaguerre M, Probst V, Rollin A. . supinehypertension.JGerontolABiolSciMedSci2014;69:878–885.
.
IncreasedTpeak-Tendintervalishighlyandindependentlyrelatedtoarrhythmic .. 393.RobertsonDA,SavvaGM,CoenRF,KennyRA.Cognitivefunctioninthepre-
eventsinBrugadasyndrome.HeartRhythm2015;12:2469–2476. .. frailtyandfrailtysyndrome.JAmGeriatrSoc2014;62:2118–2124.
.
370. Morita H, Kusano KF, Miura D, Nagase S, Nakamura K, Morita ST, Ohe T, . 394.Frewen J, King-Kallimanis B, Boyle G, Kenny RA. Recent syncope and unex-
.
ZipesDP,WuJ.FragmentedQRSasamarkerofconductionabnormalityanda . plained falls are associated with poor cognitive performance. Age Ageing
.
predictorofprognosisofBrugadasyndrome.Circulation2008;118:1697–1704. .. 2015;44:282–286.
371. PrioriSG,GaspariniM,NapolitanoC,DellaBellaP,OttonelliAG,SassoneB, .. 395.RobertsonDA,SavvaGM,KennyRA.Frailtyandcognitiveimpairment–areviewof
.
GiordanoU, Pappone C, Mascioli G, Rossetti G, De Nardis R, Colombo M. . theevidenceandcausalmechanisms.AgeingResRev2013;12:840–851.
.
RiskstratificationinBrugadasyndrome:resultsofthePRELUDE(PRogrammed .. 396.KennyRA,RichardsonDA,SteenN,BextonRS,ShawFE,BondJ.Carotidsinus
ELectrical stimUlation preDictive valuE) registry. J Am Coll Cardiol .. syndrome:amodifiableriskfactorfornonaccidentalfallsinolderadults(SAFE
.
2012;59:37–45. . PACE).JAmCollCardiol2001;38:1491–1496.
.
372. McIntoshSJ,LawsonJ,KennyRA.Clinicalcharacteristicsofvasodepressor,car- . 397.UngarA,GaliziaG,MorrioneA,MussiC,NoroG,GhirelliL,MasottiG,Rengo
.
dioinhibitory, and mixed carotid sinus syndrome in the elderly. Am J Med .. F,MarchionniN,AbeteP.Two-yearmorbidityandmortalityinelderlypatients
1993;95:203–208. .. withsyncope.AgeAgeing2011;40:696–702.
.
373. UngarA,MussiC,DelRossoA,NoroG,AbeteP,GhirelliL,CellaiT,LandiA, . 398.FinucaneC,O’ConnellMD,FanCW,SavvaGM,SoraghanCJ,NolanH,Cronin
.
SalvioliG,RengoF,MarchionniN,MasottiG,ItalianGroupfortheStudyof . H,KennyRA.Age-relatednormativechangesinphasicorthostaticbloodpres- .
Syncope in the Elderly. Diagnosis and characteristics of syncope in older .. sureinalargepopulationstudy:findingsfromTheIrishLongitudinalStudyon
patientsreferredtogeriatricdepartments.JAmGeriatrSoc2006;54:1531–1536. .. Ageing(TILDA).Circulation2014;130:1780–1789.
.
374. Galizia G, Abete P, Mussi C, Noro G, Morrione A, Langellotto A, Landi A, . 399.DiMario FJ Jr. Prospective study of children with cyanotic and pallid breath-
. CacciatoreF,MasottiG,RengoF,MarchionniN,UngarA.Roleofearlysymp- .. holdingspells.Pediatrics2001;107:265–269.
tomsinassessmentofsyncopeinelderlypeople:resultsfromtheItaliangroup .. 400.VlahosAP,KolettisTM.Familyhistoryofchildrenandadolescentswithneuro-
.
forthestudyofsyncopeintheelderly.JAmGeriatrSoc2009;57:18–23. . cardiogenicsyncope.PediatrCardiol2008;29:227. .
375. RommeJJ,vanDijkN,BoerKR,DekkerLR,StamJ,ReitsmaJB,WielingW. . 401.VlahosAP,TzoufiM,KatsourasCS,BarkaT,SiontiI,MichalisLK,Siamopoulou
.
Influenceofageandgenderontheoccurrenceandpresentationofreflexsyn- .. A, Kolettis TM. Provocation of neurocardiogenic syncope duringhead-up tilt
cope.ClinAutonRes2008;18:127–133. .. testing in children: comparison between isoproterenol and nitroglycerin.
.
376. Bhangu JS, King-Kallimanis B, Cunningham C, Kenny RA. The relationship . Pediatrics2007;119:e419–425.
.
between syncope, depression and anti-depressant use in older adults. Age .. 402.McLeodKA,WilsonN,HewittJ,NorrieJ,StephensonJB.Cardiacpacingfor
Ageing2014;43:502–509. .. severechildhoodneurallymediatedsyncopewithreflexanoxicseizures.Heart
.
377. JansenS,FrewenJ,FinucaneC,deRooijSE,vanderVeldeN,KennyRA.AFis . 1999;82:721–725.
.
associatedwithself-reportedsyncopeandfallsinageneralpopulationcohort. . 403.RajV,RoweAA,FleischSB,ParanjapeSY,ArainAM,NicolsonSE.Psychogenic
.
AgeAgeing2015;44:598–603. .. pseudosyncope:diagnosisandmanagement.AutonNeurosci2014;184:66–72.
378. JansenS,KennyRA,deRooijSE,vanderVeldeN.Self-reportedcardiovascular .. 404.LaFranceWCJr,ReuberM,GoldsteinLH.Managementofpsychogenicnonepi-
.
conditionsareassociatedwithfallsandsyncopeincommunity-dwellingolder . lepticseizures.Epilepsia2013;54:53–67.
.
adults.AgeAgeing2015;44:525–529. . 405.SaalDP,OverdijkMJ,ThijsRD,vanVlietIM,vanDijkJG.Long-termfollow-up
.
379. AronowWS.Heartdiseaseandaging.MedClinNorthAm2006;90:849–862. .. ofpsychogenicpseudosyncope.Neurology2016;87:2214–2219.
380. Jansen S, Bhangu J, de Rooij S, Daams J, Kenny RA, van der Velde N. The .. 406.LaFrance WC Jr, Baird GL, Barry JJ, Blum AS, Frank Webb A, Keitner GI,
.
Association of Cardiovascular Disorders and Falls: a systematic review. J Am . MachanJT,MillerI,SzaflarskiJP,NESTreatmentTrial(NEST-T)Consortium.
.
MedDirAssoc2016;17:193–199. .. Multicenter pilot treatment trial for psychogenic nonepileptic seizures: a
381. van der Velde N, van den Meiracker AH, Pols HA, Stricker BH, van der .. randomizedclinicaltrial.JAMAPsychiatry2014;71:997–1005.
.
CammenTJ.Withdrawaloffall-risk-increasingdrugsinolderpersons:effecton . 407.BenbadisSR,ChichkovaR.Psychogenicpseudosyncope:anunderestimatedand
.
tilt-tabletestoutcomes.JAmGeriatrSoc2007;55:734–739. . provablediagnosis.EpilepsyBehav2006;9:106–110.
.
382. Ruwald MH, Hansen ML, Lamberts M, Hansen CM, Nume AK, Vinther M, .. 408.Jecmenica-Lukic M, Poewe W, Tolosa E, Wenning GK. Premotor signs and
KoberL,Torp-PedersenC,HansenJ,GislasonGH.Comparisonofincidence, . symptomsofmultiplesystematrophy.LancetNeurol2012;11:361–368.
Downloaded
from
https://academic.oup.com/eurheartj/article/39/21/1883/4939241
by
guest
on
22
January
2026
--- Страница 69 ---
ESCGuidelines 1948c
.
409. SiderowfA,LangAE.PremotorParkinson’sdisease:conceptsanddefinitions. .. 426.Thijs RD, Kruit MC, van Buchem MA, Ferrari MD, Launer LJ, van Dijk JG.
.
MovDisord2012;27:608–616. . Syncope in migraine: the population-based CAMERA study. Neurology
.
410. Hoefnagels WA, Padberg GW, Overweg J, van der Velde EA, Roos RA. . 2006;66:1034–1037.
.
Transientlossofconsciousness:thevalueofthehistoryfordistinguishingseiz- .. 427.OvereemS,vanNuesSJ,vanderZandeWL,DonjacourCE,vanMierloP,Lammers
.
urefromsyncope.JNeurol1991;238:39–43. . GJ.Theclinicalfeaturesofcataplexy:aquestionnairestudyinnarcolepsypatients
.
411. Benbadis SR, Wolgamuth BR, Goren H, Brener S, Fouad-Tarazi F. Value of . withandwithouthypocretin-1deficiency.SleepMed2011;12:12–18.
.
tonguebitinginthediagnosisofseizures.ArchInternMed1995;155:2346–2349. .. 428.StevensDL,MatthewsWB.Cryptogenicdropattacks:anafflictionofwomen.
412. vanderLendeM,SurgesR,SanderJW,ThijsRD.Cardiacarrhythmiasduringor .. BrMedJ1973;1:439–442.
.
afterepilepticseizures.JNeurolNeurosurgPsychiatry2016;87:69–74. . 429.FanciulliA,IndelicatoE,WenningGK.Autonomichistorytakingandkeysymp-
.
413. Rugg-Gunn FJ, Simister RJ, Squirrell M, Holdright DR, Duncan JS. Cardiac . toms:whereistheautonomicdisease?In:AFanciullietal(eds).BedsideApproach
.
arrhythmias in focal epilepsy: a prospective long-term study. Lancet .. toAutonomicDisordersAClinicalTutor.Cham:SpringerVerlag;2017,15–36.
2004;364:2212–2219. .. 430.AbubakrA,WambacqI.ThediagnosticvalueofEEGsinpatientswithsyncope.
.
414. BendittDG,vanDijkG,ThijsRD.Ictalasystole:life-threateningvagalstormor . EpilepsyBehav2005;6:433–434.
.
a benign seizure self-termination mechanism? Circ Arrhythm Electrophysiol .. 431.FreemanR.Clinicalpractice.Neurogenicorthostatichypotension.NEnglJMed
2015;8:11–14. .. 2008;358:615–624.
.
415. RocamoraR,KurthenM,LickfettL,VonOertzenJ,ElgerCE.Cardiacasystolein . 432.LucchinettiCF,KimmelDW,LennonVA.Paraneoplasticandoncologicprofiles
. epilepsy:clinicalandneurophysiologicfeatures.Epilepsia2003;44:179–185. . of patients seropositive for type 1 antineuronal nuclear autoantibodies.
.
416. Schuele SU, BermeoAC, AlexopoulosAV,LocatelliER, Burgess RC, Dinner .. Neurology1998;50:652–657.
DS,Foldvary-SchaeferN.Video-electrographicandclinicalfeaturesinpatients .. 433.Vernino S, Low PA, Fealey RD, Stewart JD, Farrugia G, Lennon VA.
.
withictalasystole.Neurology2007;69:434–441. . Autoantibodiestoganglionicacetylcholinereceptorsinautoimmuneautonomic
.
417. GhearingGR,MungerTM,JaffeAS,BenarrochEE,BrittonJW.Clinicalcuesfor . neuropathies.NEnglJMed2000;343:847–855.
.
detectingictalasystole.ClinAutonRes2007;17:221–226. .. 434.McKeonA,LennonVA,LachanceDH,FealeyRD,PittockSJ.Ganglionicacetyl-
418. BestawrosM,DarbarD,ArainA,Abou-KhalilB,PlummerD,DupontWD,Raj .. choline receptor autoantibody: oncological, neurological, and serological
. SR. Ictal asystole and ictal syncope: insights into clinical management. Circ . accompaniments.ArchNeurol2009;66:735–741.
.
ArrhythmElectrophysiol2015;8:159–164. .. 435.Dantas FG, Cavalcanti AP, Rodrigues Maciel BD, Ribeiro CD, Napy Charara
419. Lamberts RJ, Thijs RD, Laffan A, Langan Y, Sander JW. Sudden unexpected .. GC,LopesJM,MartinsFilhoPF,JuniorLA.TheroleofEEGinpatientswithsyn-
.
death in epilepsy: people with nocturnal seizures may be at highest risk. . cope.JClinNeurophysiol2012;29:55–57.
.
Epilepsia2012;53:253–257. . 436.KapoorWN,KarpfM,MaherY,MillerRA,LeveyGS.Syncopeofunknownori-
.
420. LambertsRJ,BlomMT,WassenaarM,BardaiA,LeijtenFS,deHaanGJ,Sander .. gin. The need for a more cost-effective approach to its diagnosis evaluation.
JW, Thijs RD, Tan HL. Sudden cardiac arrest in people with epilepsy in the .. JAMA1982;247:2687–2691.
.
community:Circumstancesandriskfactors.Neurology2015;85:212–218. . 437.Farwell DJ, Sulke AN. Does the use of a syncope diagnostic protocol
.
421. HorrocksIA,NechayA,StephensonJB,ZuberiSM.Anoxic-epilepticseizures: . improve the investigation and management of syncope? Heart 2004;90:
.
observational study of epileptic seizures induced by syncopes. Arch Dis Child .. 52–58.
.
2005;90:1283–1287. . 438.MenduML,McAvayG,LampertR,StoehrJ,TinettiME.Yieldofdiagnostictests
.
422. HennericiM,KlemmC,RautenbergW.Thesubclavianstealphenomenon:acom- . in evaluating syncopal episodes in older patients. Arch Intern Med
.
monvasculardisorderwithrareneurologicdeficits.Neurology1988;38:669–673. .. 2009;169:1299–1305.
423. Melgar MA, Weinand ME. Thyrocervical trunk-external carotid artery bypass .. 439.SchnipperJL,AckermanRH,KrierJB,HonourM.Diagnosticyieldandutilityof
.
for positional cerebral ischemia due to common carotid artery occlusion. . neurovascularultrasonographyintheevaluationofpatientswithsyncope.Mayo
.
Reportofthreecases.NeurosurgFocus2003;14:e7. . ClinProc2005;80:480–488.
.
424. DobkinBH.Orthostatichypotensionasariskfactorforsymptomaticocclusive .. 440.Kadian-DodovD,PapolosA,OlinJW.Diagnosticutilityofcarotidarteryduplex
cerebrovasculardisease.Neurology1989;39:30–34. .. ultrasonography in the evaluation of syncope: a good test ordered for the
.
425. SavitzSI,CaplanLR.Vertebrobasilardisease.NEnglJMed2005;352:2618–2626. wrongreason.EurHeartJCardiovascImaging2015;16:621–625.
Downloaded
from
https://academic.oup.com/eurheartj/article/39/21/1883/4939241
by
guest
on
22
January
2026
--- Страница 70 ---
Delivering to 20+ European Countries.
To deliver the best
patient care, you
FREE CASE ANY LITTMANN® CARD IV
need the tools add code at the checkout to apply
FREECASE
to match.
SHOP NOW
™
Littmann® Cardiology IV
& Littmann® CORE Digital
Stethoscopes
LITTMANN
RATING
9/10
Keep your tools safe
with laser engraving.
LITTMANN
RATING
10+
♥☺♫★♠
FREE CASE ANY LITTMANN® CORE
add code at the checkout to apply
FREECASE
SHOP NOW
